Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_007294.4(BRCA1):c.*1363A>T	BRCA1		not specified	Uncertain significance(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000438907	17	41196332	17	43044315	438907	432889	rs1332532415	NC_000017.11:43044314:T:A
NM_007294.4(BRCA1):c.*1358A>G	BRCA1		not specified	Uncertain significance(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV001336623	17	41196337	17	43044320	1336623	1327634		NC_000017.11:43044319:T:C
NM_007294.4(BRCA1):c.*1336A>G	BRCA1		not specified	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV001336422	17	41196359	17	43044342	1336422	1327433		NC_000017.11:43044341:T:C
NM_007294.4(BRCA1):c.*1332G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	VCV000209232	17	41196363	17	43044346	209232	206190	rs8176320	NC_000017.11:43044345:C:T
NM_007294.4(BRCA1):c.*1327G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Sep 28, 2016)	reviewed by expert panel	VCV000264789	17	41196368	17	43044351	264789	259533	rs184237074	NC_000017.11:43044350:C:T
NM_007294.4(BRCA1):c.*1323A>G	BRCA1		Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000323408	17	41196372	17	43044355	323408	338560	rs189382442	NC_000017.11:43044354:T:C
NM_007294.4(BRCA1):c.*1292T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000323409	17	41196403	17	43044386	323409	338571	rs182218567	NC_000017.11:43044385:A:G
NM_007294.4(BRCA1):c.*1287C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	VCV000132777	17	41196408	17	43044391	132777	136525	rs12516	NC_000017.11:43044390:G:A
NM_007294.4(BRCA1):c.*1286C>T	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Oct 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000371821	17	41196409	17	43044392	371821	358925	rs548275991	NC_000017.11:43044391:G:A
NM_007294.4(BRCA1):c.*1285C>A	BRCA1		Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000323410	17	41196410	17	43044393	323410	328613	rs757676381	NC_000017.11:43044392:G:T
NM_007294.4(BRCA1):c.*1281C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000888573	17	41196414	17	43044397	888573	877636	rs975464399	NC_000017.11:43044396:G:A
NM_007294.4(BRCA1):c.*1271T>C	BRCA1		Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000441519	17	41196424	17	43044407	441519	435101	rs1555574034	NC_000017.11:43044406:A:G
NM_007294.4(BRCA1):c.*1186A>G	BRCA1		not specified	Uncertain significance(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV001336800	17	41196509	17	43044492	1336800	1327811		NC_000017.11:43044491:T:C
NM_007294.4(BRCA1):c.*1139G>A	BRCA1		Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 10, 2022)	criteria provided, single submitter	VCV001692954	17	41196556	17	43044539	1692954	1685394		NC_000017.11:43044538:C:T
NM_007294.4(BRCA1):c.*1139G>T	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Oct 24, 2022)	criteria provided, single submitter	VCV001118010	17	41196556	17	43044539	1118010	1104863		NC_000017.11:43044538:C:A
NM_007294.4(BRCA1):c.*1113G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	VCV000209233	17	41196582	17	43044565	209233	206191	rs111791349	NC_000017.11:43044564:C:T
NM_007294.4(BRCA1):c.*1086A>C	BRCA1		not specified	Uncertain significance(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV001337395	17	41196609	17	43044592	1337395	1328404		NC_000017.11:43044591:T:G
NM_007294.4(BRCA1):c.*954A>C	BRCA1		not specified	Uncertain significance(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV001336919	17	41196741	17	43044724	1336919	1327930		NC_000017.11:43044723:T:G
NM_007294.4(BRCA1):c.*928C>T	BRCA1		not specified	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV001336748	17	41196767	17	43044750	1336748	1327759		NC_000017.11:43044749:G:A
NM_007294.4(BRCA1):c.*859A>C	BRCA1		not specified	Uncertain significance(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV001336739	17	41196836	17	43044819	1336739	1327750		NC_000017.11:43044818:T:G
NM_007294.4(BRCA1):c.*800T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000548794	17	41196895	17	43044878	548794	539357	rs1555574136	NC_000017.11:43044877:A:G
NM_007294.4(BRCA1):c.*781C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	VCV000132778	17	41196914	17	43044897	132778	136526	rs8176319	NC_000017.11:43044896:G:A
NM_007294.4(BRCA1):c.*750A>G	BRCA1		not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	Benign/Likely benign(Last reviewed: Dec 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000323414	17	41196945	17	43044928	323414	344643	rs138782023	NC_000017.11:43044927:T:C
NM_007294.4(BRCA1):c.*743G>T	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000323415	17	41196952	17	43044935	323415	346058	rs886052971	NC_000017.11:43044934:C:A
NM_007294.4(BRCA1):c.*713C>T	BRCA1		not specified	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV001337343	17	41196982	17	43044965	1337343	1328352		NC_000017.11:43044964:G:A
NM_007294.4(BRCA1):c.*693C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000323416	17	41197002	17	43044985	323416	346059	rs540031582	NC_000017.11:43044984:G:A
NM_007294.4(BRCA1):c.*685C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000890274	17	41197010	17	43044993	890274	877637	rs952941718	NC_000017.11:43044992:G:C
NM_007294.4(BRCA1):c.*683C>G	BRCA1		not specified	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV001337128	17	41197012	17	43044995	1337128	1328138		NC_000017.11:43044994:G:C
NM_007294.4(BRCA1):c.*595G>A	BRCA1		not specified	Uncertain significance(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001337626	17	41197100	17	43045083	1337626	1328635		NC_000017.11:43045082:C:T
NM_007294.4(BRCA1):c.*548G>C	BRCA1		not specified	Uncertain significance(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV001337425	17	41197147	17	43045130	1337425	1328434		NC_000017.11:43045129:C:G
NM_007294.4(BRCA1):c.*528G>C	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV000415550	17	41197167	17	43045150	415550	401933	rs1060504556	NC_000017.11:43045149:C:G
NM_007294.4(BRCA1):c.*485G>A	BRCA1		not specified|Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Apr 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000323417	17	41197210	17	43045193	323417	328615	rs527725740	NC_000017.11:43045192:C:T
NM_007294.4(BRCA1):c.*482T>G	BRCA1		not specified	Uncertain significance(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV001336673	17	41197213	17	43045196	1336673	1327684		NC_000017.11:43045195:A:C
NM_007294.4(BRCA1):c.*465G>A	BRCA1		not specified|Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Jul 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000323418	17	41197230	17	43045213	323418	344644	rs886052972	NC_000017.11:43045212:C:T
NM_007294.4(BRCA1):c.*421G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	VCV000209234	17	41197274	17	43045257	209234	206192	rs8176318	NC_000017.11:43045256:C:A
NM_007294.4(BRCA1):c.*387T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000323419	17	41197308	17	43045291	323419	328618	rs886052973	NC_000017.11:43045290:A:C
NM_007294.4(BRCA1):c.*306C>G	BRCA1		not specified	Uncertain significance(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV001336445	17	41197389	17	43045372	1336445	1327456		NC_000017.11:43045371:G:C
NM_007294.4(BRCA1):c.*291C>T	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Apr 20, 2022)	criteria provided, single submitter	VCV000240767	17	41197404	17	43045387	240767	242753	rs878854928	NC_000017.11:43045386:G:A
NM_007294.4(BRCA1):c.*272A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000890840	17	41197423	17	43045406	890840	877638	rs8176317	NC_000017.11:43045405:T:C
NM_007294.4(BRCA1):c.*265G>A	BRCA1		not specified	Uncertain significance(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV001337397	17	41197430	17	43045413	1337397	1328406		NC_000017.11:43045412:C:T
NM_007294.4(BRCA1):c.*228A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	VCV000209235	17	41197467	17	43045450	209235	206193	rs56108540	NC_000017.11:43045449:T:C
NM_007294.4(BRCA1):c.*186G>A	BRCA1		not specified	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV001336952	17	41197509	17	43045492	1336952	1327962		NC_000017.11:43045491:C:T
NM_007294.4(BRCA1):c.*136C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Mar 27, 2020)	criteria provided, single submitter	VCV001803223	17	41197559	17	43045542	1803223	1860252		NC_000017.11:43045541:G:C
NM_007294.4(BRCA1):c.*106C>T	BRCA1		Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 2, 2021)	criteria provided, single submitter	VCV001332042	17	41197589	17	43045572	1332042	1322762		NC_000017.11:43045571:G:A
NM_007294.4(BRCA1):c.*106C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000125875	17	41197589	17	43045572	125875	131413	rs189442183	NC_000017.11:43045571:G:C
NM_007294.4(BRCA1):c.*105T>C	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 18, 2021)	criteria provided, single submitter	VCV001332352	17	41197590	17	43045573	1332352	1323070		NC_000017.11:43045572:A:G
NM_007294.4(BRCA1):c.*58C>G	BRCA1		Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 30, 2021)	criteria provided, single submitter	VCV001692955	17	41197637	17	43045620	1692955	1685395		NC_000017.11:43045619:G:C
NM_007294.4(BRCA1):c.*58C>T	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Dec 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000220816	17	41197637	17	43045620	220816	222644	rs137892861	NC_000017.11:43045619:G:A
NM_007294.4(BRCA1):c.*42T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Jun 22, 1999)	no assertion criteria provided	VCV000125872	17	41197653	17	43045636	125872	131410	rs273902777	NC_000017.11:43045635:A:T
NM_007294.4(BRCA1):c.*36C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	VCV000125873	17	41197659	17	43045642	125873	131411	rs3092995	NC_000017.11:43045641:G:C
NM_007294.4(BRCA1):c.*22G>C	BRCA1		not specified	Likely benign(Last reviewed: Oct 12, 2021)	no assertion criteria provided	VCV001697598	17	41197673	17	43045656	1697598	1689982		NC_000017.11:43045655:C:G
NM_007294.4(BRCA1):c.*20C>T	BRCA1		Hereditary cancer-predisposing syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2022)	criteria provided, conflicting interpretations	VCV000182099	17	41197675	17	43045658	182099	180810	rs375042815	NC_000017.11:43045657:G:A
NM_007294.4(BRCA1):c.*14C>G	BRCA1		not specified	Uncertain significance(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000422987	17	41197681	17	43045664	422987	409938	rs1064796142	NC_000017.11:43045663:G:C
NM_007294.4(BRCA1):c.*13A>G	BRCA1		Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000491024	17	41197682	17	43045665	491024	484988	rs762552027	NC_000017.11:43045664:T:C
NM_007294.4(BRCA1):c.*7C>G	BRCA1		Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000923111	17	41197688	17	43045671	923111	913856	rs2050851767	NC_000017.11:43045670:G:C
NM_007294.4(BRCA1):c.*4C>T	BRCA1		Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 3, 2020)	criteria provided, conflicting interpretations	VCV000377575	17	41197691	17	43045674	377575	375952	rs1057520246	NC_000017.11:43045673:G:A
NM_007294.4(BRCA1):c.*3G>T	BRCA1		not specified	Likely benign(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000383136	17	41197692	17	43045675	383136	378216	rs1057521525	NC_000017.11:43045674:C:A
NM_007294.4(BRCA1):c.*1C>T	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000141903	17	41197694	17	43045677	141903	151617	rs587782097	NC_000017.11:43045676:G:A
NM_007294.4(BRCA1):c.5592A>G (p.Ter1864Trp)	BRCA1		Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Sep 22, 2022)	criteria provided, single submitter	VCV001506762	17	41197695	17	43045678	1506762	1426822		NC_000017.11:43045677:T:C
NM_007294.4(BRCA1):c.5591G>A (p.Ter1864=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000924118	17	41197696	17	43045679	924118	913857	rs2050852399	NC_000017.11:43045678:C:T
NM_007294.4(BRCA1):c.5588A>G (p.Tyr1863Cys)	BRCA1	Y1863C, Y1884C, Y1816C, Y759C, Y1566C, Y1694C, Y1736C, Y1774C, Y1775C, Y1792C, Y1835C, Y1836C, Y1844C, Y1885C, Y632C, Y678C, Y693C, Y713C, Y719C, Y733C, Y734C, Y735C, Y994C, Y1567C, Y1709C, Y1735C, Y1752C, Y1793C, Y1795C, Y1796C, Y1821C, Y1883C, Y650C, Y651C, Y672C, Y680C, Y688C, Y692C, Y712C, Y715C, Y718C, Y720C, Y760C, Y782C, Y1751C, Y1779C, Y1814C, Y1815C, Y1819C, Y1820C, Y1837C, Y1843C, Y1859C, Y1860C, Y1861C, Y583C, Y592C, Y646C, Y647C, Y670C, Y671C, Y690C, Y711C, Y717C, Y756C, Y757C, Y1734C, Y1750C, Y1773C, Y1791C, Y1794C, Y1822C, Y1858C, Y1862C, Y451C, Y633C, Y689C, Y721C, Y758C, Y781C, Y995C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000631316	17	41197699	17	43045682	631316	618547	rs1567756242	NC_000017.11:43045681:T:C
NM_007294.4(BRCA1):c.5587T>G (p.Tyr1863Asp)	BRCA1	Y1863D, Y759D, Y1816D, Y1884D, Y1566D, Y1694D, Y1709D, Y1734D, Y1774D, Y1779D, Y1796D, Y1815D, Y1820D, Y1883D, Y671D, Y680D, Y688D, Y692D, Y712D, Y719D, Y720D, Y758D, Y1736D, Y1750D, Y1752D, Y1792D, Y1859D, Y1862D, Y646D, Y690D, Y713D, Y715D, Y717D, Y721D, Y735D, Y760D, Y782D, Y994D, Y995D, Y1751D, Y1773D, Y1791D, Y1793D, Y1794D, Y1837D, Y1844D, Y1858D, Y1860D, Y1861D, Y1885D, Y451D, Y592D, Y632D, Y633D, Y647D, Y651D, Y670D, Y672D, Y711D, Y734D, Y756D, Y781D, Y1567D, Y1735D, Y1775D, Y1795D, Y1814D, Y1819D, Y1821D, Y1822D, Y1835D, Y1836D, Y1843D, Y583D, Y650D, Y678D, Y689D, Y693D, Y718D, Y733D, Y757D	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000231744	17	41197700	17	43045683	231744	235922	rs763740623	NC_000017.11:43045682:A:C
NM_007294.4(BRCA1):c.5586C>G (p.His1862Gln)	BRCA1	H758Q, H1862Q, H1883Q, H1815Q, H1708Q, H1751Q, H1774Q, H1792Q, H1793Q, H1814Q, H1819Q, H1821Q, H1843Q, H1860Q, H1861Q, H645Q, H677Q, H679Q, H717Q, H718Q, H720Q, H756Q, H1566Q, H1733Q, H1734Q, H1749Q, H1750Q, H1790Q, H1795Q, H1813Q, H1834Q, H1836Q, H582Q, H632Q, H649Q, H710Q, H781Q, H994Q, H591Q, H650Q, H689Q, H691Q, H714Q, H734Q, H755Q, H757Q, H759Q, H993Q, H1772Q, H1773Q, H1791Q, H1794Q, H1857Q, H1858Q, H1859Q, H1884Q, H1565Q, H1693Q, H1735Q, H1778Q, H1818Q, H1820Q, H1835Q, H1842Q, H1882Q, H450Q, H631Q, H646Q, H669Q, H670Q, H671Q, H687Q, H688Q, H692Q, H711Q, H712Q, H716Q, H719Q, H732Q, H733Q, H780Q	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001522936	17	41197701	17	43045684	1522936	1460129		NC_000017.11:43045683:G:C
NM_007294.4(BRCA1):c.5586C>T (p.His1862=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000185343	17	41197701	17	43045684	185343	184861	rs774127304	NC_000017.11:43045683:G:A
NM_007294.4(BRCA1):c.5585A>G (p.His1862Arg)	BRCA1	H1862R, H758R, H1815R, H1883R, H1565R, H1750R, H1773R, H1791R, H1818R, H1821R, H1836R, H1859R, H1860R, H1861R, H582R, H649R, H679R, H687R, H688R, H692R, H716R, H718R, H733R, H755R, H756R, H759R, H780R, H1566R, H1708R, H1735R, H1749R, H1790R, H1793R, H1814R, H1819R, H1842R, H1843R, H1858R, H450R, H591R, H645R, H710R, H717R, H781R, H993R, H1733R, H1774R, H1778R, H1794R, H1820R, H1834R, H1857R, H631R, H646R, H650R, H671R, H691R, H712R, H720R, H732R, H734R, H757R, H1693R, H1734R, H1751R, H1772R, H1792R, H1795R, H1813R, H1835R, H1882R, H1884R, H632R, H669R, H670R, H677R, H689R, H711R, H714R, H719R, H994R	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV000462678	17	41197702	17	43045685	462678	467871	rs80357183	NC_000017.11:43045684:T:C
NM_007294.4(BRCA1):c.5585A>T (p.His1862Leu)	BRCA1	H1862L, H1815L, H1883L, H758L, H1708L, H1751L, H1774L, H1790L, H1792L, H1818L, H1819L, H1857L, H1859L, H450L, H582L, H591L, H632L, H645L, H646L, H669L, H688L, H689L, H691L, H711L, H1735L, H1791L, H1821L, H1835L, H1842L, H1843L, H1858L, H1861L, H1884L, H670L, H677L, H687L, H710L, H716L, H717L, H720L, H733L, H734L, H1565L, H1566L, H1693L, H1733L, H1734L, H1750L, H1773L, H1778L, H1793L, H1794L, H1795L, H1814L, H1820L, H1834L, H1836L, H649L, H671L, H712L, H714L, H719L, H755L, H756L, H781L, H993L, H1749L, H1772L, H1813L, H1860L, H1882L, H631L, H650L, H679L, H692L, H718L, H732L, H757L, H759L, H780L, H994L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 15, 2022)	criteria provided, conflicting interpretations	VCV000055637	17	41197702	17	43045685	55637	70304	rs80357183	NC_000017.11:43045684:T:A
NM_007294.4(BRCA1):c.5584C>T (p.His1862Tyr)	BRCA1	H1565Y, H1735Y, H1750Y, H1814Y, H1819Y, H1836Y, H1842Y, H1859Y, H1862Y, H1883Y, H1884Y, H582Y, H591Y, H632Y, H677Y, H710Y, H720Y, H734Y, H755Y, H781Y, H993Y, H1693Y, H1708Y, H1774Y, H1792Y, H1794Y, H1858Y, H1860Y, H1861Y, H631Y, H650Y, H669Y, H670Y, H687Y, H688Y, H716Y, H719Y, H732Y, H756Y, H1566Y, H1751Y, H1772Y, H1773Y, H1793Y, H1813Y, H1815Y, H1821Y, H1834Y, H1835Y, H1882Y, H645Y, H712Y, H717Y, H718Y, H733Y, H758Y, H780Y, H1733Y, H1734Y, H1749Y, H1778Y, H1790Y, H1791Y, H1795Y, H1818Y, H1820Y, H1843Y, H1857Y, H450Y, H646Y, H649Y, H671Y, H679Y, H689Y, H691Y, H692Y, H711Y, H714Y, H757Y, H759Y, H994Y	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 19, 2021)	criteria provided, single submitter	VCV001748439	17	41197703	17	43045686	1748439	1806687		NC_000017.11:43045685:G:A
NM_007294.4(BRCA1):c.5583C>A (p.Ser1861Arg)	BRCA1	S1692R, S1748R, S1773R, S1792R, S1842R, S1859R, S648R, S649R, S691R, S717R, S719R, S731R, S779R, S780R, S1733R, S1771R, S1777R, S1789R, S1812R, S1814R, S1818R, S1833R, S1834R, S1841R, S1856R, S1857R, S1861R, S449R, S631R, S676R, S678R, S690R, S713R, S718R, S993R, S1564R, S1707R, S1732R, S1790R, S1813R, S1817R, S1819R, S1858R, S1881R, S644R, S645R, S670R, S688R, S710R, S711R, S715R, S716R, S733R, S756R, S757R, S758R, S992R, S1565R, S1734R, S1749R, S1750R, S1772R, S1791R, S1793R, S1794R, S1820R, S1835R, S1860R, S1882R, S1883R, S581R, S590R, S630R, S668R, S669R, S686R, S687R, S709R, S732R, S754R, S755R	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jun 27, 2022)	criteria provided, single submitter	VCV002011282	17	41197704	17	43045687	2011282	2074356		NC_000017.11:43045686:G:T
NM_007294.4(BRCA1):c.5582G>A (p.Ser1861Asn)	BRCA1	S1814N, S757N, S1861N, S1882N, S1565N, S1748N, S1773N, S1793N, S1794N, S1812N, S1818N, S1834N, S1881N, S1883N, S449N, S590N, S644N, S648N, S669N, S670N, S687N, S691N, S709N, S732N, S755N, S779N, S1692N, S1707N, S1732N, S1733N, S1750N, S1791N, S1792N, S1819N, S1835N, S1858N, S1860N, S649N, S716N, S719N, S756N, S993N, S1564N, S1771N, S1772N, S1777N, S1790N, S1817N, S1820N, S1833N, S1842N, S1856N, S678N, S688N, S710N, S718N, S733N, S754N, S758N, S1734N, S1749N, S1789N, S1813N, S1841N, S1857N, S1859N, S581N, S630N, S631N, S645N, S668N, S676N, S686N, S690N, S711N, S713N, S715N, S717N, S731N, S780N, S992N	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Sep 16, 2021)	criteria provided, single submitter	VCV001381587	17	41197705	17	43045688	1381587	1496549		NC_000017.11:43045687:C:T
NM_007294.4(BRCA1):c.5580C>A (p.His1860Gln)	BRCA1	H1563Q, H1706Q, H1732Q, H1733Q, H1749Q, H1770Q, H1788Q, H1855Q, H1856Q, H1860Q, H1882Q, H448Q, H630Q, H675Q, H686Q, H710Q, H712Q, H732Q, H756Q, H991Q, H1691Q, H1747Q, H1748Q, H1771Q, H1772Q, H1793Q, H1817Q, H1833Q, H1880Q, H580Q, H589Q, H643Q, H647Q, H668Q, H677Q, H685Q, H689Q, H690Q, H708Q, H714Q, H716Q, H718Q, H778Q, H731Q, H755Q, H757Q, H992Q, H1564Q, H1731Q, H1776Q, H1789Q, H1791Q, H1811Q, H1818Q, H1819Q, H1840Q, H1841Q, H1857Q, H1859Q, H629Q, H644Q, H648Q, H667Q, H669Q, H687Q, H730Q, H1790Q, H1792Q, H1812Q, H1813Q, H1816Q, H1832Q, H1834Q, H1858Q, H1881Q, H709Q, H715Q, H717Q, H753Q, H754Q, H779Q	Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 2, 2021)	criteria provided, single submitter	VCV001748423	17	41197707	17	43045690	1748423	1806671		NC_000017.11:43045689:G:T
NM_007294.4(BRCA1):c.5580C>G (p.His1860Gln)	BRCA1	H1813Q, H756Q, H1860Q, H1881Q, H1706Q, H1770Q, H1792Q, H1818Q, H1819Q, H1857Q, H1858Q, H1882Q, H448Q, H669Q, H685Q, H689Q, H712Q, H716Q, H718Q, H753Q, H754Q, H779Q, H1563Q, H1748Q, H1749Q, H1790Q, H1791Q, H1812Q, H1816Q, H1832Q, H589Q, H644Q, H648Q, H675Q, H690Q, H710Q, H715Q, H731Q, H732Q, H755Q, H991Q, H1731Q, H1733Q, H1747Q, H1771Q, H1776Q, H1789Q, H1811Q, H1840Q, H1841Q, H1855Q, H1856Q, H1859Q, H580Q, H630Q, H647Q, H668Q, H677Q, H687Q, H708Q, H730Q, H778Q, H992Q, H1564Q, H1691Q, H1732Q, H1772Q, H1788Q, H1793Q, H1817Q, H1833Q, H1834Q, H1880Q, H629Q, H643Q, H667Q, H686Q, H709Q, H714Q, H717Q, H757Q	not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Aug 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000803401	17	41197707	17	43045690	803401	791755	rs1597796507	NC_000017.11:43045689:G:C
NM_007294.4(BRCA1):c.5579A>C (p.His1860Pro)	BRCA1	H1860P, H1881P, H756P, H1813P, H1748P, H1771P, H1789P, H1812P, H1818P, H1857P, H1859P, H643P, H644P, H669P, H675P, H685P, H686P, H689P, H710P, H714P, H715P, H730P, H731P, H755P, H779P, H991P, H1706P, H1731P, H1732P, H1772P, H1790P, H1793P, H1811P, H1833P, H1840P, H1882P, H448P, H580P, H668P, H690P, H753P, H757P, H778P, H1563P, H1733P, H1749P, H1770P, H1788P, H1832P, H1841P, H1855P, H1858P, H1880P, H629P, H647P, H648P, H687P, H712P, H716P, H717P, H718P, H754P, H1564P, H1691P, H1747P, H1776P, H1791P, H1792P, H1816P, H1817P, H1819P, H1834P, H1856P, H589P, H630P, H667P, H677P, H708P, H709P, H732P, H992P	not provided	Benign(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000041833	17	41197708	17	43045691	41833	50272	rs201196020	NC_000017.11:43045690:T:G
NM_007294.4(BRCA1):c.5578C>A (p.His1860Asn)	BRCA1	H1818N, H1819N, H1832N, H1833N, H1834N, H1840N, H1841N, H1855N, H1856N, H1857N, H1858N, H1859N, H1860N, H1880N, H1881N, H1882N, H448N, H580N, H589N, H629N, H630N, H643N, H644N, H647N, H648N, H667N, H668N, H669N, H675N, H677N, H685N, H686N, H687N, H689N, H690N, H708N, H709N, H710N, H712N, H714N, H715N, H716N, H717N, H718N, H730N, H731N, H732N, H753N, H754N, H755N, H756N, H757N, H778N, H779N, H991N, H992N, H1563N, H1564N, H1691N, H1706N, H1731N, H1732N, H1733N, H1747N, H1748N, H1749N, H1770N, H1771N, H1772N, H1776N, H1788N, H1789N, H1790N, H1791N, H1792N, H1793N, H1811N, H1812N, H1813N, H1816N, H1817N	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 3, 2022)	criteria provided, single submitter	VCV001714923	17	41197709	17	43045692	1714923	1777924		NC_000017.11:43045691:G:T
NM_007294.4(BRCA1):c.5577C>T (p.Pro1859=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: May 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV001748394	17	41197710	17	43045693	1748394	1806642		NC_000017.11:43045692:G:A
NM_007294.4(BRCA1):c.5576C>T (p.Pro1859Leu)	BRCA1	P1769L, P1790L, P1816L, P1831L, P1855L, P1859L, P579L, P628L, P647L, P666L, P667L, P711L, P715L, P717L, P729L, P730L, P755L, P756L, P991L, P1563L, P1730L, P1732L, P1747L, P1771L, P1775L, P1788L, P1792L, P1817L, P1854L, P1856L, P1881L, P629L, P674L, P686L, P707L, P709L, P731L, P754L, P1690L, P1731L, P1770L, P1787L, P1791L, P1812L, P1815L, P1832L, P1839L, P1880L, P588L, P642L, P676L, P684L, P685L, P688L, P714L, P716L, P753L, P778L, P990L, P1562L, P1705L, P1746L, P1748L, P1789L, P1810L, P1811L, P1818L, P1833L, P1840L, P1857L, P1858L, P1879L, P447L, P643L, P646L, P668L, P689L, P708L, P713L, P752L, P777L	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jul 27, 2022)	criteria provided, single submitter	VCV002090625	17	41197711	17	43045694	2090625	2148429		NC_000017.11:43045693:G:A
NM_007294.4(BRCA1):c.5576C>G (p.Pro1859Arg)	BRCA1	P1859R, P1812R, P755R, P1880R, P1879R, P447R, P579R, P629R, P666R, P676R, P707R, P708R, P713R, P714R, P730R, P756R, P777R, P1732R, P1747R, P1787R, P1788R, P1810R, P1816R, P1839R, P1854R, P588R, P646R, P647R, P667R, P685R, P688R, P709R, P711R, P754R, P991R, P1690R, P1769R, P1770R, P1771R, P1775R, P1789R, P1790R, P1791R, P1818R, P1858R, P642R, P684R, P716R, P717R, P729R, P731R, P753R, P990R, P1562R, P1730R, P1731R, P1748R, P1792R, P1815R, P1817R, P1831R, P1840R, P1855R, P1856R, P1881R, P628R, P643R, P668R, P674R, P686R, P689R, P715R, P752R, P778R, P1563R, P1705R, P1746R, P1811R, P1832R, P1833R, P1857R	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055634	17	41197711	17	43045694	55634	70301	rs80357322	NC_000017.11:43045693:G:C
NM_007294.4(BRCA1):c.5575C>T (p.Pro1859Ser)	BRCA1	P1859S, P1812S, P1880S, P755S, P1563S, P1690S, P1731S, P1747S, P1770S, P1771S, P1788S, P1791S, P1792S, P1833S, P1854S, P1858S, P1879S, P588S, P643S, P668S, P674S, P685S, P707S, P753S, P754S, P777S, P1562S, P1732S, P1769S, P1787S, P1789S, P1790S, P1811S, P1816S, P1832S, P1855S, P1857S, P1881S, P628S, P629S, P642S, P646S, P647S, P676S, P688S, P713S, P716S, P717S, P729S, P778S, P991S, P1705S, P1746S, P1748S, P1775S, P1817S, P1818S, P1856S, P447S, P579S, P666S, P667S, P684S, P686S, P689S, P708S, P709S, P711S, P714S, P730S, P731S, P752S, P756S, P990S, P1730S, P1810S, P1815S, P1831S, P1839S, P1840S, P715S	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Dec 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000462677	17	41197712	17	43045695	462677	468103	rs1555574342	NC_000017.11:43045694:G:A
NM_007294.4(BRCA1):c.5575C>A (p.Pro1859Thr)	BRCA1	P1859T, P1812T, P1880T, P755T, P1705T, P1730T, P1769T, P1790T, P1811T, P1816T, P1818T, P1831T, P1856T, P1857T, P1879T, P588T, P629T, P646T, P647T, P684T, P715T, P730T, P753T, P1563T, P1746T, P1747T, P1787T, P1791T, P1817T, P1833T, P1839T, P1855T, P667T, P688T, P689T, P709T, P731T, P752T, P777T, P991T, P1690T, P1748T, P1789T, P1810T, P1854T, P1881T, P447T, P628T, P642T, P674T, P711T, P713T, P729T, P778T, P990T, P1562T, P1731T, P1732T, P1770T, P1771T, P1775T, P1788T, P1792T, P1815T, P1832T, P1840T, P1858T, P579T, P643T, P666T, P668T, P676T, P685T, P686T, P707T, P708T, P714T, P716T, P717T, P754T, P756T	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: May 10, 2022)	criteria provided, single submitter	VCV000462676	17	41197712	17	43045695	462676	468106	rs1555574342	NC_000017.11:43045694:G:T
NM_007294.4(BRCA1):c.5574C>G (p.Ile1858Met)	BRCA1	I1858M, I1811M, I1879M, I754M, I1561M, I1689M, I1731M, I1788M, I1789M, I1790M, I1817M, I1830M, I1831M, I1853M, I1855M, I1878M, I1880M, I587M, I628M, I645M, I665M, I666M, I687M, I707M, I712M, I714M, I777M, I990M, I1768M, I1786M, I1787M, I1810M, I1832M, I1838M, I1854M, I1856M, I627M, I641M, I667M, I673M, I675M, I688M, I716M, I729M, I751M, I753M, I755M, I1745M, I1770M, I1809M, I1814M, I1815M, I1839M, I1857M, I646M, I683M, I706M, I708M, I710M, I730M, I1562M, I1704M, I1729M, I1730M, I1746M, I1747M, I1769M, I1774M, I1791M, I1816M, I446M, I578M, I642M, I684M, I685M, I713M, I715M, I728M, I752M, I776M, I989M	Hereditary cancer-predisposing syndrome|not provided|not specified|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jan 17, 2023)	criteria provided, multiple submitters, no conflicts	VCV000438943	17	41197713	17	43045696	438943	432890	rs876659941	NC_000017.11:43045695:G:C
NM_007294.4(BRCA1):c.5574C>T (p.Ile1858=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000232711	17	41197713	17	43045696	232711	235923	rs876659941	NC_000017.11:43045695:G:A
NM_007294.4(BRCA1):c.5573T>A (p.Ile1858Asn)	BRCA1	I1811N, I1858N, I1879N, I754N, I1562N, I1731N, I1769N, I1788N, I1830N, I1838N, I628N, I646N, I666N, I667N, I687N, I707N, I714N, I728N, I777N, I1561N, I1704N, I1729N, I1768N, I1770N, I1786N, I1789N, I1816N, I1839N, I1854N, I1857N, I641N, I673N, I710N, I712N, I730N, I755N, I990N, I1689N, I1745N, I1746N, I1787N, I1790N, I1791N, I1810N, I1817N, I1831N, I1853N, I1855N, I1880N, I446N, I683N, I684N, I685N, I708N, I713N, I716N, I729N, I752N, I989N, I1730N, I1747N, I1774N, I1809N, I1814N, I1815N, I1832N, I1856N, I1878N, I578N, I587N, I627N, I642N, I645N, I665N, I675N, I688N, I706N, I715N, I751N, I753N, I776N	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV000851795	17	41197714	17	43045697	851795	845357	rs755427809	NC_000017.11:43045696:A:T
NM_007294.4(BRCA1):c.5573T>C (p.Ile1858Thr)	BRCA1	I1858T, I754T, I1879T, I1811T, I1704T, I1814T, I1830T, I1831T, I1832T, I1838T, I1857T, I446T, I578T, I587T, I641T, I673T, I683T, I685T, I688T, I706T, I707T, I712T, I729T, I753T, I755T, I1561T, I1562T, I1689T, I1731T, I1774T, I1786T, I1816T, I1817T, I1854T, I1856T, I1880T, I642T, I666T, I667T, I687T, I714T, I728T, I751T, I989T, I1730T, I1768T, I1769T, I1770T, I1787T, I1788T, I1790T, I1809T, I1815T, I1839T, I1853T, I1855T, I1878T, I665T, I684T, I710T, I715T, I730T, I776T, I777T, I1729T, I1745T, I1746T, I1747T, I1789T, I1791T, I1810T, I627T, I628T, I645T, I646T, I675T, I708T, I713T, I716T, I752T, I990T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2022)	criteria provided, conflicting interpretations	VCV000186496	17	41197714	17	43045697	186496	184863	rs755427809	NC_000017.11:43045696:A:G
NM_007294.4(BRCA1):c.5572A>T (p.Ile1858Phe)	BRCA1	I1858F, I1811F, I1879F, I754F, I1704F, I1731F, I1774F, I1786F, I1809F, I1814F, I1832F, I1853F, I628F, I665F, I666F, I706F, I712F, I716F, I730F, I751F, I755F, I989F, I990F, I1561F, I1562F, I1689F, I1729F, I1730F, I1747F, I1769F, I1770F, I1788F, I1816F, I1838F, I1857F, I446F, I587F, I627F, I645F, I667F, I708F, I728F, I729F, I753F, I685F, I687F, I688F, I710F, I713F, I714F, I715F, I776F, I777F, I1787F, I1791F, I1810F, I1817F, I1854F, I1856F, I1878F, I1880F, I641F, I642F, I683F, I684F, I1745F, I1746F, I1768F, I1789F, I1790F, I1815F, I1830F, I1831F, I1839F, I1855F, I578F, I646F, I673F, I675F, I707F, I752F	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Feb 2, 2022)	criteria provided, single submitter	VCV000409352	17	41197715	17	43045698	409352	402454	rs765656957	NC_000017.11:43045697:T:A
NM_007294.4(BRCA1):c.5572A>C (p.Ile1858Leu)	BRCA1	I1858L, I1879L, I1811L, I754L, I1561L, I1562L, I1730L, I1745L, I1786L, I1789L, I1830L, I1831L, I1856L, I1857L, I1880L, I578L, I666L, I675L, I685L, I688L, I713L, I716L, I729L, I753L, I777L, I989L, I1689L, I1731L, I1747L, I1774L, I1788L, I1809L, I1810L, I1814L, I1832L, I1838L, I1839L, I446L, I628L, I645L, I667L, I673L, I687L, I706L, I707L, I708L, I715L, I751L, I752L, I776L, I642L, I683L, I710L, I714L, I728L, I755L, I1704L, I1787L, I1815L, I1817L, I1853L, I1854L, I1878L, I1729L, I1746L, I1768L, I1769L, I1770L, I1790L, I1791L, I1816L, I1855L, I587L, I627L, I641L, I646L, I665L, I684L, I712L, I730L, I990L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000183951	17	41197715	17	43045698	183951	184864	rs765656957	NC_000017.11:43045697:T:G
NM_007294.4(BRCA1):c.5571G>T (p.Gln1857His)	BRCA1	Q1857H, Q753H, Q1878H, Q1810H, Q1744H, Q1785H, Q1787H, Q1829H, Q586H, Q641H, Q664H, Q674H, Q682H, Q705H, Q714H, Q729H, Q988H, Q989H, Q1561H, Q1688H, Q1729H, Q1767H, Q1789H, Q1809H, Q1813H, Q1816H, Q1830H, Q1831H, Q577H, Q640H, Q644H, Q672H, Q687H, Q712H, Q713H, Q754H, Q776H, Q1560H, Q1703H, Q1746H, Q1769H, Q1788H, Q1790H, Q1815H, Q1852H, Q1853H, Q1855H, Q1879H, Q626H, Q666H, Q683H, Q707H, Q709H, Q711H, Q727H, Q751H, Q752H, Q775H, Q1728H, Q1730H, Q1745H, Q1768H, Q1773H, Q1786H, Q1808H, Q1814H, Q1837H, Q1838H, Q1854H, Q1856H, Q1877H, Q445H, Q627H, Q645H, Q665H, Q684H, Q686H, Q706H, Q715H, Q728H, Q750H	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jan 3, 2023)	criteria provided, multiple submitters, no conflicts	VCV000246518	17	41197716	17	43045699	246518	245017	rs28897699	NC_000017.11:43045698:C:A
NM_007294.4(BRCA1):c.5571G>C (p.Gln1857His)	BRCA1	Q1857H, Q1810H, Q1878H, Q753H, Q1688H, Q1746H, Q1785H, Q1786H, Q1808H, Q1809H, Q1813H, Q1829H, Q1830H, Q1831H, Q1837H, Q445H, Q640H, Q644H, Q645H, Q672H, Q674H, Q683H, Q684H, Q715H, Q776H, Q989H, Q1561H, Q1730H, Q1744H, Q1768H, Q1769H, Q1787H, Q1814H, Q1838H, Q1854H, Q626H, Q664H, Q682H, Q707H, Q714H, Q752H, Q775H, Q1703H, Q1728H, Q1729H, Q1767H, Q1788H, Q1790H, Q1815H, Q1852H, Q1856H, Q1877H, Q577H, Q586H, Q627H, Q641H, Q666H, Q706H, Q709H, Q727H, Q751H, Q754H, Q1560H, Q1745H, Q1773H, Q1789H, Q1816H, Q1853H, Q1855H, Q1879H, Q665H, Q686H, Q687H, Q705H, Q711H, Q712H, Q713H, Q728H, Q729H, Q750H, Q988H	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 22, 2021)	criteria provided, single submitter	VCV000185265	17	41197716	17	43045699	185265	184865	rs28897699	NC_000017.11:43045698:C:G
NM_007294.4(BRCA1):c.5568C>G (p.Pro1856=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Oct 25, 2021)	criteria provided, single submitter	VCV000415577	17	41197719	17	43045702	415577	402014	rs876659994	NC_000017.11:43045701:G:C
NM_007294.4(BRCA1):c.5568C>A (p.Pro1856=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000232797	17	41197719	17	43045702	232797	235924	rs876659994	NC_000017.11:43045701:G:T
NM_007294.4(BRCA1):c.5567C>T (p.Pro1856Leu)	BRCA1	P1856L, P1877L, P752L, P1809L, P1560L, P1727L, P1766L, P1767L, P1784L, P1785L, P1786L, P1828L, P1830L, P585L, P625L, P626L, P683L, P705L, P706L, P708L, P710L, P712L, P713L, P726L, P750L, P774L, P988L, P1729L, P1743L, P1787L, P1815L, P1837L, P1853L, P1878L, P444L, P639L, P664L, P682L, P685L, P749L, P987L, P1559L, P1702L, P1728L, P1745L, P1768L, P1772L, P1788L, P1808L, P1814L, P1836L, P576L, P643L, P663L, P665L, P673L, P681L, P686L, P711L, P751L, P1687L, P1744L, P1789L, P1807L, P1812L, P1813L, P1829L, P1851L, P1852L, P1854L, P1855L, P1876L, P640L, P644L, P671L, P704L, P714L, P727L, P728L, P753L, P775L	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000921369	17	41197720	17	43045703	921369	913858	rs2050857212	NC_000017.11:43045702:G:A
NM_007294.4(BRCA1):c.5566C>A (p.Pro1856Thr)	BRCA1	P1856T, P1809T, P752T, P1877T, P1559T, P1702T, P1767T, P1768T, P1807T, P1829T, P1830T, P1836T, P1851T, P1854T, P1876T, P585T, P639T, P663T, P664T, P671T, P682T, P686T, P705T, P706T, P708T, P711T, P712T, P713T, P728T, P749T, P774T, P988T, P1744T, P1745T, P1772T, P1784T, P1785T, P1787T, P1788T, P1812T, P1813T, P1814T, P1837T, P1855T, P1878T, P626T, P681T, P704T, P710T, P714T, P751T, P753T, P775T, P1729T, P1766T, P1786T, P1789T, P1828T, P1853T, P576T, P640T, P673T, P683T, P685T, P1560T, P1687T, P1727T, P1728T, P1743T, P1808T, P1815T, P1852T, P444T, P625T, P643T, P644T, P665T, P726T, P727T, P750T, P987T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2022)	criteria provided, conflicting interpretations	VCV000409334	17	41197721	17	43045704	409334	401936	rs80357274	NC_000017.11:43045703:G:T
NM_007294.4(BRCA1):c.5566C>T (p.Pro1856Ser)	BRCA1	P1856S, P1809S, P752S, P1877S, P1727S, P1766S, P1768S, P1785S, P1787S, P1807S, P1830S, P1836S, P1855S, P1876S, P576S, P626S, P644S, P673S, P726S, P727S, P750S, P988S, P1559S, P1687S, P1744S, P1784S, P1786S, P1788S, P1808S, P1812S, P1815S, P1828S, P1837S, P1878S, P665S, P683S, P686S, P704S, P705S, P708S, P712S, P713S, P749S, P751S, P775S, P1728S, P1743S, P1745S, P1789S, P1813S, P1829S, P1851S, P1852S, P1853S, P585S, P625S, P640S, P643S, P664S, P671S, P711S, P753S, P774S, P1560S, P1702S, P1729S, P1767S, P1772S, P1814S, P1854S, P444S, P639S, P663S, P681S, P682S, P685S, P706S, P710S, P714S, P728S, P987S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	Likely benign(Last reviewed: Sep 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000055632	17	41197721	17	43045704	55632	70299	rs80357274	NC_000017.11:43045703:G:A
NM_007294.4(BRCA1):c.5565A>T (p.Ile1855=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869060	17	41197722	17	43045705	869060	853070	rs758449088	NC_000017.11:43045704:T:A
NM_007294.4(BRCA1):c.5565A>G (p.Ile1855Met)	BRCA1	I751M, I1876M, I1808M, I1855M, I1701M, I1726M, I1771M, I1851M, I1854M, I643M, I664M, I681M, I705M, I712M, I713M, I750M, I752M, I1784M, I1786M, I1806M, I1811M, I1828M, I1829M, I1852M, I443M, I638M, I662M, I672M, I680M, I682M, I709M, I727M, I749M, I1559M, I1686M, I1727M, I1765M, I1766M, I1767M, I1807M, I1812M, I1814M, I1827M, I1835M, I1836M, I1877M, I575M, I584M, I625M, I639M, I670M, I685M, I707M, I710M, I711M, I774M, I986M, I1558M, I1728M, I1742M, I1743M, I1744M, I1783M, I1785M, I1787M, I1788M, I1813M, I1850M, I1853M, I1875M, I624M, I642M, I663M, I684M, I703M, I704M, I725M, I726M, I748M, I773M, I987M	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869059	17	41197722	17	43045705	869059	853071	rs758449088	NC_000017.11:43045704:T:C
NM_007294.4(BRCA1):c.5565A>C (p.Ile1855=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427301	17	41197722	17	43045705	427301	416420	rs758449088	NC_000017.11:43045704:T:G
NM_007294.4(BRCA1):c.5564T>G (p.Ile1855Arg)	BRCA1	I751R, I1855R, I1876R, I1808R, I1766R, I1771R, I1784R, I1806R, I1807R, I1811R, I1812R, I1814R, I1835R, I1851R, I1877R, I625R, I662R, I664R, I670R, I681R, I684R, I703R, I707R, I712R, I726R, I727R, I752R, I773R, I986R, I987R, I1686R, I1742R, I1785R, I1787R, I1828R, I1836R, I1853R, I443R, I584R, I710R, I713R, I749R, I1726R, I1743R, I1765R, I1767R, I1788R, I1813R, I1827R, I1850R, I1854R, I638R, I642R, I663R, I682R, I704R, I705R, I709R, I725R, I748R, I1558R, I1559R, I1701R, I1727R, I1728R, I1744R, I1783R, I1786R, I1829R, I1852R, I1875R, I575R, I624R, I639R, I643R, I672R, I680R, I685R, I711R, I750R, I774R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869058	17	41197723	17	43045706	869058	853072	rs900082291	NC_000017.11:43045705:A:C
NM_007294.4(BRCA1):c.5564T>A (p.Ile1855Lys)	BRCA1	I1855K, I1876K, I751K, I1808K, I1686K, I1726K, I1742K, I1767K, I1783K, I1784K, I1786K, I1814K, I1829K, I1850K, I1854K, I575K, I638K, I639K, I663K, I680K, I703K, I707K, I749K, I750K, I752K, I774K, I1558K, I1701K, I1727K, I1771K, I1806K, I1807K, I1827K, I1836K, I1877K, I584K, I625K, I642K, I670K, I681K, I682K, I986K, I1743K, I1744K, I1787K, I1788K, I1812K, I1828K, I1835K, I1852K, I443K, I643K, I662K, I664K, I684K, I704K, I705K, I710K, I711K, I748K, I1559K, I1728K, I1765K, I1766K, I1785K, I1811K, I1813K, I1851K, I1853K, I1875K, I624K, I672K, I685K, I709K, I712K, I713K, I725K, I726K, I727K, I773K, I987K	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868679	17	41197723	17	43045706	868679	853073	rs900082291	NC_000017.11:43045705:A:T
NM_007294.4(BRCA1):c.5564T>C (p.Ile1855Thr)	BRCA1	I1855T, I1808T, I751T, I1876T, I1686T, I1743T, I1744T, I1784T, I1788T, I1835T, I638T, I663T, I670T, I680T, I681T, I703T, I710T, I725T, I750T, I774T, I987T, I1558T, I1727T, I1742T, I1771T, I1786T, I1787T, I1807T, I1813T, I1829T, I1853T, I443T, I624T, I625T, I664T, I682T, I707T, I709T, I713T, I726T, I748T, I749T, I1559T, I1701T, I1765T, I1783T, I1806T, I1811T, I1836T, I1850T, I1851T, I1854T, I1875T, I642T, I643T, I704T, I711T, I712T, I727T, I752T, I986T, I1726T, I1728T, I1766T, I1767T, I1785T, I1812T, I1814T, I1827T, I1828T, I1852T, I1877T, I575T, I584T, I639T, I662T, I672T, I684T, I685T, I705T, I773T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 20, 2021)	criteria provided, conflicting interpretations	VCV000482917	17	41197723	17	43045706	482917	478640	rs900082291	NC_000017.11:43045705:A:G
NM_007294.4(BRCA1):c.5563A>T (p.Ile1855Leu)	BRCA1	I1808L, I1855L, I751L, I1876L, I1727L, I1766L, I1812L, I1814L, I1829L, I1851L, I1853L, I575L, I584L, I639L, I642L, I643L, I681L, I712L, I713L, I749L, I752L, I774L, I1701L, I1728L, I1784L, I1787L, I1806L, I1807L, I1836L, I1854L, I1877L, I625L, I663L, I664L, I682L, I685L, I704L, I710L, I725L, I727L, I987L, I1686L, I1726L, I1742L, I1743L, I1744L, I1771L, I1785L, I1811L, I1813L, I1835L, I1850L, I1852L, I1875L, I638L, I662L, I672L, I680L, I684L, I703L, I748L, I750L, I773L, I1558L, I1559L, I1765L, I1767L, I1783L, I1786L, I1788L, I1827L, I1828L, I443L, I624L, I670L, I705L, I707L, I709L, I711L, I726L, I986L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868678	17	41197724	17	43045707	868678	853074	rs2050858402	NC_000017.11:43045706:T:A
NM_007294.4(BRCA1):c.5563A>G (p.Ile1855Val)	BRCA1	I1808V, I1876V, I751V, I1855V, I1558V, I1686V, I1727V, I1728V, I1744V, I1785V, I1811V, I1812V, I1827V, I1852V, I1854V, I443V, I575V, I584V, I638V, I662V, I672V, I681V, I707V, I713V, I727V, I774V, I987V, I1701V, I1765V, I1767V, I1783V, I1784V, I1806V, I1807V, I1813V, I1829V, I1835V, I1851V, I1877V, I625V, I663V, I680V, I684V, I703V, I709V, I712V, I748V, I773V, I1559V, I1726V, I1743V, I1771V, I1787V, I1814V, I1828V, I624V, I639V, I664V, I670V, I682V, I705V, I710V, I750V, I752V, I1742V, I1766V, I1786V, I1788V, I1836V, I1850V, I1853V, I1875V, I642V, I643V, I685V, I704V, I711V, I725V, I726V, I749V, I986V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868677	17	41197724	17	43045707	868677	853075	rs2050858402	NC_000017.11:43045706:T:C
NM_007294.4(BRCA1):c.5563A>C (p.Ile1855Leu)	BRCA1	I1808L, I1876L, I751L, I1855L, I1559L, I1744L, I1767L, I1811L, I1812L, I1828L, I1836L, I1850L, I575L, I638L, I663L, I664L, I670L, I705L, I711L, I725L, I752L, I1686L, I1727L, I1743L, I1787L, I1829L, I1835L, I1875L, I443L, I584L, I624L, I642L, I672L, I680L, I684L, I685L, I704L, I707L, I709L, I750L, I774L, I986L, I987L, I1558L, I1701L, I1766L, I1771L, I1785L, I1807L, I1813L, I1814L, I1827L, I1851L, I1852L, I1853L, I1854L, I625L, I643L, I682L, I710L, I727L, I773L, I1726L, I1728L, I1742L, I1765L, I1783L, I1784L, I1786L, I1788L, I1806L, I1877L, I639L, I662L, I681L, I703L, I712L, I713L, I726L, I748L, I749L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868676	17	41197724	17	43045707	868676	853076	rs2050858402	NC_000017.11:43045706:T:G
NM_007294.4(BRCA1):c.5562G>T (p.Leu1854=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868675	17	41197725	17	43045708	868675	853077	rs786201648	NC_000017.11:43045707:C:A
NM_007294.4(BRCA1):c.5562G>C (p.Leu1854=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868674	17	41197725	17	43045708	868674	853078	rs786201648	NC_000017.11:43045707:C:G
NM_007294.4(BRCA1):c.5562G>A (p.Leu1854=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000184730	17	41197725	17	43045708	184730	184866	rs786201648	NC_000017.11:43045707:C:T
NM_007294.4(BRCA1):c.5561T>G (p.Leu1854Arg)	BRCA1	L750R, L1807R, L1854R, L1875R, L1726R, L1741R, L1805R, L1826R, L1835R, L1850R, L583R, L662R, L681R, L683R, L712R, L751R, L772R, L1742R, L1743R, L1764R, L1765R, L1782R, L1783R, L1811R, L1813R, L1828R, L1851R, L1874R, L442R, L574R, L624R, L661R, L679R, L684R, L704R, L709R, L710R, L985R, L1685R, L1700R, L1725R, L1727R, L1766R, L1784R, L1785R, L1786R, L1806R, L1810R, L1849R, L1852R, L623R, L641R, L642R, L663R, L680R, L702R, L703R, L708R, L711R, L724R, L725R, L747R, L748R, L749R, L773R, L986R, L1557R, L1558R, L1770R, L1787R, L1812R, L1827R, L1834R, L1853R, L1876R, L637R, L638R, L669R, L671R, L706R, L726R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867670	17	41197726	17	43045709	867670	853079	rs80356996	NC_000017.11:43045708:A:C
NM_007294.4(BRCA1):c.5561T>A (p.Leu1854Gln)	BRCA1	L1807Q, L750Q, L1854Q, L1875Q, L1557Q, L1727Q, L1765Q, L1782Q, L1787Q, L1805Q, L1812Q, L1828Q, L1834Q, L1849Q, L1852Q, L1853Q, L623Q, L641Q, L662Q, L669Q, L671Q, L680Q, L708Q, L749Q, L772Q, L1685Q, L1700Q, L1741Q, L1743Q, L1783Q, L1784Q, L1785Q, L1813Q, L1850Q, L583Q, L624Q, L661Q, L683Q, L706Q, L724Q, L726Q, L985Q, L986Q, L1558Q, L1725Q, L1742Q, L1764Q, L1766Q, L1770Q, L1786Q, L1806Q, L1835Q, L1874Q, L442Q, L642Q, L663Q, L681Q, L702Q, L709Q, L710Q, L725Q, L748Q, L1726Q, L1810Q, L1811Q, L1826Q, L1827Q, L1851Q, L1876Q, L574Q, L637Q, L638Q, L679Q, L684Q, L703Q, L704Q, L711Q, L712Q, L747Q, L751Q, L773Q	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867669	17	41197726	17	43045709	867669	853080	rs80356996	NC_000017.11:43045708:A:T
NM_007294.4(BRCA1):c.5561T>C (p.Leu1854Pro)	BRCA1	L1854P, L1875P, L750P, L1807P, L1557P, L1700P, L1783P, L1785P, L1828P, L1835P, L1849P, L623P, L669P, L702P, L708P, L709P, L711P, L712P, L1743P, L1770P, L1782P, L1784P, L1805P, L1806P, L1811P, L1851P, L1852P, L1853P, L1874P, L624P, L642P, L662P, L683P, L706P, L724P, L725P, L747P, L772P, L985P, L1558P, L1741P, L1742P, L1764P, L1765P, L1766P, L1786P, L1787P, L1813P, L1834P, L1876P, L442P, L583P, L637P, L638P, L663P, L680P, L684P, L703P, L704P, L726P, L748P, L749P, L986P, L1685P, L1725P, L1726P, L1727P, L1810P, L1812P, L1826P, L1827P, L1850P, L574P, L641P, L661P, L671P, L679P, L681P, L710P, L751P, L773P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 17, 2021)	criteria provided, conflicting interpretations	VCV000055631	17	41197726	17	43045709	55631	70298	rs80356996	NC_000017.11:43045708:A:G
NM_007294.4(BRCA1):c.5560C>T (p.Leu1854=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867668	17	41197727	17	43045710	867668	853081	rs2050859600	NC_000017.11:43045709:G:A
NM_007294.4(BRCA1):c.5560C>G (p.Leu1854Val)	BRCA1	L1812V, L1828V, L1834V, L624V, L661V, L702V, L711V, L726V, L748V, L749V, L985V, L1854V, L1875V, L1807V, L750V, L1685V, L1742V, L1766V, L1786V, L1811V, L1826V, L1849V, L1851V, L1874V, L583V, L642V, L703V, L704V, L725V, L751V, L1557V, L1558V, L1727V, L1764V, L1765V, L1785V, L1787V, L1806V, L1850V, L1852V, L1853V, L1876V, L623V, L641V, L679V, L681V, L683V, L708V, L709V, L724V, L747V, L1783V, L1805V, L1813V, L1827V, L1835V, L442V, L574V, L637V, L638V, L662V, L663V, L669V, L671V, L680V, L684V, L706V, L710V, L712V, L772V, L773V, L986V, L1726V, L1741V, L1743V, L1770V, L1782V, L1700V, L1725V, L1784V, L1810V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867667	17	41197727	17	43045710	867667	853082	rs2050859600	NC_000017.11:43045709:G:C
NM_007294.4(BRCA1):c.5560C>A (p.Leu1854Met)	BRCA1	L1807M, L1854M, L1875M, L750M, L1700M, L1766M, L1785M, L1813M, L1834M, L1852M, L1853M, L1874M, L641M, L661M, L669M, L671M, L702M, L703M, L711M, L726M, L986M, L1685M, L1726M, L1764M, L1786M, L1806M, L1826M, L1827M, L1851M, L583M, L623M, L624M, L638M, L681M, L706M, L708M, L709M, L748M, L749M, L772M, L773M, L1558M, L1727M, L1741M, L1765M, L1770M, L1787M, L1805M, L1828M, L1835M, L1876M, L442M, L642M, L663M, L680M, L683M, L704M, L724M, L751M, L985M, L1557M, L1725M, L1742M, L1743M, L1782M, L1783M, L1784M, L1810M, L1811M, L1812M, L1849M, L1850M, L574M, L637M, L662M, L679M, L684M, L710M, L712M, L725M, L747M	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867666	17	41197727	17	43045710	867666	853083	rs2050859600	NC_000017.11:43045709:G:T
NM_007294.4(BRCA1):c.5559C>T (p.Tyr1853=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867665	17	41197728	17	43045711	867665	853084	rs80357336	NC_000017.11:43045710:G:A
NM_007294.4(BRCA1):c.5559C>G (p.Tyr1853Ter)	BRCA1	Y1853*, Y749*, Y1874*, Y1806*, Y1556*, Y1741*, Y1763*, Y1764*, Y1782*, Y1805*, Y1827*, Y1834*, Y1849*, Y1873*, Y441*, Y573*, Y640*, Y661*, Y680*, Y746*, Y748*, Y772*, Y1740*, Y1742*, Y1781*, Y1784*, Y1785*, Y1804*, Y1809*, Y1810*, Y1833*, Y1848*, Y623*, Y637*, Y641*, Y668*, Y679*, Y701*, Y708*, Y709*, Y1684*, Y1699*, Y1724*, Y1725*, Y1765*, Y1783*, Y1786*, Y1851*, Y1852*, Y660*, Y662*, Y670*, Y678*, Y702*, Y703*, Y707*, Y711*, Y723*, Y724*, Y747*, Y750*, Y771*, Y985*, Y1557*, Y1726*, Y1769*, Y1811*, Y1812*, Y1825*, Y1826*, Y1850*, Y1875*, Y582*, Y622*, Y636*, Y682*, Y683*, Y705*, Y710*, Y725*, Y984*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	VCV000055630	17	41197728	17	43045711	55630	70297	rs80357336	NC_000017.11:43045710:G:C
NM_007294.4(BRCA1):c.5559C>A (p.Tyr1853Ter)	BRCA1	Y1853*, Y1806*, Y1874*, Y749*, Y1556*, Y1557*, Y1742*, Y1781*, Y1784*, Y1805*, Y1809*, Y1810*, Y1826*, Y1850*, Y1852*, Y660*, Y678*, Y680*, Y682*, Y725*, Y771*, Y1726*, Y1741*, Y1769*, Y1782*, Y1812*, Y1825*, Y1833*, Y1849*, Y1875*, Y623*, Y640*, Y662*, Y670*, Y701*, Y705*, Y707*, Y709*, Y711*, Y746*, Y748*, Y750*, Y984*, Y1684*, Y1699*, Y1725*, Y1764*, Y1785*, Y1786*, Y1811*, Y1848*, Y1851*, Y441*, Y582*, Y636*, Y679*, Y702*, Y703*, Y724*, Y747*, Y1724*, Y1740*, Y1763*, Y1765*, Y1783*, Y1804*, Y1827*, Y1834*, Y1873*, Y573*, Y622*, Y637*, Y641*, Y661*, Y668*, Y683*, Y708*, Y710*, Y723*, Y772*, Y985*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055629	17	41197728	17	43045711	55629	70296	rs80357336	NC_000017.11:43045710:G:T
NM_007294.4(BRCA1):c.5558A>T (p.Tyr1853Phe)	BRCA1	Y1806F, Y1853F, Y1874F, Y749F, Y1725F, Y1740F, Y1765F, Y1812F, Y1827F, Y582F, Y640F, Y668F, Y670F, Y683F, Y701F, Y705F, Y708F, Y709F, Y711F, Y747F, Y1556F, Y1724F, Y1726F, Y1763F, Y1764F, Y1782F, Y1805F, Y1825F, Y1834F, Y1851F, Y1873F, Y662F, Y702F, Y707F, Y710F, Y723F, Y724F, Y748F, Y772F, Y984F, Y1699F, Y1741F, Y1742F, Y1783F, Y1784F, Y1785F, Y1786F, Y1804F, Y1809F, Y1811F, Y1826F, Y1849F, Y1850F, Y1852F, Y1875F, Y441F, Y573F, Y622F, Y637F, Y660F, Y661F, Y679F, Y682F, Y703F, Y771F, Y1557F, Y1684F, Y1769F, Y1781F, Y1810F, Y1833F, Y1848F, Y623F, Y636F, Y641F, Y678F, Y680F, Y725F, Y746F, Y750F, Y985F	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 4, 2020)	criteria provided, single submitter	VCV000865017	17	41197729	17	43045712	865017	853085	rs80357258	NC_000017.11:43045711:T:A
NM_007294.4(BRCA1):c.5558A>C (p.Tyr1853Ser)	BRCA1	Y1853S, Y749S, Y1806S, Y1874S, Y1556S, Y1725S, Y1726S, Y1763S, Y1769S, Y1781S, Y1782S, Y1783S, Y1785S, Y1805S, Y1826S, Y1848S, Y1849S, Y637S, Y641S, Y670S, Y679S, Y702S, Y703S, Y708S, Y711S, Y725S, Y771S, Y985S, Y1699S, Y1765S, Y1812S, Y1850S, Y1851S, Y636S, Y640S, Y662S, Y668S, Y678S, Y680S, Y701S, Y723S, Y746S, Y747S, Y1557S, Y1742S, Y1784S, Y1811S, Y1833S, Y1873S, Y622S, Y623S, Y661S, Y683S, Y709S, Y724S, Y748S, Y750S, Y1684S, Y1724S, Y1740S, Y1741S, Y1764S, Y1786S, Y1804S, Y1809S, Y1810S, Y1825S, Y1827S, Y1834S, Y1852S, Y1875S, Y441S, Y573S, Y582S, Y660S, Y682S, Y705S, Y707S, Y710S, Y772S, Y984S	Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000865016	17	41197729	17	43045712	865016	853086	rs80357258	NC_000017.11:43045711:T:G
NM_007294.4(BRCA1):c.5558A>G (p.Tyr1853Cys)	BRCA1	Y1853C, Y1806C, Y749C, Y1874C, Y1556C, Y1557C, Y1699C, Y1740C, Y1741C, Y1742C, Y1784C, Y1765C, Y1783C, Y1811C, Y1825C, Y1827C, Y1849C, Y1852C, Y441C, Y636C, Y640C, Y668C, Y670C, Y679C, Y683C, Y709C, Y710C, Y724C, Y746C, Y771C, Y772C, Y1785C, Y1805C, Y1809C, Y1810C, Y1826C, Y1850C, Y573C, Y622C, Y661C, Y680C, Y682C, Y701C, Y703C, Y711C, Y725C, Y748C, Y750C, Y985C, Y1724C, Y1781C, Y1782C, Y1786C, Y1812C, Y1833C, Y1873C, Y1875C, Y582C, Y623C, Y641C, Y660C, Y702C, Y705C, Y747C, Y1684C, Y1725C, Y1726C, Y1763C, Y1764C, Y1769C, Y1804C, Y1834C, Y1848C, Y1851C, Y637C, Y662C, Y678C, Y707C, Y708C, Y723C, Y984C	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000055627	17	41197729	17	43045712	55627	70294	rs80357258	NC_000017.11:43045711:T:C
NM_007294.4(BRCA1):c.5557T>G (p.Tyr1853Asp)	BRCA1	Y1806D, Y1874D, Y749D, Y1853D, Y1684D, Y1769D, Y1786D, Y1809D, Y1826D, Y1850D, Y441D, Y573D, Y641D, Y661D, Y668D, Y670D, Y678D, Y679D, Y682D, Y683D, Y705D, Y707D, Y746D, Y1699D, Y1763D, Y1764D, Y1765D, Y1783D, Y1810D, Y1811D, Y1812D, Y1825D, Y1827D, Y1833D, Y1849D, Y1852D, Y1873D, Y1875D, Y622D, Y623D, Y637D, Y701D, Y710D, Y1556D, Y1726D, Y1742D, Y1782D, Y1785D, Y1804D, Y1834D, Y1848D, Y1851D, Y582D, Y640D, Y662D, Y680D, Y708D, Y711D, Y725D, Y748D, Y985D, Y1557D, Y1724D, Y1725D, Y1740D, Y1741D, Y1781D, Y1784D, Y1805D, Y636D, Y660D, Y702D, Y703D, Y709D, Y723D, Y724D, Y747D, Y750D, Y771D, Y772D, Y984D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865015	17	41197730	17	43045713	865015	853087	rs2050860958	NC_000017.11:43045712:A:C
NM_007294.4(BRCA1):c.5557T>C (p.Tyr1853His)	BRCA1	Y1806H, Y1853H, Y1874H, Y749H, Y1684H, Y1765H, Y1784H, Y1810H, Y1825H, Y1827H, Y1873H, Y441H, Y670H, Y679H, Y724H, Y1726H, Y1741H, Y1783H, Y1785H, Y1809H, Y1811H, Y1826H, Y1852H, Y573H, Y582H, Y637H, Y641H, Y668H, Y682H, Y702H, Y708H, Y771H, Y984H, Y1724H, Y1740H, Y1764H, Y1769H, Y1781H, Y1786H, Y1804H, Y1805H, Y1834H, Y1848H, Y1851H, Y1875H, Y623H, Y636H, Y660H, Y680H, Y705H, Y709H, Y746H, Y747H, Y748H, Y1556H, Y1557H, Y1699H, Y1725H, Y1742H, Y1763H, Y1782H, Y1812H, Y1833H, Y1849H, Y1850H, Y622H, Y640H, Y661H, Y662H, Y678H, Y683H, Y701H, Y703H, Y707H, Y710H, Y711H, Y723H, Y725H, Y750H, Y772H, Y985H	Hereditary breast ovarian cancer syndrome	Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000865014	17	41197730	17	43045713	865014	853088	rs2050860958	NC_000017.11:43045712:A:G
NM_007294.4(BRCA1):c.5557T>A (p.Tyr1853Asn)	BRCA1	Y1853N, Y1806N, Y1874N, Y749N, Y1740N, Y1742N, Y1784N, Y1785N, Y1827N, Y1848N, Y1850N, Y573N, Y623N, Y636N, Y640N, Y683N, Y701N, Y710N, Y723N, Y771N, Y772N, Y984N, Y1684N, Y1724N, Y1763N, Y1782N, Y1811N, Y1812N, Y1826N, Y1873N, Y1875N, Y641N, Y668N, Y705N, Y707N, Y709N, Y725N, Y750N, Y1556N, Y1557N, Y1699N, Y1725N, Y1726N, Y1764N, Y1765N, Y1769N, Y1781N, Y1804N, Y1805N, Y1809N, Y1825N, Y1834N, Y1851N, Y1852N, Y441N, Y661N, Y662N, Y680N, Y682N, Y711N, Y724N, Y1741N, Y1783N, Y1786N, Y1810N, Y1833N, Y1849N, Y582N, Y622N, Y637N, Y660N, Y670N, Y678N, Y679N, Y702N, Y703N, Y708N, Y746N, Y747N, Y748N, Y985N	not specified|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2022)	criteria provided, conflicting interpretations	VCV000433738	17	41197730	17	43045713	433738	427518	rs2050860958	NC_000017.11:43045712:A:T
NM_007294.4(BRCA1):c.5556C>A (p.Thr1852=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869043	17	41197731	17	43045714	869043	853090	rs80356841	NC_000017.11:43045713:G:T
NM_007294.4(BRCA1):c.5556C>T (p.Thr1852=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Apr 15, 2021)	criteria provided, single submitter	VCV000865013	17	41197731	17	43045714	865013	853089	rs80356841	NC_000017.11:43045713:G:A
NM_007294.4(BRCA1):c.5556C>G (p.Thr1852=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000055626	17	41197731	17	43045714	55626	70293	rs80356841	NC_000017.11:43045713:G:C
NM_007294.4(BRCA1):c.5555C>G (p.Thr1852Ser)	BRCA1	T1852S, T748S, T1805S, T1873S, T1739S, T1780S, T1781S, T1808S, T1811S, T1824S, T1825S, T1847S, T1850S, T581S, T669S, T677S, T681S, T702S, T706S, T709S, T722S, T724S, T770S, T984S, T1683S, T1723S, T1724S, T1740S, T1741S, T1762S, T1803S, T1810S, T1833S, T1848S, T1872S, T1874S, T621S, T661S, T667S, T682S, T700S, T704S, T723S, T747S, T983S, T1555S, T1556S, T1698S, T1763S, T1768S, T1782S, T1785S, T1804S, T1809S, T1826S, T1832S, T440S, T572S, T622S, T635S, T640S, T679S, T701S, T707S, T710S, T745S, T771S, T1725S, T1764S, T1783S, T1784S, T1849S, T1851S, T636S, T639S, T659S, T660S, T678S, T708S, T746S, T749S	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jun 27, 2022)	criteria provided, single submitter	VCV000869042	17	41197732	17	43045715	869042	853091	rs730881502	NC_000017.11:43045714:G:C
NM_007294.4(BRCA1):c.5555C>A (p.Thr1852Asn)	BRCA1	T748N, T1805N, T1852N, T1873N, T1556N, T1683N, T1739N, T1763N, T1782N, T1785N, T1808N, T1832N, T1833N, T1874N, T581N, T635N, T659N, T661N, T667N, T679N, T702N, T724N, T747N, T771N, T983N, T640N, T677N, T678N, T681N, T707N, T745N, T749N, T984N, T1698N, T1725N, T1740N, T1762N, T1764N, T1780N, T1781N, T1784N, T1803N, T1809N, T1810N, T1824N, T1847N, T1848N, T1851N, T1872N, T636N, T660N, T682N, T701N, T704N, T708N, T722N, T723N, T1723N, T1724N, T1741N, T1768N, T1783N, T1804N, T1811N, T1825N, T621N, T622N, T1555N, T1826N, T1849N, T1850N, T440N, T572N, T639N, T669N, T700N, T706N, T709N, T710N, T746N, T770N	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869041	17	41197732	17	43045715	869041	853092	rs730881502	NC_000017.11:43045714:G:T
NM_007294.4(BRCA1):c.5555C>T (p.Thr1852Ile)	BRCA1	T1852I, T1805I, T1873I, T748I, T1556I, T1698I, T1741I, T1762I, T1782I, T1784I, T1803I, T1808I, T1826I, T1833I, T1874I, T581I, T635I, T659I, T661I, T702I, T706I, T707I, T709I, T771I, T1555I, T1739I, T1740I, T1780I, T1809I, T1811I, T1825I, T1850I, T622I, T636I, T679I, T682I, T708I, T722I, T723I, T746I, T749I, T984I, T1724I, T1725I, T1763I, T1764I, T1768I, T1804I, T1810I, T1824I, T1848I, T1872I, T621I, T640I, T660I, T667I, T678I, T701I, T704I, T745I, T747I, T770I, T1683I, T1723I, T1781I, T1783I, T1785I, T1832I, T1847I, T1849I, T1851I, T440I, T572I, T639I, T669I, T677I, T681I, T700I, T710I, T724I, T983I	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 28, 2022)	criteria provided, conflicting interpretations	VCV000182174	17	41197732	17	43045715	182174	180811	rs730881502	NC_000017.11:43045714:G:A
NM_007294.4(BRCA1):c.5554A>T (p.Thr1852Ser)	BRCA1	T1852S, T1873S, T1805S, T748S, T1698S, T1739S, T1782S, T1804S, T1808S, T1810S, T1811S, T1849S, T1851S, T1872S, T572S, T581S, T622S, T667S, T669S, T678S, T681S, T702S, T709S, T723S, T745S, T747S, T984S, T1556S, T1724S, T1740S, T1763S, T1768S, T1784S, T1785S, T1809S, T1825S, T1833S, T1847S, T440S, T621S, T660S, T679S, T707S, T708S, T724S, T1555S, T1762S, T1764S, T1781S, T1783S, T1803S, T1824S, T1832S, T1848S, T1874S, T636S, T639S, T659S, T677S, T700S, T701S, T706S, T710S, T771S, T1683S, T1723S, T1725S, T1741S, T1780S, T1826S, T1850S, T635S, T640S, T661S, T682S, T704S, T722S, T746S, T749S, T770S, T983S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869040	17	41197733	17	43045716	869040	853093	rs1555574370	NC_000017.11:43045715:T:A
NM_007294.4(BRCA1):c.5554A>C (p.Thr1852Pro)	BRCA1	T1852P, T1873P, T1805P, T748P, T1683P, T1739P, T1741P, T1782P, T1783P, T1832P, T1848P, T1850P, T581P, T660P, T661P, T678P, T682P, T700P, T709P, T710P, T723P, T747P, T749P, T770P, T984P, T1698P, T1723P, T1725P, T1764P, T1780P, T1803P, T1808P, T1809P, T1810P, T1826P, T1833P, T440P, T636P, T640P, T659P, T667P, T701P, T702P, T706P, T708P, T722P, T1555P, T1556P, T1740P, T1762P, T1768P, T1781P, T1785P, T1804P, T1824P, T1849P, T622P, T639P, T746P, T983P, T1724P, T1763P, T1784P, T1811P, T1825P, T1847P, T1851P, T1872P, T1874P, T572P, T621P, T635P, T669P, T677P, T679P, T681P, T704P, T707P, T724P, T745P, T771P	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869039	17	41197733	17	43045716	869039	853094	rs1555574370	NC_000017.11:43045715:T:G
NM_007294.4(BRCA1):c.5554A>G (p.Thr1852Ala)	BRCA1	T1852A, T1805A, T1873A, T748A, T1698A, T1723A, T1762A, T1810A, T1811A, T1847A, T1851A, T622A, T660A, T678A, T681A, T682A, T724A, T747A, T984A, T1555A, T1724A, T1725A, T1739A, T1763A, T1764A, T1783A, T1784A, T1785A, T1804A, T1833A, T440A, T581A, T621A, T636A, T640A, T661A, T677A, T701A, T704A, T708A, T722A, T745A, T749A, T771A, T1556A, T1683A, T1741A, T1780A, T1781A, T1803A, T1824A, T1826A, T1848A, T1849A, T1850A, T572A, T659A, T667A, T669A, T700A, T702A, T709A, T710A, T770A, T983A, T1740A, T1768A, T1782A, T1808A, T1809A, T1825A, T1832A, T1872A, T1874A, T635A, T639A, T679A, T706A, T707A, T723A, T746A	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 2, 2016)	criteria provided, single submitter	VCV000441287	17	41197733	17	43045716	441287	435102	rs1555574370	NC_000017.11:43045715:T:C
NM_007294.4(BRCA1):c.5553C>G (p.Asp1851Glu)	BRCA1	D1851E, D1872E, D747E, D1804E, D1555E, D1739E, D1761E, D1762E, D1779E, D1803E, D1807E, D1809E, D1810E, D1823E, D1824E, D1846E, D1850E, D439E, D620E, D621E, D638E, D666E, D678E, D705E, D706E, D708E, D722E, D723E, D745E, D746E, D982E, D1682E, D1697E, D1723E, D1724E, D1767E, D1783E, D1784E, D1802E, D1825E, D1873E, D571E, D668E, D707E, D721E, D744E, D1763E, D1780E, D1781E, D1831E, D1871E, D580E, D635E, D658E, D660E, D676E, D680E, D701E, D703E, D709E, D769E, D983E, D1554E, D1722E, D1738E, D1740E, D1782E, D1808E, D1832E, D1847E, D1848E, D1849E, D634E, D639E, D659E, D677E, D681E, D699E, D700E, D748E, D770E	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868661	17	41197734	17	43045717	868661	853095	rs80357326	NC_000017.11:43045716:G:C
NM_007294.4(BRCA1):c.5553C>T (p.Asp1851=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Aug 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000630989	17	41197734	17	43045717	630989	618548	rs80357326	NC_000017.11:43045716:G:A
NM_007294.4(BRCA1):c.5553C>A (p.Asp1851Glu)	BRCA1	D1851E, D1872E, D747E, D1804E, D1682E, D1722E, D1724E, D1739E, D1761E, D1810E, D1831E, D439E, D580E, D658E, D666E, D676E, D681E, D699E, D701E, D705E, D722E, D723E, D745E, D746E, D748E, D1723E, D1767E, D1779E, D1780E, D1803E, D1809E, D1823E, D1846E, D1847E, D1849E, D1850E, D621E, D638E, D639E, D703E, D707E, D709E, D721E, D744E, D770E, D1555E, D1697E, D1762E, D1802E, D1808E, D1832E, D1848E, D571E, D620E, D634E, D635E, D660E, D668E, D680E, D708E, D769E, D982E, D1554E, D1738E, D1740E, D1763E, D1781E, D1782E, D1783E, D1784E, D1807E, D1824E, D1825E, D1871E, D1873E, D659E, D677E, D678E, D700E, D706E, D983E	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000055624	17	41197734	17	43045717	55624	70291	rs80357326	NC_000017.11:43045716:G:T
NM_007294.4(BRCA1):c.5552A>T (p.Asp1851Val)	BRCA1	D1804V, D1851V, D747V, D1872V, D1555V, D1767V, D1779V, D1781V, D1783V, D1808V, D1810V, D1824V, D1848V, D1871V, D620V, D621V, D659V, D678V, D699V, D709V, D746V, D769V, D770V, D982V, D707V, D721V, D722V, D983V, D1697V, D1722V, D1763V, D1823V, D1847V, D1849V, D439V, D580V, D635V, D638V, D676V, D700V, D701V, D708V, D744V, D748V, D1682V, D1724V, D1738V, D1761V, D1780V, D1782V, D1784V, D1802V, D1807V, D1809V, D1825V, D1831V, D1832V, D1850V, D1873V, D666V, D668V, D677V, D680V, D681V, D1554V, D1723V, D1739V, D1740V, D1762V, D1803V, D1846V, D571V, D634V, D639V, D658V, D660V, D703V, D705V, D706V, D723V, D745V	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jul 12, 2021)	criteria provided, single submitter	VCV000868660	17	41197735	17	43045718	868660	853096	rs2050862656	NC_000017.11:43045717:T:A
NM_007294.4(BRCA1):c.5552A>G (p.Asp1851Gly)	BRCA1	D1804G, D1851G, D747G, D1872G, D1554G, D1724G, D1738G, D1767G, D1783G, D1807G, D1810G, D1825G, D1831G, D1832G, D1848G, D580G, D621G, D639G, D680G, D703G, D705G, D707G, D723G, D746G, D982G, D1682G, D1697G, D1723G, D1824G, D1846G, D1847G, D1850G, D571G, D658G, D659G, D677G, D701G, D709G, D722G, D745G, D748G, D983G, D1555G, D1763G, D1779G, D1781G, D1782G, D1784G, D1803G, D1808G, D1871G, D620G, D634G, D660G, D668G, D699G, D700G, D706G, D721G, D744G, D1722G, D1739G, D1740G, D1761G, D1762G, D1780G, D1802G, D1809G, D1823G, D1849G, D1873G, D439G, D635G, D638G, D666G, D676G, D678G, D681G, D708G, D769G, D770G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868659	17	41197735	17	43045718	868659	853097	rs2050862656	NC_000017.11:43045717:T:C
NM_007294.4(BRCA1):c.5552A>C (p.Asp1851Ala)	BRCA1	D1804A, D1872A, D1851A, D747A, D1554A, D1682A, D1722A, D1723A, D1763A, D1767A, D1809A, D1810A, D1823A, D1831A, D1847A, D1873A, D571A, D639A, D678A, D699A, D705A, D744A, D769A, D770A, D983A, D1697A, D1724A, D1738A, D1779A, D1781A, D1802A, D1807A, D1825A, D1848A, D1850A, D580A, D621A, D634A, D660A, D668A, D676A, D680A, D700A, D703A, D706A, D721A, D722A, D748A, D982A, D1739A, D1783A, D1849A, D439A, D635A, D658A, D681A, D701A, D707A, D708A, D709A, D1555A, D1740A, D1761A, D1762A, D1780A, D1782A, D1784A, D1803A, D1808A, D1824A, D1832A, D1846A, D1871A, D620A, D638A, D659A, D666A, D677A, D723A, D745A, D746A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868658	17	41197735	17	43045718	868658	853098	rs2050862656	NC_000017.11:43045717:T:G
NM_007294.4(BRCA1):c.5551G>T (p.Asp1851Tyr)	BRCA1	D1872Y, D1851Y, D747Y, D1804Y, D1825Y, D1831Y, D1832Y, D571Y, D580Y, D639Y, D659Y, D676Y, D677Y, D681Y, D700Y, D701Y, D705Y, D709Y, D721Y, D1554Y, D1697Y, D1722Y, D1723Y, D1724Y, D1740Y, D1761Y, D1763Y, D1781Y, D1783Y, D1802Y, D1803Y, D1739Y, D1779Y, D1808Y, D1810Y, D1824Y, D1848Y, D1850Y, D1871Y, D621Y, D660Y, D678Y, D723Y, D746Y, D982Y, D1682Y, D1738Y, D1767Y, D1807Y, D1809Y, D1849Y, D1873Y, D439Y, D635Y, D658Y, D699Y, D703Y, D706Y, D707Y, D708Y, D748Y, D769Y, D1555Y, D1762Y, D1780Y, D1782Y, D1784Y, D1823Y, D1846Y, D1847Y, D620Y, D634Y, D638Y, D666Y, D668Y, D680Y, D722Y, D744Y, D745Y, D770Y, D983Y	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868657	17	41197736	17	43045719	868657	853099	rs2050862880	NC_000017.11:43045718:C:A
NM_007294.4(BRCA1):c.5551G>C (p.Asp1851His)	BRCA1	D747H, D1872H, D1851H, D1804H, D1554H, D1724H, D1738H, D1739H, D1783H, D1784H, D1807H, D1810H, D1823H, D1824H, D1825H, D1848H, D1850H, D571H, D666H, D678H, D708H, D744H, D746H, D748H, D1555H, D1682H, D1697H, D1723H, D1780H, D1831H, D1832H, D1846H, D1849H, D1871H, D1873H, D621H, D659H, D660H, D676H, D699H, D700H, D703H, D707H, D721H, D745H, D770H, D1740H, D1761H, D1762H, D1767H, D1781H, D1802H, D1847H, D439H, D634H, D668H, D680H, D681H, D709H, D722H, D723H, D769H, D982H, D983H, D1722H, D1763H, D1779H, D1782H, D1803H, D1808H, D1809H, D580H, D620H, D635H, D638H, D639H, D658H, D677H, D701H, D705H, D706H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868656	17	41197736	17	43045719	868656	853100	rs2050862880	NC_000017.11:43045718:C:G
NM_007294.4(BRCA1):c.5551G>A (p.Asp1851Asn)	BRCA1	D1851N, D1872N, D747N, D1804N, D1554N, D1682N, D1767N, D1779N, D1781N, D1783N, D1810N, D1832N, D1849N, D580N, D621N, D634N, D638N, D668N, D681N, D708N, D721N, D723N, D983N, D1723N, D1782N, D1807N, D1824N, D1831N, D1848N, D1850N, D439N, D635N, D676N, D677N, D680N, D701N, D707N, D709N, D722N, D746N, D770N, D1555N, D1722N, D1724N, D1738N, D1761N, D1780N, D1802N, D1803N, D1808N, D1809N, D1823N, D1846N, D1847N, D1873N, D620N, D659N, D660N, D700N, D703N, D705N, D706N, D745N, D769N, D1697N, D1739N, D1740N, D1762N, D1763N, D1784N, D1825N, D1871N, D571N, D639N, D658N, D666N, D678N, D699N, D744N, D748N, D982N	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV000853644	17	41197736	17	43045719	853644	845359	rs2050862880	NC_000017.11:43045718:C:T
NM_007294.4(BRCA1):c.5550G>T (p.Leu1850=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867655	17	41197737	17	43045720	867655	853101	rs786201502	NC_000017.11:43045719:C:A
NM_007294.4(BRCA1):c.5550G>A (p.Leu1850=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jun 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000403718	17	41197737	17	43045720	403718	390695	rs786201502	NC_000017.11:43045719:C:T
NM_007294.4(BRCA1):c.5550G>C (p.Leu1850=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000184500	17	41197737	17	43045720	184500	184867	rs786201502	NC_000017.11:43045719:C:G
NM_007294.4(BRCA1):c.5549T>G (p.Leu1850Arg)	BRCA1	L1803R, L1850R, L1871R, L746R, L1681R, L1722R, L1737R, L1762R, L1780R, L1801R, L1807R, L1809R, L1847R, L1849R, L1872R, L579R, L620R, L637R, L657R, L665R, L676R, L705R, L721R, L1554R, L1721R, L1760R, L1766R, L1779R, L1782R, L1808R, L1824R, L1830R, L1846R, L1848R, L633R, L675R, L720R, L745R, L768R, L1738R, L1739R, L1778R, L1783R, L1806R, L1823R, L1845R, L1870R, L438R, L619R, L638R, L658R, L677R, L679R, L702R, L704R, L707R, L981R, L982R, L1553R, L1696R, L1723R, L1761R, L1781R, L1802R, L1822R, L1831R, L570R, L634R, L659R, L667R, L680R, L698R, L699R, L700R, L706R, L708R, L722R, L743R, L744R, L747R, L769R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867654	17	41197738	17	43045721	867654	853102	rs2050863562	NC_000017.11:43045720:A:C
NM_007294.4(BRCA1):c.5549T>C (p.Leu1850Pro)	BRCA1	L1803P, L1850P, L1871P, L746P, L1738P, L1761P, L1779P, L1801P, L1802P, L1806P, L438P, L620P, L638P, L657P, L665P, L699P, L704P, L707P, L721P, L745P, L1554P, L1681P, L1760P, L1778P, L1781P, L1782P, L1824P, L1830P, L1870P, L1872P, L570P, L619P, L634P, L675P, L677P, L679P, L680P, L722P, L744P, L747P, L769P, L981P, L982P, L1553P, L1696P, L1721P, L1739P, L1762P, L1766P, L1808P, L1809P, L1822P, L1845P, L1846P, L1847P, L633P, L658P, L659P, L676P, L743P, L768P, L1722P, L1723P, L1737P, L1780P, L1783P, L1807P, L1823P, L1831P, L1848P, L1849P, L579P, L637P, L667P, L698P, L700P, L702P, L705P, L706P, L708P, L720P	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867653	17	41197738	17	43045721	867653	853103	rs2050863562	NC_000017.11:43045720:A:G
NM_007294.4(BRCA1):c.5549T>A (p.Leu1850Gln)	BRCA1	L746Q, L1850Q, L1871Q, L1803Q, L1553Q, L1554Q, L1721Q, L1766Q, L1780Q, L1802Q, L1807Q, L1822Q, L1824Q, L1831Q, L1845Q, L1870Q, L1872Q, L579Q, L620Q, L634Q, L637Q, L676Q, L699Q, L702Q, L722Q, L745Q, L747Q, L982Q, L1696Q, L1738Q, L1762Q, L1779Q, L1781Q, L1783Q, L1801Q, L1808Q, L1847Q, L1848Q, L658Q, L659Q, L665Q, L680Q, L706Q, L708Q, L721Q, L768Q, L1681Q, L1723Q, L1737Q, L1760Q, L1761Q, L1806Q, L1823Q, L438Q, L570Q, L619Q, L677Q, L679Q, L704Q, L705Q, L720Q, L769Q, L1722Q, L1739Q, L1778Q, L1782Q, L1809Q, L1830Q, L1846Q, L1849Q, L633Q, L638Q, L657Q, L667Q, L675Q, L698Q, L700Q, L707Q, L743Q, L744Q, L981Q	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867652	17	41197738	17	43045721	867652	853104	rs2050863562	NC_000017.11:43045720:A:T
NM_007294.4(BRCA1):c.5548C>T (p.Leu1850=)	BRCA1		not provided|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Oct 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000867651	17	41197739	17	43045722	867651	853105	rs2050863835	NC_000017.11:43045721:G:A
NM_007294.4(BRCA1):c.5548C>G (p.Leu1850Val)	BRCA1	L746V, L1803V, L1871V, L1850V, L1681V, L1722V, L1760V, L1780V, L1802V, L1809V, L1845V, L1846V, L1849V, L620V, L634V, L638V, L657V, L658V, L675V, L698V, L702V, L706V, L747V, L1723V, L1737V, L1738V, L1761V, L1778V, L1781V, L1783V, L1806V, L1824V, L1870V, L438V, L570V, L579V, L720V, L721V, L745V, L982V, L1766V, L1779V, L1801V, L1808V, L1822V, L1847V, L1872V, L619V, L633V, L667V, L676V, L677V, L679V, L699V, L700V, L704V, L708V, L722V, L743V, L768V, L769V, L1553V, L1554V, L1696V, L1721V, L1739V, L1762V, L1782V, L1807V, L1823V, L1830V, L1831V, L1848V, L637V, L659V, L665V, L680V, L705V, L707V, L744V, L981V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865005	17	41197739	17	43045722	865005	853106	rs2050863835	NC_000017.11:43045721:G:C
NM_007294.4(BRCA1):c.5548C>A (p.Leu1850Met)	BRCA1	L1803M, L746M, L1850M, L1871M, L1554M, L1739M, L1766M, L1781M, L1783M, L1801M, L1807M, L1822M, L1830M, L1831M, L1846M, L1848M, L1870M, L620M, L634M, L676M, L680M, L698M, L706M, L721M, L769M, L1696M, L1721M, L1760M, L1762M, L1780M, L1808M, L1847M, L438M, L619M, L638M, L657M, L675M, L677M, L679M, L700M, L704M, L720M, L722M, L768M, L981M, L1681M, L1722M, L1723M, L1738M, L1778M, L1806M, L1809M, L1823M, L1824M, L579M, L633M, L658M, L659M, L665M, L702M, L708M, L743M, L745M, L747M, L667M, L699M, L705M, L707M, L744M, L982M, L1553M, L1737M, L1761M, L1779M, L1782M, L1802M, L1845M, L1849M, L1872M, L570M, L637M	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865004	17	41197739	17	43045722	865004	853107	rs2050863835	NC_000017.11:43045721:G:T
NM_007294.4(BRCA1):c.5547G>T (p.Glu1849Asp)	BRCA1	E1802D, E1870D, E745D, E1849D, E1695D, E1722D, E1737D, E1759D, E1760D, E1779D, E1781D, E1807D, E1823D, E1871D, E632D, E633D, E636D, E675D, E698D, E703D, E719D, E743D, E744D, E980D, E1553D, E1736D, E1780D, E1808D, E1847D, E578D, E637D, E657D, E658D, E678D, E679D, E697D, E704D, E705D, E706D, E720D, E767D, E981D, E1552D, E1680D, E1720D, E1721D, E1738D, E1761D, E1765D, E1778D, E1801D, E1805D, E1821D, E1846D, E1848D, E1869D, E437D, E569D, E619D, E674D, E699D, E707D, E768D, E1777D, E1782D, E1800D, E1806D, E1822D, E1829D, E1830D, E1844D, E1845D, E618D, E656D, E664D, E666D, E676D, E701D, E721D, E742D, E746D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865003	17	41197740	17	43045723	865003	853108	rs1426388214	NC_000017.11:43045722:C:A
NM_007294.4(BRCA1):c.5547G>C (p.Glu1849Asp)	BRCA1	E1802D, E1870D, E745D, E1849D, E1721D, E1760D, E1778D, E1800D, E1807D, E1821D, E1846D, E578D, E633D, E636D, E637D, E666D, E697D, E698D, E707D, E719D, E721D, E744D, E980D, E706D, E720D, E746D, E981D, E1680D, E1695D, E1737D, E1738D, E1759D, E1765D, E1779D, E1781D, E1806D, E1823D, E1829D, E1844D, E1845D, E569D, E656D, E658D, E674D, E675D, E699D, E701D, E743D, E767D, E1552D, E1553D, E1720D, E1736D, E1782D, E1801D, E1830D, E1848D, E1869D, E618D, E657D, E676D, E679D, E704D, E1722D, E1761D, E1777D, E1780D, E1805D, E1808D, E1822D, E1847D, E1871D, E437D, E619D, E632D, E664D, E678D, E703D, E705D, E742D, E768D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865002	17	41197740	17	43045723	865002	853109	rs1426388214	NC_000017.11:43045722:C:G
NM_007294.4(BRCA1):c.5547G>A (p.Glu1849=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000482953	17	41197740	17	43045723	482953	478546	rs1426388214	NC_000017.11:43045722:C:T
NM_007294.4(BRCA1):c.5546A>T (p.Glu1849Val)	BRCA1	E1802V, E1870V, E745V, E1849V, E1552V, E1759V, E1780V, E1801V, E1869V, E578V, E618V, E633V, E636V, E658V, E664V, E666V, E676V, E699V, E703V, E704V, E721V, E744V, E746V, E1722V, E1738V, E1760V, E1778V, E1781V, E1800V, E1822V, E1823V, E1829V, E569V, E657V, E675V, E678V, E698V, E701V, E707V, E767V, E768V, E980V, E1680V, E1695V, E1720V, E1765V, E1779V, E1782V, E1806V, E1808V, E1821V, E1830V, E437V, E637V, E674V, E697V, E706V, E720V, E981V, E1553V, E1721V, E1736V, E1737V, E1761V, E1777V, E1805V, E1807V, E1844V, E1845V, E1846V, E1847V, E1848V, E1871V, E619V, E632V, E656V, E679V, E705V, E719V, E742V, E743V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865001	17	41197741	17	43045724	865001	853110	rs2050864495	NC_000017.11:43045723:T:A
NM_007294.4(BRCA1):c.5546A>G (p.Glu1849Gly)	BRCA1	E1870G, E745G, E1802G, E1849G, E1722G, E1760G, E1765G, E1821G, E1830G, E1844G, E1848G, E437G, E658G, E697G, E703G, E706G, E720G, E721G, E744G, E768G, E1552G, E1695G, E1720G, E1721G, E1738G, E1777G, E1780G, E1781G, E1800G, E1805G, E1847G, E618G, E619G, E632G, E664G, E698G, E699G, E701G, E705G, E707G, E743G, E980G, E1680G, E1736G, E1778G, E1782G, E1806G, E1807G, E1808G, E1822G, E1823G, E1829G, E1846G, E1871G, E633G, E637G, E666G, E674G, E676G, E679G, E704G, E742G, E981G, E1553G, E1737G, E1759G, E1761G, E1779G, E1801G, E1845G, E1869G, E569G, E578G, E636G, E656G, E657G, E675G, E678G, E719G, E746G, E767G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865000	17	41197741	17	43045724	865000	853111	rs2050864495	NC_000017.11:43045723:T:C
NM_007294.4(BRCA1):c.5546A>C (p.Glu1849Ala)	BRCA1	E1849A, E745A, E1802A, E1870A, E1736A, E1761A, E1780A, E1801A, E1821A, E1822A, E1847A, E578A, E618A, E658A, E699A, E701A, E706A, E981A, E1552A, E1553A, E1720A, E1765A, E1777A, E1778A, E1806A, E1807A, E1830A, E1844A, E1848A, E1871A, E437A, E569A, E633A, E657A, E678A, E697A, E698A, E742A, E743A, E768A, E1721A, E1722A, E1759A, E1760A, E1782A, E1805A, E1823A, E1829A, E619A, E632A, E637A, E675A, E676A, E679A, E703A, E705A, E707A, E719A, E744A, E1680A, E1695A, E1737A, E1738A, E1779A, E1781A, E1800A, E1808A, E1845A, E1846A, E1869A, E636A, E656A, E664A, E666A, E674A, E704A, E720A, E721A, E746A, E767A, E980A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864999	17	41197741	17	43045724	864999	853112	rs2050864495	NC_000017.11:43045723:T:G
NM_007294.4(BRCA1):c.5545G>T (p.Glu1849Ter)	BRCA1	E1870*, E1802*, E1849*, E745*, E1553*, E1680*, E1720*, E1738*, E1759*, E1761*, E1782*, E1805*, E1821*, E1830*, E1845*, E1871*, E619*, E633*, E657*, E658*, E664*, E666*, E675*, E678*, E707*, E981*, E1721*, E1736*, E1737*, E1760*, E1777*, E1779*, E1780*, E1806*, E1807*, E1822*, E1846*, E1848*, E1869*, E578*, E632*, E697*, E703*, E705*, E721*, E743*, E744*, E768*, E980*, E1552*, E1695*, E1722*, E1823*, E1829*, E618*, E636*, E656*, E674*, E679*, E699*, E706*, E719*, E720*, E767*, E1765*, E1778*, E1781*, E1800*, E1801*, E1808*, E1844*, E1847*, E437*, E569*, E637*, E676*, E698*, E701*, E704*, E742*, E746*	Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000869030	17	41197742	17	43045725	869030	853113	rs2050864747	NC_000017.11:43045724:C:A
NM_007294.4(BRCA1):c.5545G>C (p.Glu1849Gln)	BRCA1	E1802Q, E1849Q, E745Q, E1870Q, E1552Q, E1720Q, E1736Q, E1760Q, E1778Q, E1781Q, E1807Q, E1821Q, E1846Q, E1847Q, E437Q, E578Q, E658Q, E697Q, E703Q, E743Q, E1680Q, E1737Q, E1777Q, E1782Q, E1800Q, E1822Q, E1829Q, E1830Q, E1845Q, E1848Q, E1869Q, E618Q, E632Q, E636Q, E657Q, E674Q, E676Q, E679Q, E699Q, E719Q, E742Q, E744Q, E1722Q, E1738Q, E1779Q, E1780Q, E1808Q, E1823Q, E1871Q, E569Q, E637Q, E656Q, E675Q, E704Q, E707Q, E720Q, E746Q, E767Q, E980Q, E1553Q, E1695Q, E1721Q, E1759Q, E1761Q, E1765Q, E1801Q, E1805Q, E1806Q, E1844Q, E619Q, E633Q, E664Q, E666Q, E678Q, E698Q, E701Q, E705Q, E706Q, E721Q, E768Q, E981Q	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869029	17	41197742	17	43045725	869029	853114	rs2050864747	NC_000017.11:43045724:C:G
NM_007294.4(BRCA1):c.5545G>A (p.Glu1849Lys)	BRCA1	E745K, E1802K, E1849K, E1870K, E1801K, E1805K, E1821K, E1823K, E1829K, E1871K, E578K, E632K, E657K, E664K, E666K, E679K, E699K, E743K, E746K, E1552K, E1721K, E1736K, E1777K, E1780K, E1800K, E1806K, E1822K, E1844K, E633K, E636K, E637K, E674K, E697K, E701K, E704K, E706K, E768K, E980K, E1553K, E1680K, E1695K, E1720K, E1737K, E1760K, E1761K, E1778K, E1781K, E1782K, E1807K, E1808K, E1845K, E1848K, E1869K, E656K, E658K, E675K, E678K, E703K, E719K, E742K, E767K, E1722K, E1738K, E1759K, E1765K, E1779K, E1830K, E1846K, E1847K, E437K, E569K, E618K, E619K, E676K, E698K, E705K, E707K, E720K, E721K, E744K, E981K	Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 19, 2022)	criteria provided, single submitter	VCV000869028	17	41197742	17	43045725	869028	853115	rs2050864747	NC_000017.11:43045724:C:T
NM_007294.4(BRCA1):c.5544G>T (p.Gln1848His)	BRCA1	Q1801H, Q1848H, Q744H, Q1869H, Q1679H, Q1720H, Q1737H, Q1758H, Q1778H, Q1779H, Q1806H, Q1845H, Q1847H, Q436H, Q568H, Q632H, Q657H, Q678H, Q698H, Q703H, Q706H, Q719H, Q741H, Q745H, Q1551H, Q1694H, Q1764H, Q1781H, Q1804H, Q1805H, Q1820H, Q1821H, Q1822H, Q1868H, Q618H, Q636H, Q655H, Q674H, Q675H, Q677H, Q742H, Q1719H, Q1721H, Q1759H, Q1760H, Q1776H, Q1800H, Q631H, Q635H, Q656H, Q665H, Q697H, Q704H, Q705H, Q767H, Q980H, Q1552H, Q1735H, Q1736H, Q1777H, Q1780H, Q1799H, Q1807H, Q1828H, Q1829H, Q1843H, Q1844H, Q1846H, Q1870H, Q577H, Q617H, Q663H, Q673H, Q696H, Q700H, Q702H, Q718H, Q720H, Q743H, Q766H, Q979H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869027	17	41197743	17	43045726	869027	853116	rs2050865178	NC_000017.11:43045725:C:A
NM_007294.4(BRCA1):c.5544G>C (p.Gln1848His)	BRCA1	Q1801H, Q1848H, Q744H, Q1869H, Q1736H, Q1776H, Q1779H, Q1806H, Q1820H, Q1844H, Q1846H, Q436H, Q568H, Q674H, Q678H, Q698H, Q703H, Q719H, Q745H, Q1719H, Q1720H, Q1735H, Q1764H, Q1777H, Q1800H, Q1804H, Q1805H, Q1822H, Q1828H, Q1829H, Q1868H, Q618H, Q656H, Q665H, Q673H, Q677H, Q696H, Q704H, Q979H, Q1551H, Q1552H, Q1679H, Q1737H, Q1758H, Q1778H, Q1781H, Q1821H, Q1847H, Q631H, Q632H, Q655H, Q663H, Q675H, Q697H, Q700H, Q702H, Q706H, Q720H, Q742H, Q767H, Q980H, Q1694H, Q1721H, Q1759H, Q1760H, Q1780H, Q1799H, Q1807H, Q1843H, Q1845H, Q1870H, Q577H, Q617H, Q635H, Q636H, Q657H, Q705H, Q718H, Q741H, Q743H, Q766H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869026	17	41197743	17	43045726	869026	853117	rs2050865178	NC_000017.11:43045725:C:G
NM_007294.4(BRCA1):c.5544G>A (p.Gln1848=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Benign/Likely benign(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000869025	17	41197743	17	43045726	869025	853118	rs2050865178	NC_000017.11:43045725:C:T
NM_007294.4(BRCA1):c.5543A>T (p.Gln1848Leu)	BRCA1	Q744L, Q1848L, Q1869L, Q1801L, Q1551L, Q1737L, Q1807L, Q1821L, Q1828L, Q1844L, Q1846L, Q1868L, Q436L, Q617L, Q700L, Q702L, Q704L, Q720L, Q745L, Q980L, Q1552L, Q1694L, Q1759L, Q1760L, Q1764L, Q1776L, Q1778L, Q1800L, Q1805L, Q1820L, Q1843L, Q1845L, Q577L, Q655L, Q656L, Q657L, Q674L, Q678L, Q697L, Q698L, Q705L, Q741L, Q742L, Q743L, Q1719L, Q1735L, Q1736L, Q1777L, Q1779L, Q1780L, Q1799L, Q1804L, Q1806L, Q1822L, Q1847L, Q618L, Q631L, Q636L, Q703L, Q718L, Q719L, Q1679L, Q1720L, Q1721L, Q1758L, Q1781L, Q1829L, Q1870L, Q568L, Q632L, Q635L, Q663L, Q665L, Q673L, Q675L, Q677L, Q696L, Q706L, Q766L, Q767L, Q979L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869024	17	41197744	17	43045727	869024	853119	rs2050865445	NC_000017.11:43045726:T:A
NM_007294.4(BRCA1):c.5543A>G (p.Gln1848Arg)	BRCA1	Q1801R, Q1848R, Q744R, Q1869R, Q1679R, Q1721R, Q1737R, Q1776R, Q1777R, Q1799R, Q1805R, Q1847R, Q568R, Q636R, Q696R, Q702R, Q705R, Q706R, Q720R, Q745R, Q766R, Q767R, Q1551R, Q1720R, Q1736R, Q1779R, Q1780R, Q1781R, Q1804R, Q1820R, Q1822R, Q1843R, Q1844R, Q1845R, Q1846R, Q1870R, Q618R, Q632R, Q635R, Q655R, Q656R, Q665R, Q673R, Q675R, Q700R, Q704R, Q718R, Q979R, Q1694R, Q1719R, Q1758R, Q1760R, Q1807R, Q1821R, Q1828R, Q577R, Q617R, Q631R, Q674R, Q678R, Q698R, Q703R, Q719R, Q742R, Q743R, Q980R, Q1552R, Q1735R, Q1759R, Q1764R, Q1778R, Q1800R, Q1806R, Q1829R, Q1868R, Q436R, Q657R, Q663R, Q677R, Q697R, Q741R	Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 13, 2021)	criteria provided, single submitter	VCV000869023	17	41197744	17	43045727	869023	853120	rs2050865445	NC_000017.11:43045726:T:C
NM_007294.4(BRCA1):c.5543A>C (p.Gln1848Pro)	BRCA1	Q1801P, Q1869P, Q1848P, Q744P, Q1552P, Q1721P, Q1735P, Q1759P, Q1778P, Q1779P, Q1780P, Q1799P, Q1806P, Q1828P, Q1844P, Q1846P, Q1847P, Q617P, Q631P, Q636P, Q674P, Q706P, Q718P, Q741P, Q745P, Q767P, Q1679P, Q1694P, Q1720P, Q1736P, Q1758P, Q1760P, Q1800P, Q1804P, Q1805P, Q1820P, Q1829P, Q1868P, Q568P, Q632P, Q656P, Q657P, Q678P, Q696P, Q698P, Q700P, Q719P, Q1551P, Q1719P, Q1764P, Q1776P, Q1777P, Q1781P, Q1807P, Q1821P, Q1822P, Q1843P, Q1845P, Q1870P, Q577P, Q618P, Q655P, Q665P, Q677P, Q702P, Q703P, Q705P, Q720P, Q766P, Q980P, Q1737P, Q436P, Q635P, Q663P, Q673P, Q675P, Q697P, Q704P, Q742P, Q743P, Q979P	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868640	17	41197744	17	43045727	868640	853121	rs2050865445	NC_000017.11:43045726:T:G
NM_007294.4(BRCA1):c.5542C>G (p.Gln1848Glu)	BRCA1	Q1869E, Q1801E, Q1848E, Q744E, Q1679E, Q1719E, Q1721E, Q1758E, Q1760E, Q1776E, Q1778E, Q1781E, Q1806E, Q618E, Q631E, Q657E, Q674E, Q678E, Q702E, Q720E, Q766E, Q979E, Q1551E, Q1552E, Q1694E, Q1720E, Q1735E, Q1764E, Q1779E, Q1820E, Q1828E, Q1843E, Q1845E, Q1868E, Q617E, Q655E, Q663E, Q673E, Q696E, Q698E, Q705E, Q719E, Q741E, Q767E, Q1737E, Q1777E, Q1800E, Q1805E, Q1807E, Q1846E, Q1870E, Q436E, Q568E, Q577E, Q635E, Q656E, Q665E, Q675E, Q677E, Q704E, Q706E, Q718E, Q743E, Q1736E, Q1759E, Q1780E, Q1799E, Q1804E, Q1821E, Q1822E, Q1829E, Q1844E, Q1847E, Q632E, Q636E, Q697E, Q700E, Q703E, Q742E, Q745E, Q980E	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868639	17	41197745	17	43045728	868639	853122	rs886040303	NC_000017.11:43045727:G:C
NM_007294.4(BRCA1):c.5542C>A (p.Gln1848Lys)	BRCA1	Q1848K, Q1801K, Q1869K, Q744K, Q1759K, Q1779K, Q1780K, Q1799K, Q1804K, Q1807K, Q1845K, Q1868K, Q436K, Q631K, Q656K, Q677K, Q697K, Q703K, Q742K, Q745K, Q1551K, Q1679K, Q1721K, Q1736K, Q1758K, Q1760K, Q1778K, Q1781K, Q1800K, Q1806K, Q1829K, Q1847K, Q636K, Q655K, Q673K, Q700K, Q702K, Q704K, Q705K, Q718K, Q743K, Q979K, Q1552K, Q1694K, Q1764K, Q1821K, Q1822K, Q1828K, Q1843K, Q1846K, Q1870K, Q617K, Q618K, Q632K, Q657K, Q674K, Q675K, Q698K, Q719K, Q741K, Q767K, Q1719K, Q1720K, Q1735K, Q1737K, Q1776K, Q1777K, Q1805K, Q1820K, Q1844K, Q568K, Q577K, Q635K, Q663K, Q665K, Q678K, Q696K, Q706K, Q720K, Q766K, Q980K	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868638	17	41197745	17	43045728	868638	853123	rs886040303	NC_000017.11:43045727:G:T
NM_007294.4(BRCA1):c.5542C>T (p.Gln1848Ter)	BRCA1	Q1848*, Q1801*, Q1869*, Q744*, Q1551*, Q1679*, Q1719*, Q1737*, Q1759*, Q1777*, Q1778*, Q1780*, Q1804*, Q1807*, Q1820*, Q1821*, Q1844*, Q1847*, Q1868*, Q577*, Q618*, Q636*, Q706*, Q719*, Q766*, Q767*, Q1694*, Q1721*, Q1735*, Q1736*, Q1758*, Q1764*, Q1776*, Q1799*, Q1828*, Q1843*, Q568*, Q631*, Q632*, Q665*, Q677*, Q678*, Q698*, Q704*, Q741*, Q745*, Q979*, Q1552*, Q1779*, Q1781*, Q1800*, Q1805*, Q1846*, Q635*, Q657*, Q663*, Q673*, Q696*, Q697*, Q700*, Q703*, Q720*, Q742*, Q980*, Q1720*, Q1760*, Q1806*, Q1822*, Q1829*, Q1845*, Q1870*, Q436*, Q617*, Q655*, Q656*, Q674*, Q675*, Q702*, Q705*, Q718*, Q743*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	VCV000266562	17	41197745	17	43045728	266562	261566	rs886040303	NC_000017.11:43045727:G:A
NM_007294.4(BRCA1):c.5541C>G (p.Cys1847Trp)	BRCA1	C1847W, C1800W, C1868W, C743W, C1550W, C1551W, C1693W, C1719W, C1734W, C1735W, C1736W, C1759W, C1779W, C1799W, C1805W, C1821W, C1827W, C1828W, C435W, C630W, C634W, C656W, C674W, C676W, C741W, C978W, C1718W, C1757W, C1777W, C1778W, C1803W, C1844W, C1867W, C655W, C672W, C697W, C718W, C719W, C1720W, C1758W, C1763W, C1780W, C1806W, C1842W, C1843W, C1845W, C1846W, C1869W, C617W, C635W, C654W, C664W, C677W, C696W, C699W, C701W, C704W, C705W, C717W, C740W, C979W, C1678W, C1775W, C1776W, C1798W, C1804W, C1819W, C1820W, C567W, C576W, C616W, C631W, C662W, C673W, C695W, C702W, C703W, C742W, C744W, C765W, C766W	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Sep 10, 2022)	criteria provided, single submitter	VCV000868637	17	41197746	17	43045729	868637	853124	rs397509295	NC_000017.11:43045728:G:C
NM_007294.4(BRCA1):c.5541C>T (p.Cys1847=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jan 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000415547	17	41197746	17	43045729	415547	402619	rs397509295	NC_000017.11:43045728:G:A
NM_007294.4(BRCA1):c.5541C>A (p.Cys1847Ter)	BRCA1	C1847*, C1800*, C1868*, C743*, C1678*, C1719*, C1720*, C1734*, C1735*, C1736*, C1758*, C1777*, C1780*, C1803*, C1804*, C1806*, C1820*, C1827*, C1828*, C1867*, C631*, C664*, C673*, C676*, C699*, C701*, C705*, C744*, C978*, C979*, C1551*, C1776*, C1778*, C1779*, C1819*, C1843*, C1844*, C616*, C695*, C717*, C740*, C741*, C1550*, C1718*, C1763*, C1805*, C567*, C617*, C634*, C655*, C662*, C674*, C677*, C696*, C704*, C719*, C742*, C766*, C630*, C635*, C654*, C656*, C672*, C697*, C702*, C703*, C718*, C765*, C1693*, C1757*, C1759*, C1775*, C1798*, C1799*, C1821*, C1842*, C1845*, C1846*, C1869*, C435*, C576*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055622	17	41197746	17	43045729	55622	70289	rs397509295	NC_000017.11:43045728:G:T
NM_007294.4(BRCA1):c.5540G>C (p.Cys1847Ser)	BRCA1	C1847S, C743S, C1800S, C1868S, C1550S, C1719S, C1720S, C1777S, C1780S, C1819S, C1827S, C1843S, C1867S, C1869S, C631S, C655S, C662S, C674S, C697S, C699S, C701S, C703S, C718S, C744S, C765S, C766S, C1551S, C1735S, C1736S, C1758S, C1798S, C1803S, C1804S, C1805S, C1806S, C1820S, C1842S, C1845S, C576S, C616S, C630S, C656S, C664S, C677S, C695S, C696S, C741S, C742S, C979S, C617S, C634S, C654S, C702S, C705S, C1678S, C1757S, C1776S, C1778S, C1846S, C435S, C567S, C1693S, C1718S, C1734S, C1759S, C1763S, C1775S, C1779S, C1799S, C1821S, C1828S, C1844S, C635S, C672S, C673S, C676S, C704S, C717S, C719S, C740S, C978S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867639	17	41197747	17	43045730	867639	853125	rs1182000313	NC_000017.11:43045729:C:G
NM_007294.4(BRCA1):c.5540G>A (p.Cys1847Tyr)	BRCA1	C1800Y, C743Y, C1847Y, C1868Y, C1718Y, C1734Y, C1775Y, C1778Y, C1799Y, C1846Y, C1867Y, C576Y, C630Y, C631Y, C672Y, C674Y, C705Y, C717Y, C744Y, C1719Y, C1757Y, C1758Y, C1779Y, C1804Y, C1819Y, C1820Y, C1821Y, C1827Y, C1845Y, C635Y, C654Y, C655Y, C695Y, C697Y, C701Y, C740Y, C742Y, C979Y, C1551Y, C1693Y, C1720Y, C1736Y, C1759Y, C1776Y, C1780Y, C1828Y, C1843Y, C1844Y, C435Y, C616Y, C617Y, C673Y, C676Y, C704Y, C718Y, C719Y, C741Y, C765Y, C1550Y, C1678Y, C1735Y, C1763Y, C1777Y, C1798Y, C1803Y, C1805Y, C1806Y, C1842Y, C1869Y, C567Y, C634Y, C656Y, C662Y, C664Y, C677Y, C696Y, C699Y, C702Y, C703Y, C766Y, C978Y	Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 22, 2022)	criteria provided, conflicting interpretations	VCV000867638	17	41197747	17	43045730	867638	853126	rs1182000313	NC_000017.11:43045729:C:T
NM_007294.4(BRCA1):c.5540G>T (p.Cys1847Phe)	BRCA1	C1847F, C1800F, C1868F, C743F, C1718F, C1734F, C1736F, C1763F, C1776F, C1778F, C1779F, C1799F, C1820F, C1846F, C635F, C654F, C662F, C677F, C697F, C701F, C705F, C740F, C1678F, C1693F, C1720F, C1777F, C1798F, C1805F, C1821F, C1842F, C1843F, C435F, C567F, C576F, C616F, C617F, C655F, C673F, C676F, C699F, C702F, C719F, C978F, C1719F, C1735F, C1758F, C1775F, C1780F, C1804F, C1819F, C1827F, C1844F, C1845F, C1867F, C1869F, C630F, C631F, C634F, C664F, C672F, C703F, C717F, C718F, C742F, C744F, C765F, C1550F, C1551F, C1757F, C1759F, C1803F, C1806F, C1828F, C656F, C674F, C695F, C696F, C704F, C741F, C766F, C979F	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jul 19, 2022)	criteria provided, single submitter	VCV000582037	17	41197747	17	43045730	582037	569065	rs1182000313	NC_000017.11:43045729:C:A
NM_007294.4(BRCA1):c.5539T>G (p.Cys1847Gly)	BRCA1	C1847G, C1868G, C743G, C1800G, C1693G, C1720G, C1757G, C1779G, C1803G, C1804G, C1820G, C1821G, C1845G, C435G, C631G, C673G, C674G, C699G, C702G, C705G, C717G, C978G, C1550G, C1719G, C1734G, C1735G, C1777G, C1799G, C1819G, C1842G, C1844G, C567G, C617G, C655G, C664G, C697G, C701G, C703G, C719G, C765G, C766G, C979G, C1551G, C1718G, C1759G, C1763G, C1775G, C1778G, C1798G, C1805G, C1843G, C1846G, C1869G, C616G, C672G, C695G, C696G, C704G, C718G, C744G, C1678G, C1736G, C1758G, C1776G, C1780G, C1806G, C1827G, C1828G, C1867G, C576G, C630G, C634G, C635G, C654G, C656G, C662G, C676G, C677G, C740G, C741G, C742G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867637	17	41197748	17	43045731	867637	853127	rs2050866725	NC_000017.11:43045730:A:C
NM_007294.4(BRCA1):c.5539T>C (p.Cys1847Arg)	BRCA1	C1800R, C1847R, C1868R, C743R, C567R, C677R, C696R, C703R, C741R, C766R, C978R, C979R, C1693R, C1734R, C1759R, C1780R, C1803R, C1819R, C1820R, C1827R, C1842R, C435R, C1550R, C1551R, C1678R, C1735R, C1736R, C1763R, C1775R, C1798R, C1804R, C1821R, C1846R, C1869R, C655R, C672R, C673R, C705R, C717R, C718R, C744R, C765R, C1719R, C1720R, C1757R, C1776R, C1777R, C1805R, C1828R, C1843R, C1845R, C1867R, C616R, C631R, C635R, C662R, C664R, C674R, C676R, C695R, C697R, C699R, C701R, C740R, C742R, C1718R, C1758R, C1778R, C1779R, C1799R, C1806R, C1844R, C576R, C617R, C630R, C634R, C654R, C656R, C702R, C704R, C719R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867636	17	41197748	17	43045731	867636	853128	rs2050866725	NC_000017.11:43045730:A:G
NM_007294.4(BRCA1):c.5539T>A (p.Cys1847Ser)	BRCA1	C1868S, C1800S, C1847S, C743S, C1678S, C1693S, C1720S, C1759S, C1763S, C1779S, C1798S, C1806S, C1820S, C1828S, C1867S, C1869S, C631S, C655S, C662S, C674S, C703S, C704S, C717S, C741S, C978S, C1551S, C1719S, C1775S, C1776S, C1777S, C1804S, C1805S, C1843S, C1844S, C1846S, C435S, C630S, C673S, C696S, C702S, C705S, C1734S, C1736S, C1757S, C1799S, C1821S, C1827S, C1842S, C567S, C576S, C616S, C634S, C635S, C654S, C672S, C676S, C697S, C718S, C719S, C742S, C766S, C979S, C1550S, C1718S, C1735S, C1758S, C1778S, C1780S, C1803S, C1819S, C1845S, C617S, C656S, C664S, C677S, C695S, C699S, C701S, C740S, C744S, C765S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867635	17	41197748	17	43045731	867635	853129	rs2050866725	NC_000017.11:43045730:A:T
NM_007294.4(BRCA1):c.5538G>T (p.Gln1846His)	BRCA1	Q1846H, Q1867H, Q742H, Q1799H, Q1718H, Q1734H, Q1735H, Q1757H, Q1762H, Q1777H, Q1797H, Q1798H, Q1818H, Q1819H, Q1826H, Q1844H, Q434H, Q575H, Q654H, Q655H, Q671H, Q675H, Q696H, Q698H, Q702H, Q703H, Q743H, Q978H, Q1550H, Q1677H, Q1717H, Q1719H, Q1758H, Q1778H, Q1803H, Q1805H, Q1843H, Q1845H, Q616H, Q630H, Q653H, Q672H, Q676H, Q695H, Q717H, Q1549H, Q1733H, Q1756H, Q1774H, Q1776H, Q1779H, Q1804H, Q1820H, Q1841H, Q1866H, Q1868H, Q615H, Q633H, Q634H, Q673H, Q716H, Q718H, Q739H, Q764H, Q977H, Q1692H, Q1775H, Q1802H, Q1827H, Q1842H, Q566H, Q629H, Q661H, Q663H, Q694H, Q700H, Q701H, Q704H, Q740H, Q741H, Q765H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867634	17	41197749	17	43045732	867634	853130	rs80356849	NC_000017.11:43045731:C:A
NM_007294.4(BRCA1):c.5538G>C (p.Gln1846His)	BRCA1	Q1846H, Q1867H, Q742H, Q1799H, Q1692H, Q1718H, Q1756H, Q1776H, Q1777H, Q1803H, Q1804H, Q1842H, Q1866H, Q1868H, Q566H, Q616H, Q630H, Q653H, Q661H, Q672H, Q694H, Q702H, Q716H, Q718H, Q743H, Q764H, Q978H, Q1549H, Q1677H, Q1719H, Q1758H, Q1774H, Q1778H, Q1779H, Q1797H, Q1805H, Q1818H, Q1820H, Q1841H, Q1844H, Q1845H, Q575H, Q633H, Q654H, Q663H, Q675H, Q701H, Q741H, Q1733H, Q1734H, Q1735H, Q1762H, Q1819H, Q1826H, Q1827H, Q1843H, Q634H, Q655H, Q696H, Q698H, Q700H, Q1550H, Q1717H, Q1757H, Q1775H, Q1798H, Q1802H, Q434H, Q615H, Q629H, Q671H, Q673H, Q676H, Q695H, Q703H, Q704H, Q717H, Q739H, Q740H, Q765H, Q977H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 14, 2022)	criteria provided, conflicting interpretations	VCV000482930	17	41197749	17	43045732	482930	478549	rs80356849	NC_000017.11:43045731:C:G
NM_007294.4(BRCA1):c.5538G>A (p.Gln1846=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000055621	17	41197749	17	43045732	55621	70288	rs80356849	NC_000017.11:43045731:C:T
NM_007294.4(BRCA1):c.5537A>T (p.Gln1846Leu)	BRCA1	Q1867L, Q742L, Q1799L, Q1846L, Q1692L, Q1733L, Q1734L, Q1757L, Q1774L, Q1776L, Q1778L, Q1802L, Q1805L, Q1820L, Q1826L, Q1841L, Q1843L, Q566L, Q629L, Q633L, Q654L, Q661L, Q663L, Q676L, Q698L, Q700L, Q703L, Q716L, Q764L, Q765L, Q978L, Q1549L, Q1550L, Q1677L, Q1735L, Q1762L, Q1797L, Q1844L, Q1845L, Q616L, Q695L, Q739L, Q1718L, Q1719L, Q1758L, Q1777L, Q1798L, Q1803L, Q1818L, Q1819L, Q1842L, Q1868L, Q634L, Q653L, Q671L, Q672L, Q673L, Q675L, Q694L, Q696L, Q701L, Q702L, Q717L, Q740L, Q741L, Q1717L, Q1756L, Q1775L, Q1779L, Q1804L, Q1827L, Q1866L, Q434L, Q575L, Q615L, Q630L, Q655L, Q704L, Q718L, Q743L, Q977L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864987	17	41197750	17	43045733	864987	853131	rs2050867530	NC_000017.11:43045732:T:A
NM_007294.4(BRCA1):c.5537A>G (p.Gln1846Arg)	BRCA1	Q1867R, Q1799R, Q742R, Q1846R, Q1549R, Q1756R, Q1777R, Q1798R, Q1803R, Q1844R, Q566R, Q575R, Q630R, Q702R, Q704R, Q765R, Q1677R, Q1733R, Q1762R, Q1779R, Q1802R, Q1804R, Q1826R, Q1827R, Q616R, Q634R, Q653R, Q654R, Q661R, Q694R, Q695R, Q698R, Q701R, Q739R, Q764R, Q1550R, Q1717R, Q1718R, Q1735R, Q1757R, Q1758R, Q1775R, Q1805R, Q1819R, Q1841R, Q1843R, Q1845R, Q1868R, Q615R, Q633R, Q675R, Q700R, Q703R, Q740R, Q741R, Q743R, Q1692R, Q1719R, Q1734R, Q1774R, Q1776R, Q1778R, Q1797R, Q1818R, Q1820R, Q1842R, Q1866R, Q434R, Q629R, Q655R, Q663R, Q671R, Q672R, Q673R, Q676R, Q696R, Q716R, Q717R, Q718R, Q977R, Q978R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864986	17	41197750	17	43045733	864986	853132	rs2050867530	NC_000017.11:43045732:T:C
NM_007294.4(BRCA1):c.5537A>C (p.Gln1846Pro)	BRCA1	Q1799P, Q1846P, Q1867P, Q742P, Q1717P, Q1719P, Q1735P, Q1775P, Q1779P, Q1797P, Q1798P, Q1818P, Q1841P, Q1845P, Q615P, Q630P, Q653P, Q661P, Q672P, Q700P, Q717P, Q741P, Q765P, Q1718P, Q1758P, Q1774P, Q1778P, Q1803P, Q1819P, Q1826P, Q1827P, Q1843P, Q1844P, Q434P, Q633P, Q634P, Q655P, Q663P, Q675P, Q676P, Q695P, Q718P, Q764P, Q1677P, Q1692P, Q1733P, Q1734P, Q1756P, Q1757P, Q1777P, Q1804P, Q1866P, Q1868P, Q566P, Q616P, Q629P, Q673P, Q694P, Q696P, Q701P, Q702P, Q703P, Q704P, Q716P, Q740P, Q743P, Q977P, Q1549P, Q1550P, Q1762P, Q1776P, Q1802P, Q1805P, Q1820P, Q1842P, Q575P, Q654P, Q671P, Q698P, Q739P, Q978P	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864985	17	41197750	17	43045733	864985	853133	rs2050867530	NC_000017.11:43045732:T:G
NM_007294.4(BRCA1):c.5536C>G (p.Gln1846Glu)	BRCA1	Q1867E, Q1799E, Q1846E, Q742E, Q1677E, Q1692E, Q1734E, Q1756E, Q1757E, Q1762E, Q1775E, Q1797E, Q1802E, Q1803E, Q1819E, Q1827E, Q1844E, Q575E, Q615E, Q654E, Q661E, Q673E, Q676E, Q695E, Q701E, Q716E, Q764E, Q977E, Q1549E, Q1718E, Q1735E, Q1779E, Q1798E, Q1820E, Q1842E, Q1845E, Q1866E, Q434E, Q566E, Q634E, Q672E, Q702E, Q717E, Q739E, Q741E, Q743E, Q978E, Q1550E, Q1717E, Q1719E, Q1733E, Q1758E, Q1776E, Q1777E, Q1841E, Q1868E, Q616E, Q630E, Q633E, Q653E, Q663E, Q694E, Q696E, Q700E, Q703E, Q718E, Q765E, Q1774E, Q1778E, Q1804E, Q1805E, Q1818E, Q1826E, Q1843E, Q629E, Q655E, Q671E, Q675E, Q698E, Q704E, Q740E	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864984	17	41197751	17	43045734	864984	853134	rs80356873	NC_000017.11:43045733:G:C
NM_007294.4(BRCA1):c.5536C>A (p.Gln1846Lys)	BRCA1	Q742K, Q1846K, Q1799K, Q1867K, Q1550K, Q1692K, Q1719K, Q1735K, Q1776K, Q1797K, Q1798K, Q1804K, Q1819K, Q1844K, Q616K, Q663K, Q672K, Q703K, Q716K, Q740K, Q741K, Q743K, Q977K, Q1717K, Q1756K, Q1774K, Q1775K, Q1802K, Q1805K, Q1820K, Q1826K, Q1827K, Q1842K, Q566K, Q575K, Q653K, Q661K, Q675K, Q695K, Q698K, Q700K, Q702K, Q717K, Q739K, Q765K, Q1677K, Q1757K, Q1777K, Q1778K, Q1779K, Q1803K, Q1843K, Q1845K, Q1866K, Q1868K, Q434K, Q615K, Q630K, Q633K, Q671K, Q694K, Q696K, Q701K, Q718K, Q764K, Q978K, Q1549K, Q1718K, Q1733K, Q1734K, Q1758K, Q1762K, Q1818K, Q1841K, Q629K, Q634K, Q654K, Q655K, Q673K, Q676K, Q704K	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000825811	17	41197751	17	43045734	825811	813639	rs80356873	NC_000017.11:43045733:G:T
NM_007294.4(BRCA1):c.5536C>T (p.Gln1846Ter)	BRCA1	Q1846*, Q1867*, Q1799*, Q742*, Q1719*, Q1733*, Q1734*, Q1775*, Q1797*, Q1805*, Q1819*, Q1826*, Q1827*, Q1842*, Q1868*, Q434*, Q566*, Q629*, Q630*, Q654*, Q671*, Q676*, Q700*, Q701*, Q703*, Q717*, Q718*, Q740*, Q978*, Q1717*, Q1718*, Q1756*, Q1757*, Q1758*, Q1779*, Q1798*, Q1803*, Q1820*, Q1843*, Q575*, Q615*, Q634*, Q653*, Q655*, Q672*, Q673*, Q696*, Q739*, Q764*, Q1549*, Q1677*, Q1762*, Q1774*, Q1776*, Q1802*, Q1804*, Q1818*, Q1841*, Q1844*, Q1845*, Q694*, Q695*, Q702*, Q704*, Q765*, Q977*, Q1550*, Q1692*, Q1735*, Q1777*, Q1778*, Q1866*, Q616*, Q633*, Q661*, Q663*, Q675*, Q698*, Q716*, Q741*, Q743*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055620	17	41197751	17	43045734	55620	70287	rs80356873	NC_000017.11:43045733:G:A
NM_007294.4(BRCA1):c.5535C>T (p.Tyr1845=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864983	17	41197752	17	43045735	864983	853135	rs80356977	NC_000017.11:43045734:G:A
NM_007294.4(BRCA1):c.5535C>G (p.Tyr1845Ter)	BRCA1	Y1845*, Y1798*, Y741*, Y1866*, Y1676*, Y1717*, Y1761*, Y1797*, Y1802*, Y1818*, Y1841*, Y433*, Y614*, Y632*, Y652*, Y671*, Y674*, Y693*, Y697*, Y699*, Y701*, Y702*, Y763*, Y977*, Y1549*, Y1733*, Y1734*, Y1755*, Y1757*, Y1775*, Y1776*, Y1801*, Y1817*, Y1826*, Y1843*, Y1844*, Y1865*, Y565*, Y629*, Y654*, Y660*, Y670*, Y672*, Y694*, Y695*, Y703*, Y717*, Y738*, Y764*, Y1718*, Y1756*, Y1774*, Y1796*, Y1804*, Y1825*, Y1842*, Y662*, Y715*, Y742*, Y976*, Y1803*, Y1819*, Y1840*, Y1867*, Y574*, Y615*, Y628*, Y633*, Y653*, Y675*, Y700*, Y716*, Y739*, Y740*, Y1548*, Y1691*, Y1716*, Y1732*, Y1773*, Y1777*, Y1778*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	VCV000266559	17	41197752	17	43045735	266559	261568	rs80356977	NC_000017.11:43045734:G:C
NM_007294.4(BRCA1):c.5535C>A (p.Tyr1845Ter)	BRCA1	Y1845*, Y1798*, Y1866*, Y741*, Y1676*, Y1717*, Y1755*, Y1801*, Y1802*, Y1804*, Y1825*, Y1826*, Y1842*, Y565*, Y629*, Y632*, Y662*, Y675*, Y694*, Y695*, Y701*, Y703*, Y716*, Y977*, Y1548*, Y1549*, Y1718*, Y1797*, Y1803*, Y1819*, Y1841*, Y1865*, Y1867*, Y433*, Y652*, Y660*, Y674*, Y738*, Y740*, Y763*, Y976*, Y1732*, Y1733*, Y1734*, Y1756*, Y1774*, Y1776*, Y1777*, Y1778*, Y1817*, Y1818*, Y1843*, Y1844*, Y614*, Y693*, Y697*, Y699*, Y700*, Y717*, Y742*, Y1691*, Y1716*, Y1757*, Y1761*, Y1773*, Y1775*, Y1796*, Y1840*, Y574*, Y615*, Y628*, Y633*, Y653*, Y654*, Y670*, Y671*, Y672*, Y702*, Y715*, Y739*, Y764*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055619	17	41197752	17	43045735	55619	70286	rs80356977	NC_000017.11:43045734:G:T
NM_007294.4(BRCA1):c.5534A>T (p.Tyr1845Phe)	BRCA1	Y1798F, Y1866F, Y741F, Y1845F, Y1549F, Y1716F, Y1717F, Y1756F, Y1761F, Y1773F, Y1775F, Y1778F, Y1797F, Y1802F, Y1804F, Y1840F, Y1865F, Y615F, Y629F, Y652F, Y653F, Y671F, Y694F, Y715F, Y717F, Y740F, Y977F, Y1548F, Y1691F, Y1777F, Y1796F, Y1817F, Y1819F, Y1842F, Y433F, Y565F, Y574F, Y614F, Y628F, Y654F, Y662F, Y703F, Y716F, Y1676F, Y1733F, Y1755F, Y1801F, Y1818F, Y1825F, Y1826F, Y1867F, Y632F, Y660F, Y672F, Y675F, Y693F, Y699F, Y700F, Y701F, Y738F, Y739F, Y763F, Y1841F, Y1843F, Y1844F, Y633F, Y670F, Y674F, Y695F, Y697F, Y702F, Y742F, Y764F, Y976F, Y1718F, Y1732F, Y1734F, Y1757F, Y1774F, Y1776F, Y1803F	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869019	17	41197753	17	43045736	869019	853136	rs876660280	NC_000017.11:43045735:T:A
NM_007294.4(BRCA1):c.5534A>C (p.Tyr1845Ser)	BRCA1	Y1798S, Y741S, Y1866S, Y1845S, Y1691S, Y1755S, Y1757S, Y1778S, Y1801S, Y1803S, Y1804S, Y1844S, Y565S, Y652S, Y662S, Y674S, Y701S, Y702S, Y739S, Y740S, Y977S, Y1548S, Y1549S, Y1717S, Y1733S, Y1777S, Y1796S, Y1818S, Y1826S, Y1867S, Y433S, Y574S, Y629S, Y632S, Y653S, Y670S, Y694S, Y697S, Y703S, Y715S, Y717S, Y1676S, Y1716S, Y1718S, Y1732S, Y1756S, Y1774S, Y1802S, Y1817S, Y1840S, Y1843S, Y1865S, Y614S, Y615S, Y672S, Y699S, Y700S, Y738S, Y764S, Y976S, Y1734S, Y1761S, Y1773S, Y1775S, Y1776S, Y1797S, Y1819S, Y1825S, Y1841S, Y1842S, Y628S, Y633S, Y654S, Y660S, Y671S, Y675S, Y693S, Y695S, Y716S, Y742S, Y763S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869018	17	41197753	17	43045736	869018	853137	rs876660280	NC_000017.11:43045735:T:G
NM_007294.4(BRCA1):c.5534A>G (p.Tyr1845Cys)	BRCA1	Y1845C, Y1866C, Y1798C, Y741C, Y1548C, Y1549C, Y1676C, Y1775C, Y1777C, Y1801C, Y1802C, Y1825C, Y1840C, Y1841C, Y1842C, Y1844C, Y615C, Y628C, Y653C, Y654C, Y660C, Y675C, Y700C, Y701C, Y738C, Y739C, Y740C, Y1756C, Y1761C, Y1773C, Y1776C, Y1778C, Y1803C, Y1804C, Y1865C, Y574C, Y629C, Y652C, Y670C, Y672C, Y695C, Y699C, Y715C, Y717C, Y764C, Y1691C, Y1732C, Y1755C, Y1774C, Y1796C, Y1797C, Y1817C, Y1818C, Y1819C, Y433C, Y632C, Y662C, Y674C, Y693C, Y697C, Y702C, Y703C, Y716C, Y763C, Y977C, Y1716C, Y1717C, Y1718C, Y1733C, Y1734C, Y1757C, Y1826C, Y1843C, Y1867C, Y565C, Y614C, Y633C, Y671C, Y694C, Y742C, Y976C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 5, 2022)	criteria provided, conflicting interpretations	VCV000233238	17	41197753	17	43045736	233238	235925	rs876660280	NC_000017.11:43045735:T:C
NM_007294.4(BRCA1):c.5533T>G (p.Tyr1845Asp)	BRCA1	Y1798D, Y741D, Y1845D, Y1866D, Y1676D, Y1716D, Y1732D, Y1774D, Y1777D, Y1778D, Y1801D, Y1844D, Y565D, Y632D, Y662D, Y674D, Y716D, Y739D, Y977D, Y1548D, Y1733D, Y1756D, Y1757D, Y1761D, Y1773D, Y1817D, Y1825D, Y1842D, Y1843D, Y1865D, Y1867D, Y628D, Y660D, Y670D, Y671D, Y700D, Y717D, Y740D, Y742D, Y763D, Y764D, Y976D, Y1691D, Y1717D, Y1718D, Y1734D, Y1775D, Y1776D, Y1797D, Y1803D, Y1818D, Y1841D, Y574D, Y614D, Y629D, Y652D, Y654D, Y672D, Y693D, Y694D, Y697D, Y702D, Y715D, Y1549D, Y1755D, Y1796D, Y1802D, Y1804D, Y1819D, Y1826D, Y1840D, Y433D, Y615D, Y633D, Y653D, Y675D, Y695D, Y699D, Y701D, Y703D, Y738D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869017	17	41197754	17	43045737	869017	853138	rs2050869285	NC_000017.11:43045736:A:C
NM_007294.4(BRCA1):c.5533T>C (p.Tyr1845His)	BRCA1	Y1798H, Y1845H, Y1866H, Y741H, Y1549H, Y1676H, Y1717H, Y1718H, Y1755H, Y1757H, Y1774H, Y1803H, Y1817H, Y1819H, Y628H, Y652H, Y670H, Y693H, Y699H, Y701H, Y717H, Y739H, Y740H, Y976H, Y977H, Y697H, Y716H, Y738H, Y1548H, Y1691H, Y1733H, Y1756H, Y1773H, Y1777H, Y1801H, Y1818H, Y1842H, Y1867H, Y565H, Y574H, Y615H, Y633H, Y653H, Y662H, Y694H, Y695H, Y715H, Y764H, Y1732H, Y1761H, Y1776H, Y1778H, Y1797H, Y1825H, Y1840H, Y1841H, Y1844H, Y1865H, Y433H, Y614H, Y629H, Y654H, Y674H, Y675H, Y1716H, Y1734H, Y1775H, Y1796H, Y1802H, Y1804H, Y1826H, Y1843H, Y632H, Y660H, Y671H, Y672H, Y700H, Y702H, Y703H, Y742H, Y763H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869016	17	41197754	17	43045737	869016	853139	rs2050869285	NC_000017.11:43045736:A:G
NM_007294.4(BRCA1):c.5533T>A (p.Tyr1845Asn)	BRCA1	Y1798N, Y1845N, Y1866N, Y741N, Y1548N, Y1732N, Y1773N, Y1774N, Y1777N, Y1778N, Y1797N, Y1817N, Y1819N, Y1842N, Y565N, Y653N, Y671N, Y694N, Y699N, Y701N, Y702N, Y740N, Y742N, Y763N, Y1691N, Y1717N, Y1775N, Y1796N, Y1803N, Y1818N, Y1840N, Y1844N, Y433N, Y615N, Y675N, Y697N, Y764N, Y977N, Y1549N, Y1733N, Y1734N, Y1755N, Y1757N, Y1776N, Y1801N, Y1804N, Y1843N, Y1865N, Y614N, Y632N, Y652N, Y662N, Y670N, Y695N, Y715N, Y716N, Y717N, Y738N, Y976N, Y1676N, Y1716N, Y1718N, Y1756N, Y1761N, Y1802N, Y1825N, Y1826N, Y1841N, Y1867N, Y574N, Y628N, Y629N, Y633N, Y654N, Y660N, Y672N, Y674N, Y693N, Y700N, Y703N, Y739N	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869015	17	41197754	17	43045737	869015	853140	rs2050869285	NC_000017.11:43045736:A:T
NM_007294.4(BRCA1):c.5532C>G (p.Leu1844=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868629	17	41197755	17	43045738	868629	853141	rs80356829	NC_000017.11:43045737:G:C
NM_007294.4(BRCA1):c.5532C>A (p.Leu1844=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 29, 2021)	criteria provided, single submitter	VCV000868628	17	41197755	17	43045738	868628	853142	rs80356829	NC_000017.11:43045737:G:T
NM_007294.4(BRCA1):c.5532C>T (p.Leu1844=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000055616	17	41197755	17	43045738	55616	70283	rs80356829	NC_000017.11:43045737:G:A
NM_007294.4(BRCA1):c.5531T>A (p.Leu1844His)	BRCA1	L1797H, L740H, L1844H, L1865H, L1717H, L1732H, L1756H, L1772H, L1776H, L1818H, L1839H, L1840H, L1843H, L1864H, L573H, L669H, L674H, L693H, L698H, L699H, L702H, L714H, L762H, L1715H, L1731H, L1754H, L1773H, L1774H, L1800H, L1802H, L1825H, L1842H, L613H, L628H, L632H, L652H, L700H, L701H, L716H, L738H, L976H, L1548H, L1675H, L1690H, L1733H, L1777H, L1801H, L1803H, L1816H, L1824H, L432H, L651H, L653H, L661H, L670H, L671H, L694H, L696H, L715H, L741H, L763H, L1547H, L1716H, L1755H, L1760H, L1775H, L1795H, L1796H, L1817H, L1841H, L1866H, L564H, L614H, L627H, L631H, L659H, L673H, L692H, L737H, L739H, L975H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868627	17	41197756	17	43045739	868627	853143	rs80357323	NC_000017.11:43045738:A:T
NM_007294.4(BRCA1):c.5531T>C (p.Leu1844Pro)	BRCA1	L1844P, L740P, L1797P, L1865P, L1548P, L1754P, L1755P, L1756P, L1772P, L1773P, L1775P, L1800P, L1803P, L1816P, L1818P, L1824P, L1840P, L1842P, L564P, L627P, L652P, L696P, L702P, L714P, L1675P, L1732P, L1733P, L1796P, L1802P, L1817P, L1841P, L432P, L628P, L631P, L659P, L670P, L671P, L673P, L674P, L692P, L701P, L738P, L975P, L976P, L1547P, L1716P, L1717P, L1777P, L1795P, L1801P, L1825P, L1839P, L1864P, L1866P, L573P, L614P, L632P, L669P, L693P, L694P, L698P, L739P, L741P, L762P, L1690P, L1715P, L1731P, L1760P, L1774P, L1776P, L1843P, L613P, L651P, L653P, L661P, L699P, L700P, L715P, L716P, L737P, L763P	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2022)	criteria provided, conflicting interpretations	VCV000419732	17	41197756	17	43045739	419732	409940	rs80357323	NC_000017.11:43045738:A:G
NM_007294.4(BRCA1):c.5531T>G (p.Leu1844Arg)	BRCA1	L1844R, L740R, L1865R, L1797R, L1732R, L1775R, L1776R, L1796R, L1801R, L1825R, L1841R, L1864R, L573R, L627R, L628R, L631R, L653R, L659R, L739R, L1675R, L1690R, L1754R, L1756R, L1760R, L1800R, L1803R, L1817R, L1842R, L1866R, L564R, L613R, L632R, L651R, L692R, L698R, L699R, L702R, L716R, L975R, L976R, L1548R, L1717R, L1731R, L1755R, L1772R, L1773R, L1802R, L1818R, L1824R, L1840R, L614R, L652R, L671R, L674R, L696R, L701R, L738R, L741R, L1547R, L1715R, L1716R, L1733R, L1774R, L1777R, L1795R, L1816R, L1839R, L1843R, L432R, L661R, L669R, L670R, L673R, L693R, L694R, L700R, L714R, L715R, L737R, L762R, L763R	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055615	17	41197756	17	43045739	55615	70282	rs80357323	NC_000017.11:43045738:A:C
NM_007294.4(BRCA1):c.5530C>T (p.Leu1844Phe)	BRCA1	L740F, L1844F, L1797F, L1865F, L1547F, L1675F, L1716F, L1731F, L1777F, L1795F, L1796F, L1803F, L1816F, L1825F, L1842F, L1843F, L1864F, L432F, L564F, L613F, L628F, L661F, L692F, L699F, L702F, L716F, L738F, L976F, L1733F, L1754F, L1755F, L1774F, L1775F, L1776F, L1800F, L1817F, L1840F, L573F, L670F, L671F, L700F, L739F, L741F, L1690F, L1717F, L1772F, L1773F, L1802F, L1824F, L614F, L651F, L653F, L669F, L674F, L693F, L701F, L714F, L715F, L762F, L763F, L696F, L698F, L737F, L975F, L1548F, L1715F, L1732F, L1756F, L1760F, L1801F, L1818F, L1839F, L1841F, L1866F, L627F, L631F, L632F, L652F, L659F, L673F, L694F	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 6, 2022)	criteria provided, single submitter	VCV000868626	17	41197757	17	43045740	868626	853144	rs1471435242	NC_000017.11:43045739:G:A
NM_007294.4(BRCA1):c.5530C>G (p.Leu1844Val)	BRCA1	L1844V, L1865V, L740V, L1797V, L1772V, L1773V, L1774V, L1795V, L1800V, L1817V, L1839V, L1841V, L1843V, L564V, L613V, L631V, L659V, L670V, L673V, L674V, L696V, L699V, L700V, L715V, L741V, L763V, L975V, L1716V, L1717V, L1731V, L1733V, L1754V, L1755V, L1756V, L1760V, L1777V, L1796V, L1803V, L1816V, L1825V, L1840V, L1842V, L1864V, L1866V, L614V, L653V, L671V, L692V, L694V, L698V, L738V, L739V, L1548V, L1690V, L1775V, L1801V, L1818V, L1824V, L432V, L573V, L627V, L651V, L652V, L669V, L693V, L702V, L737V, L762V, L1547V, L1675V, L1715V, L1732V, L1776V, L1802V, L628V, L632V, L661V, L701V, L714V, L716V, L976V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868625	17	41197757	17	43045740	868625	853145	rs1471435242	NC_000017.11:43045739:G:C
NM_007294.4(BRCA1):c.5530C>A (p.Leu1844Ile)	BRCA1	L1844I, L1865I, L740I, L1797I, L1715I, L1716I, L1731I, L1733I, L1754I, L1796I, L1817I, L1825I, L1841I, L1842I, L670I, L674I, L696I, L714I, L737I, L975I, L1548I, L1756I, L1760I, L1774I, L1547I, L1675I, L1690I, L1717I, L1772I, L1773I, L1775I, L1795I, L1800I, L1802I, L1818I, L1824I, L1839I, L1840I, L1866I, L573I, L613I, L628I, L631I, L652I, L661I, L673I, L698I, L702I, L738I, L739I, L762I, L1776I, L1801I, L1816I, L432I, L564I, L614I, L632I, L659I, L669I, L692I, L693I, L700I, L701I, L715I, L716I, L741I, L976I, L1732I, L1755I, L1777I, L1803I, L1843I, L1864I, L627I, L651I, L653I, L671I, L694I, L699I, L763I	not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2021)	criteria provided, conflicting interpretations	VCV000482889	17	41197757	17	43045740	482889	478642	rs1471435242	NC_000017.11:43045739:G:T
NM_007294.4(BRCA1):c.5529A>T (p.Ala1843=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867628	17	41197758	17	43045741	867628	853146	rs1160863525	NC_000017.11:43045740:T:A
NM_007294.4(BRCA1):c.5529A>G (p.Ala1843=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000631293	17	41197758	17	43045741	631293	618549	rs1160863525	NC_000017.11:43045740:T:C
NM_007294.4(BRCA1):c.5529A>C (p.Ala1843=)	BRCA1		Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000482890	17	41197758	17	43045741	482890	478503	rs1160863525	NC_000017.11:43045740:T:G
NM_007294.4(BRCA1):c.5528C>G (p.Ala1843Gly)	BRCA1	A1796G, A1864G, A1843G, A739G, A1714G, A1715G, A1716G, A1732G, A1754G, A1755G, A1772G, A1775G, A1799G, A1865G, A631G, A651G, A670G, A692G, A693G, A698G, A699G, A736G, A740G, A762G, A974G, A1546G, A1674G, A1689G, A1730G, A1774G, A1794G, A1795G, A1800G, A1801G, A1802G, A1823G, A1839G, A1840G, A1841G, A572G, A627G, A630G, A650G, A669G, A691G, A697G, A738G, A761G, A1547G, A1731G, A1753G, A1759G, A1776G, A1815G, A1824G, A431G, A612G, A613G, A626G, A652G, A660G, A668G, A673G, A695G, A700G, A714G, A715G, A975G, A1771G, A1773G, A1816G, A1817G, A1838G, A1842G, A1863G, A563G, A658G, A672G, A701G, A713G, A737G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867627	17	41197759	17	43045742	867627	853147	rs730881447	NC_000017.11:43045741:G:C
NM_007294.4(BRCA1):c.5528C>T (p.Ala1843Val)	BRCA1	A1843V, A1864V, A739V, A1796V, A1546V, A1674V, A1714V, A1772V, A1799V, A1801V, A1823V, A1824V, A1839V, A1863V, A1865V, A563V, A572V, A650V, A658V, A660V, A693V, A695V, A697V, A700V, A737V, A974V, A1547V, A1731V, A1753V, A1771V, A1776V, A1795V, A1800V, A1817V, A1838V, A1842V, A431V, A612V, A651V, A652V, A670V, A672V, A691V, A713V, A740V, A975V, A1716V, A1732V, A1754V, A1755V, A1773V, A1775V, A1794V, A1802V, A1815V, A1816V, A1840V, A1841V, A630V, A631V, A692V, A698V, A715V, A761V, A762V, A1689V, A1715V, A1730V, A1759V, A1774V, A613V, A626V, A627V, A668V, A669V, A673V, A699V, A701V, A714V, A736V, A738V	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 4, 2022)	criteria provided, conflicting interpretations	VCV000496396	17	41197759	17	43045742	496396	487931	rs730881447	NC_000017.11:43045741:G:A
NM_007294.4(BRCA1):c.5528C>A (p.Ala1843Glu)	BRCA1	A1843E, A1864E, A739E, A1796E, A1754E, A1799E, A1801E, A1823E, A1824E, A1865E, A431E, A627E, A630E, A660E, A668E, A695E, A699E, A701E, A1716E, A1731E, A1755E, A1774E, A1775E, A1776E, A1794E, A1816E, A1839E, A1842E, A613E, A631E, A652E, A670E, A672E, A691E, A697E, A714E, A736E, A738E, A1546E, A1547E, A1689E, A1715E, A1772E, A1773E, A1795E, A1838E, A563E, A626E, A650E, A658E, A669E, A693E, A698E, A715E, A737E, A975E, A713E, A761E, A1674E, A1714E, A1730E, A1732E, A1753E, A1759E, A1771E, A1800E, A1802E, A1815E, A1817E, A1840E, A1841E, A1863E, A572E, A612E, A651E, A673E, A692E, A700E, A740E, A762E, A974E	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 7, 2021)	criteria provided, conflicting interpretations	VCV000182082	17	41197759	17	43045742	182082	180812	rs730881447	NC_000017.11:43045741:G:T
NM_007294.4(BRCA1):c.5527G>T (p.Ala1843Ser)	BRCA1	A1843S, A1864S, A1796S, A739S, A1689S, A1716S, A1731S, A1732S, A1754S, A1774S, A1775S, A1801S, A1823S, A1842S, A612S, A613S, A650S, A668S, A670S, A692S, A695S, A697S, A700S, A701S, A762S, A975S, A1546S, A1547S, A1714S, A1753S, A1794S, A1815S, A1816S, A1824S, A1840S, A563S, A572S, A627S, A630S, A651S, A658S, A660S, A672S, A693S, A699S, A714S, A715S, A761S, A974S, A1730S, A1759S, A1773S, A1799S, A1802S, A1839S, A1863S, A431S, A698S, A737S, A740S, A1674S, A1715S, A1755S, A1771S, A1772S, A1776S, A1795S, A1800S, A1817S, A1838S, A1841S, A1865S, A626S, A631S, A652S, A669S, A673S, A691S, A713S, A736S, A738S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867626	17	41197760	17	43045743	867626	853148	rs80357019	NC_000017.11:43045742:C:A
NM_007294.4(BRCA1):c.5527G>A (p.Ala1843Thr)	BRCA1	A1864T, A739T, A1843T, A1796T, A431T, A572T, A612T, A627T, A668T, A697T, A699T, A713T, A714T, A762T, A1547T, A1674T, A1715T, A1716T, A1755T, A1776T, A1802T, A1815T, A1823T, A1839T, A1863T, A1714T, A1730T, A1732T, A1753T, A1799T, A1817T, A1841T, A1842T, A626T, A650T, A651T, A660T, A692T, A693T, A698T, A700T, A701T, A715T, A1546T, A1731T, A1772T, A1773T, A1774T, A1775T, A1794T, A1795T, A1824T, A613T, A652T, A658T, A691T, A695T, A736T, A737T, A738T, A740T, A974T, A1689T, A1754T, A1759T, A1771T, A1800T, A1801T, A1816T, A1838T, A1840T, A1865T, A563T, A630T, A631T, A669T, A670T, A672T, A673T, A761T, A975T	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864974	17	41197760	17	43045743	864974	853149	rs80357019	NC_000017.11:43045742:C:T
NM_007294.4(BRCA1):c.5527G>C (p.Ala1843Pro)	BRCA1	A1843P, A1796P, A739P, A1864P, A1754P, A1801P, A1815P, A1817P, A1841P, A431P, A572P, A627P, A650P, A651P, A658P, A668P, A693P, A698P, A737P, A1730P, A1731P, A1773P, A1795P, A1863P, A631P, A660P, A672P, A691P, A699P, A740P, A762P, A1674P, A1714P, A1732P, A1772P, A1774P, A1775P, A1794P, A1800P, A1824P, A1840P, A1865P, A563P, A626P, A652P, A673P, A692P, A697P, A700P, A715P, A974P, A1546P, A1547P, A1689P, A1715P, A1716P, A1753P, A1755P, A1759P, A1771P, A1776P, A1799P, A1802P, A1816P, A1823P, A1838P, A1839P, A1842P, A612P, A613P, A630P, A669P, A670P, A695P, A701P, A713P, A714P, A736P, A738P, A761P, A975P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000055614	17	41197760	17	43045743	55614	70281	rs80357019	NC_000017.11:43045742:C:G
NM_007294.4(BRCA1):c.5526A>T (p.Val1842=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864973	17	41197761	17	43045744	864973	853150	rs1555574397	NC_000017.11:43045743:T:A
NM_007294.4(BRCA1):c.5526A>C (p.Val1842=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864972	17	41197761	17	43045744	864972	853151	rs1555574397	NC_000017.11:43045743:T:G
NM_007294.4(BRCA1):c.5526A>G (p.Val1842=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 15, 2016)	criteria provided, single submitter	VCV000479244	17	41197761	17	43045744	479244	479231	rs1555574397	NC_000017.11:43045743:T:C
NM_007294.4(BRCA1):c.5525T>G (p.Val1842Gly)	BRCA1	V1795G, V1863G, V1842G, V738G, V1730G, V1758G, V1771G, V1814G, V1822G, V1841G, V1862G, V611G, V657G, V669G, V671G, V691G, V700G, V712G, V735G, V760G, V1545G, V1673G, V1729G, V1731G, V1770G, V1774G, V1799G, V1815G, V1840G, V430G, V649G, V659G, V672G, V697G, V698G, V713G, V737G, V761G, V1688G, V1713G, V1752G, V1753G, V1772G, V1773G, V1775G, V1793G, V1798G, V1801G, V1816G, V1838G, V1839G, V1864G, V571G, V612G, V626G, V629G, V650G, V667G, V690G, V692G, V714G, V736G, V739G, V1546G, V1714G, V1715G, V1754G, V1794G, V1800G, V1823G, V1837G, V562G, V625G, V630G, V651G, V668G, V694G, V696G, V699G, V973G, V974G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864971	17	41197762	17	43045745	864971	853152	rs1555574400	NC_000017.11:43045744:A:C
NM_007294.4(BRCA1):c.5525T>C (p.Val1842Ala)	BRCA1	V1795A, V1863A, V1842A, V738A, V1688A, V1715A, V1730A, V1754A, V1772A, V1773A, V1799A, V1800A, V1822A, V1837A, V562A, V611A, V626A, V629A, V630A, V649A, V651A, V657A, V668A, V690A, V698A, V714A, V760A, V761A, V1546A, V1714A, V1729A, V1758A, V1770A, V1775A, V1815A, V1838A, V1841A, V650A, V691A, V699A, V735A, V736A, V737A, V974A, V1545A, V1752A, V1771A, V1774A, V1793A, V1794A, V1801A, V1814A, V1839A, V1840A, V1864A, V571A, V612A, V659A, V667A, V671A, V672A, V694A, V697A, V700A, V712A, V713A, V973A, V1673A, V1713A, V1731A, V1753A, V1798A, V1816A, V1823A, V1862A, V430A, V625A, V669A, V692A, V696A, V739A	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000864970	17	41197762	17	43045745	864970	853153	rs1555574400	NC_000017.11:43045744:A:G
NM_007294.4(BRCA1):c.5525T>A (p.Val1842Glu)	BRCA1	V1842E, V738E, V1863E, V1795E, V1688E, V1713E, V1715E, V1754E, V1758E, V1771E, V1837E, V1838E, V1841E, V430E, V612E, V668E, V672E, V700E, V712E, V737E, V739E, V760E, V973E, V669E, V671E, V691E, V697E, V699E, V713E, V974E, V1545E, V1673E, V1714E, V1730E, V1731E, V1773E, V1798E, V1801E, V1814E, V1815E, V1823E, V1839E, V1840E, V571E, V630E, V1752E, V1753E, V1770E, V1774E, V1775E, V1800E, V1822E, V1864E, V562E, V649E, V659E, V667E, V696E, V698E, V735E, V736E, V1546E, V1729E, V1772E, V1793E, V1794E, V1799E, V1816E, V1862E, V611E, V625E, V626E, V629E, V650E, V651E, V657E, V690E, V692E, V694E, V714E, V761E	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000481475	17	41197762	17	43045745	481475	478643	rs1555574400	NC_000017.11:43045744:A:T
NM_007294.4(BRCA1):c.5524G>C (p.Val1842Leu)	BRCA1	V1842L, V1795L, V1863L, V738L, V1688L, V1771L, V1773L, V1801L, V1840L, V562L, V630L, V651L, V668L, V671L, V672L, V690L, V692L, V697L, V699L, V739L, V760L, V659L, V669L, V694L, V698L, V700L, V712L, V714L, V737L, V974L, V1546L, V1713L, V1715L, V1754L, V1758L, V1775L, V1798L, V1814L, V1822L, V1837L, V1839L, V1841L, V430L, V611L, V625L, V626L, V629L, V649L, V667L, V691L, V735L, V736L, V761L, V973L, V1673L, V1729L, V1730L, V1731L, V1774L, V1793L, V1794L, V1799L, V1800L, V1823L, V1838L, V1862L, V571L, V650L, V657L, V1545L, V1714L, V1752L, V1753L, V1770L, V1772L, V1815L, V1816L, V1864L, V612L, V696L, V713L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869008	17	41197763	17	43045746	869008	853155	rs1296005499	NC_000017.11:43045745:C:G
NM_007294.4(BRCA1):c.5524G>A (p.Val1842Ile)	BRCA1	V1842I, V1795I, V1863I, V738I, V1546I, V1758I, V1814I, V1838I, V1839I, V1862I, V571I, V612I, V649I, V667I, V691I, V694I, V697I, V712I, V735I, V736I, V737I, V973I, V974I, V1545I, V1713I, V1715I, V1770I, V1773I, V1775I, V1799I, V1864I, V651I, V657I, V669I, V690I, V696I, V699I, V700I, V714I, V739I, V1729I, V1730I, V1753I, V1754I, V1771I, V1774I, V1793I, V1794I, V1801I, V1815I, V1822I, V430I, V562I, V630I, V650I, V659I, V672I, V692I, V713I, V760I, V761I, V1673I, V1688I, V1714I, V1731I, V1752I, V1772I, V1798I, V1800I, V1816I, V1823I, V1837I, V1840I, V1841I, V611I, V625I, V626I, V629I, V668I, V671I, V698I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Mar 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000869007	17	41197763	17	43045746	869007	853156	rs1296005499	NC_000017.11:43045745:C:T
NM_007294.4(BRCA1):c.5524G>T (p.Val1842Leu)	BRCA1	V1863L, V1842L, V738L, V1795L, V1673L, V1752L, V1758L, V1770L, V1774L, V1793L, V1840L, V1864L, V611L, V625L, V659L, V668L, V690L, V700L, V712L, V713L, V739L, V973L, V1546L, V1713L, V1754L, V1775L, V1799L, V1801L, V1837L, V1838L, V649L, V657L, V694L, V698L, V714L, V760L, V974L, V1714L, V1730L, V1731L, V1772L, V1773L, V1794L, V1798L, V1800L, V1814L, V1816L, V1839L, V1841L, V1862L, V430L, V630L, V650L, V667L, V669L, V692L, V696L, V697L, V735L, V1545L, V1688L, V1715L, V1729L, V1753L, V1771L, V1815L, V1822L, V1823L, V562L, V571L, V612L, V626L, V629L, V651L, V671L, V672L, V691L, V699L, V736L, V737L, V761L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864969	17	41197763	17	43045746	864969	853154	rs1296005499	NC_000017.11:43045745:C:A
NM_007294.4(BRCA1):c.5523T>G (p.Ser1841Arg)	BRCA1	S1862R, S737R, S1794R, S1841R, S1672R, S1728R, S1753R, S1757R, S1769R, S1772R, S1792R, S1797R, S1813R, S1815R, S1821R, S1822R, S1863R, S429R, S625R, S629R, S697R, S699R, S711R, S734R, S760R, S1544R, S1545R, S1687R, S1729R, S1752R, S1770R, S1773R, S1774R, S1799R, S1837R, S650R, S666R, S667R, S668R, S689R, S690R, S691R, S1712R, S1714R, S1771R, S1798R, S1800R, S1836R, S1840R, S570R, S610R, S628R, S648R, S649R, S656R, S670R, S695R, S696R, S698R, S712R, S713R, S736R, S759R, S973R, S1713R, S1730R, S1751R, S1793R, S1814R, S1838R, S1839R, S1861R, S561R, S611R, S624R, S658R, S671R, S693R, S735R, S738R, S972R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869006	17	41197764	17	43045747	869006	853157	rs878854960	NC_000017.11:43045746:A:C
NM_007294.4(BRCA1):c.5523T>A (p.Ser1841Arg)	BRCA1	S1862R, S737R, S1794R, S1841R, S1545R, S1687R, S1712R, S1713R, S1728R, S1730R, S1771R, S1773R, S1774R, S1799R, S1821R, S624R, S625R, S650R, S666R, S689R, S691R, S693R, S695R, S699R, S713R, S736R, S759R, S972R, S973R, S1544R, S1672R, S1753R, S1757R, S1772R, S1838R, S1839R, S1861R, S429R, S561R, S570R, S610R, S611R, S628R, S656R, S658R, S667R, S697R, S698R, S738R, S760R, S1714R, S1769R, S1792R, S1797R, S1798R, S1813R, S1815R, S1840R, S1863R, S629R, S670R, S671R, S690R, S711R, S734R, S735R, S1729R, S1751R, S1752R, S1770R, S1793R, S1800R, S1814R, S1822R, S1836R, S1837R, S648R, S649R, S668R, S696R, S712R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869005	17	41197764	17	43045747	869005	853158	rs878854960	NC_000017.11:43045746:A:T
NM_007294.4(BRCA1):c.5523T>C (p.Ser1841=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000240824	17	41197764	17	43045747	240824	242755	rs878854960	NC_000017.11:43045746:A:G
NM_007294.4(BRCA1):c.5522G>T (p.Ser1841Ile)	BRCA1	S1794I, S1841I, S1862I, S737I, S1672I, S1687I, S1713I, S1751I, S1770I, S1797I, S1799I, S1800I, S1822I, S1837I, S561I, S624I, S625I, S648I, S668I, S691I, S693I, S711I, S712I, S735I, S972I, S736I, S1544I, S1714I, S1728I, S1771I, S1793I, S1814I, S1815I, S667I, S671I, S689I, S696I, S699I, S713I, S973I, S1545I, S1712I, S1753I, S1757I, S1772I, S1773I, S1792I, S1798I, S1813I, S1839I, S1861I, S1863I, S570I, S610I, S611I, S629I, S649I, S650I, S656I, S666I, S690I, S695I, S697I, S734I, S1729I, S1730I, S1752I, S1769I, S1774I, S1821I, S1836I, S1838I, S1840I, S429I, S628I, S658I, S670I, S698I, S738I, S759I, S760I	Hereditary breast ovarian cancer syndrome	Likely pathogenic(Last reviewed: Apr 1, 2022)	criteria provided, single submitter	VCV000869004	17	41197765	17	43045748	869004	853159	rs80357368	NC_000017.11:43045747:C:A
NM_007294.4(BRCA1):c.5522G>C (p.Ser1841Thr)	BRCA1	S1841T, S737T, S1862T, S1794T, S1757T, S1799T, S1861T, S610T, S628T, S648T, S667T, S670T, S695T, S697T, S1545T, S1713T, S1728T, S1752T, S1773T, S1813T, S1815T, S429T, S561T, S611T, S666T, S690T, S712T, S713T, S738T, S1544T, S1712T, S1730T, S1751T, S1772T, S1774T, S1797T, S1822T, S1836T, S1838T, S1839T, S1863T, S624T, S625T, S629T, S649T, S656T, S668T, S691T, S698T, S711T, S734T, S735T, S972T, S1672T, S1687T, S1714T, S1729T, S1753T, S1769T, S1770T, S1771T, S1792T, S1793T, S1798T, S1800T, S1814T, S1821T, S1837T, S1840T, S570T, S650T, S658T, S671T, S689T, S693T, S696T, S699T, S736T, S759T, S760T, S973T	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2022)	criteria provided, conflicting interpretations	VCV000423044	17	41197765	17	43045748	423044	409941	rs80357368	NC_000017.11:43045747:C:G
NM_007294.4(BRCA1):c.5522G>A (p.Ser1841Asn)	BRCA1	S1841N, S1862N, S737N, S1794N, S1714N, S1751N, S1757N, S1772N, S1773N, S1774N, S1792N, S1797N, S1798N, S1813N, S1821N, S1839N, S1861N, S611N, S625N, S628N, S629N, S650N, S668N, S689N, S759N, S1712N, S735N, S738N, S1799N, S1836N, S570N, S610N, S624N, S648N, S656N, S667N, S697N, S711N, S973N, S1544N, S1672N, S1730N, S1753N, S1769N, S1771N, S1800N, S1815N, S1822N, S1838N, S1863N, S429N, S561N, S658N, S671N, S690N, S691N, S698N, S734N, S736N, S760N, S972N, S1545N, S1687N, S1713N, S1728N, S1729N, S1752N, S1770N, S1793N, S1814N, S1837N, S1840N, S649N, S666N, S670N, S693N, S695N, S696N, S699N, S712N, S713N	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 21, 2022)	criteria provided, conflicting interpretations	VCV000055613	17	41197765	17	43045748	55613	70280	rs80357368	NC_000017.11:43045747:C:T
NM_007294.4(BRCA1):c.5521A>T (p.Ser1841Cys)	BRCA1	S1794C, S1841C, S1862C, S737C, S1545C, S1714C, S1728C, S1729C, S1730C, S1774C, S1793C, S1814C, S1815C, S1861C, S429C, S625C, S650C, S667C, S691C, S696C, S736C, S759C, S972C, S1544C, S1752C, S1769C, S1770C, S1771C, S1798C, S628C, S649C, S656C, S671C, S690C, S697C, S711C, S738C, S973C, S1672C, S1687C, S1712C, S1753C, S1800C, S1813C, S1837C, S1838C, S1863C, S561C, S610C, S611C, S624C, S629C, S648C, S666C, S668C, S689C, S712C, S713C, S734C, S1713C, S1751C, S1757C, S1772C, S1773C, S1792C, S1797C, S1799C, S1821C, S1822C, S1836C, S1839C, S1840C, S570C, S658C, S670C, S693C, S695C, S698C, S699C, S735C, S760C	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868617	17	41197766	17	43045749	868617	853160	rs80357299	NC_000017.11:43045748:T:A
NM_007294.4(BRCA1):c.5521A>G (p.Ser1841Gly)	BRCA1	S1862G, S1841G, S737G, S1794G, S1672G, S1713G, S1714G, S1729G, S1752G, S1757G, S1770G, S1771G, S1773G, S1814G, S1822G, S1839G, S1840G, S1863G, S625G, S629G, S689G, S712G, S713G, S696G, S698G, S711G, S736G, S759G, S973G, S1544G, S1751G, S1772G, S1797G, S1798G, S1815G, S1838G, S429G, S561G, S570G, S649G, S658G, S667G, S668G, S670G, S691G, S695G, S697G, S734G, S738G, S760G, S972G, S1728G, S1730G, S1753G, S1792G, S1793G, S1799G, S1800G, S1813G, S1861G, S611G, S624G, S628G, S648G, S650G, S656G, S671G, S690G, S693G, S1545G, S1687G, S1712G, S1769G, S1774G, S1821G, S1836G, S1837G, S610G, S666G, S699G, S735G	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000825803	17	41197766	17	43045749	825803	813640	rs80357299	NC_000017.11:43045748:T:C
NM_007294.4(BRCA1):c.5521A>C (p.Ser1841Arg)	BRCA1	S1841R, S1862R, S737R, S1794R, S1544R, S1687R, S1714R, S1770R, S1773R, S1774R, S1840R, S1863R, S610R, S611R, S628R, S656R, S670R, S699R, S712R, S734R, S1545R, S1712R, S1728R, S1753R, S1757R, S1772R, S1793R, S1797R, S1814R, S1822R, S1836R, S1837R, S625R, S648R, S649R, S668R, S671R, S695R, S696R, S698R, S713R, S736R, S760R, S735R, S759R, S1672R, S1713R, S1730R, S1751R, S1771R, S1792R, S1800R, S1838R, S429R, S561R, S570R, S650R, S666R, S693R, S697R, S973R, S1729R, S1752R, S1769R, S1798R, S1799R, S1813R, S1815R, S1821R, S1839R, S1861R, S624R, S629R, S658R, S667R, S689R, S690R, S691R, S711R, S738R, S972R	Hereditary breast ovarian cancer syndrome	Likely pathogenic(Last reviewed: Oct 5, 2022)	criteria provided, single submitter	VCV000037681	17	41197766	17	43045749	37681	46237	rs80357299	NC_000017.11:43045748:T:G
NM_007294.4(BRCA1):c.5520C>T (p.Asp1840=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 8, 2021)	criteria provided, single submitter	VCV000868616	17	41197767	17	43045750	868616	853161	rs2050873874	NC_000017.11:43045749:G:A
NM_007294.4(BRCA1):c.5520C>G (p.Asp1840Glu)	BRCA1	D736E, D1861E, D1840E, D1793E, D972E, D1727E, D1729E, D1770E, D1791E, D1797E, D1812E, D1813E, D1820E, D1821E, D1838E, D569E, D609E, D627E, D647E, D657E, D688E, D696E, D711E, D712E, D758E, D1544E, D1712E, D1750E, D1751E, D1773E, D1792E, D1799E, D1837E, D1862E, D610E, D624E, D667E, D670E, D695E, D710E, D971E, D1711E, D1713E, D1728E, D1752E, D1756E, D1769E, D1772E, D1796E, D1798E, D1814E, D1839E, D428E, D560E, D628E, D648E, D655E, D665E, D692E, D694E, D734E, D735E, D737E, D1543E, D1671E, D1686E, D1768E, D1771E, D1835E, D1836E, D1860E, D623E, D649E, D666E, D669E, D689E, D690E, D697E, D698E, D733E, D759E	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 11, 2022)	criteria provided, single submitter	VCV000868615	17	41197767	17	43045750	868615	853162	rs2050873874	NC_000017.11:43045749:G:C
NM_007294.4(BRCA1):c.5520C>A (p.Asp1840Glu)	BRCA1	D736E, D1840E, D1861E, D1793E, D560E, D610E, D624E, D670E, D690E, D696E, D698E, D710E, D711E, D759E, D972E, D1671E, D1756E, D1770E, D1771E, D1772E, D1812E, D1821E, D1835E, D428E, D1544E, D1711E, D1713E, D1728E, D1751E, D1752E, D1769E, D1797E, D1814E, D1860E, D1862E, D569E, D647E, D649E, D666E, D669E, D689E, D697E, D733E, D734E, D735E, D758E, D1543E, D1727E, D1796E, D1836E, D1837E, D1839E, D627E, D648E, D655E, D665E, D694E, D695E, D712E, D737E, D1686E, D1712E, D1729E, D1750E, D1768E, D1773E, D1791E, D1792E, D1798E, D1799E, D1813E, D1820E, D1838E, D609E, D623E, D628E, D657E, D667E, D688E, D692E, D971E	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868614	17	41197767	17	43045750	868614	853163	rs2050873874	NC_000017.11:43045749:G:T
NM_007294.4(BRCA1):c.5519A>T (p.Asp1840Val)	BRCA1	D1793V, D1861V, D736V, D1840V, D1671V, D1711V, D1750V, D1751V, D1756V, D1769V, D1772V, D1796V, D1812V, D1837V, D1838V, D569V, D609V, D623V, D648V, D670V, D692V, D696V, D710V, D971V, D972V, D1543V, D1712V, D1713V, D1729V, D1771V, D1791V, D1799V, D1820V, D1862V, D428V, D627V, D628V, D655V, D657V, D695V, D712V, D733V, D735V, D1544V, D1686V, D1727V, D1728V, D1752V, D1768V, D1770V, D1773V, D1813V, D1814V, D1835V, D1860V, D560V, D610V, D665V, D667V, D669V, D688V, D690V, D697V, D758V, D1792V, D1797V, D1798V, D1821V, D1836V, D1839V, D624V, D647V, D649V, D666V, D689V, D694V, D698V, D711V, D734V, D737V, D759V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868613	17	41197768	17	43045751	868613	853164	rs2050874260	NC_000017.11:43045750:T:A
NM_007294.4(BRCA1):c.5519A>G (p.Asp1840Gly)	BRCA1	D1793G, D736G, D1840G, D1861G, D1544G, D1686G, D1711G, D1750G, D1772G, D1773G, D1792G, D1796G, D1797G, D1814G, D1820G, D1837G, D1838G, D1862G, D609G, D610G, D657G, D688G, D1713G, D1727G, D1729G, D1756G, D1770G, D1791G, D1836G, D1839G, D428G, D623G, D624G, D647G, D648G, D670G, D689G, D692G, D695G, D696G, D711G, D971G, D1543G, D1671G, D1712G, D1728G, D1751G, D1752G, D1771G, D1812G, D1835G, D627G, D655G, D665G, D666G, D667G, D669G, D690G, D697G, D710G, D733G, D735G, D758G, D1768G, D1769G, D1798G, D1799G, D1813G, D1821G, D1860G, D560G, D569G, D628G, D649G, D694G, D698G, D712G, D734G, D737G, D759G, D972G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868612	17	41197768	17	43045751	868612	853165	rs2050874260	NC_000017.11:43045750:T:C
NM_007294.4(BRCA1):c.5519A>C (p.Asp1840Ala)	BRCA1	D736A, D1793A, D1840A, D1861A, D1543A, D1712A, D1727A, D1750A, D1751A, D1799A, D1812A, D1860A, D610A, D667A, D692A, D712A, D733A, D735A, D737A, D1671A, D1686A, D1728A, D1729A, D1752A, D1756A, D1772A, D1792A, D1796A, D1813A, D1814A, D1820A, D1862A, D560A, D609A, D627A, D655A, D657A, D688A, D695A, D698A, D758A, D1544A, D1711A, D1713A, D1768A, D1797A, D1821A, D1835A, D1836A, D1837A, D428A, D623A, D624A, D647A, D666A, D669A, D689A, D694A, D710A, D711A, D734A, D759A, D1769A, D1770A, D1771A, D1773A, D1791A, D1798A, D1838A, D1839A, D569A, D628A, D648A, D649A, D665A, D670A, D690A, D696A, D697A, D971A, D972A	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV000861117	17	41197768	17	43045751	861117	845360	rs2050874260	NC_000017.11:43045750:T:G
NM_007294.4(BRCA1):c.5518G>C (p.Asp1840His)	BRCA1	D1861H, D1793H, D1840H, D736H, D1543H, D1711H, D1712H, D1728H, D1768H, D1769H, D1772H, D1773H, D1799H, D1812H, D610H, D624H, D649H, D669H, D710H, D733H, D1544H, D1729H, D1750H, D1756H, D1791H, D1798H, D1821H, D1862H, D569H, D627H, D657H, D694H, D734H, D737H, D1671H, D1713H, D1727H, D1770H, D1771H, D1797H, D1820H, D1835H, D1837H, D1838H, D428H, D560H, D623H, D628H, D666H, D667H, D670H, D689H, D695H, D696H, D697H, D698H, D711H, D735H, D758H, D971H, D972H, D1686H, D1751H, D1752H, D1792H, D1796H, D1813H, D1814H, D1836H, D1839H, D1860H, D609H, D647H, D648H, D655H, D665H, D688H, D690H, D692H, D712H, D759H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867620	17	41197769	17	43045752	867620	853166	rs1567756588	NC_000017.11:43045751:C:G
NM_007294.4(BRCA1):c.5518G>T (p.Asp1840Tyr)	BRCA1	D1793Y, D1840Y, D736Y, D1861Y, D1750Y, D1772Y, D1791Y, D1797Y, D1799Y, D1836Y, D1838Y, D1839Y, D623Y, D648Y, D666Y, D690Y, D694Y, D696Y, D711Y, D712Y, D735Y, D972Y, D1543Y, D1544Y, D1686Y, D1728Y, D1751Y, D1770Y, D1771Y, D1773Y, D1812Y, D1813Y, D1862Y, D569Y, D624Y, D647Y, D665Y, D669Y, D692Y, D695Y, D710Y, D1671Y, D1711Y, D1729Y, D1768Y, D1792Y, D1796Y, D1814Y, D1820Y, D1821Y, D1860Y, D428Y, D560Y, D609Y, D628Y, D657Y, D667Y, D688Y, D697Y, D698Y, D733Y, D734Y, D737Y, D759Y, D971Y, D1712Y, D1713Y, D1727Y, D1752Y, D1756Y, D1769Y, D1798Y, D1835Y, D1837Y, D610Y, D627Y, D649Y, D655Y, D670Y, D689Y, D758Y	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV000648216	17	41197769	17	43045752	648216	645917	rs1567756588	NC_000017.11:43045751:C:A
NM_007294.4(BRCA1):c.5518G>A (p.Asp1840Asn)	BRCA1	D1840N, D1793N, D1861N, D736N, D1543N, D1773N, D1791N, D1797N, D1799N, D1814N, D1821N, D1838N, D623N, D665N, D666N, D669N, D688N, D689N, D690N, D698N, D710N, D733N, D1686N, D1713N, D1728N, D1770N, D1792N, D1796N, D1798N, D1812N, D1820N, D1836N, D1860N, D428N, D560N, D627N, D628N, D655N, D670N, D696N, D697N, D734N, D735N, D1544N, D1671N, D1711N, D1750N, D1751N, D1752N, D1768N, D1771N, D1772N, D1813N, D1835N, D648N, D649N, D657N, D692N, D695N, D711N, D712N, D759N, D971N, D972N, D1712N, D1727N, D1729N, D1756N, D1769N, D1837N, D1839N, D1862N, D569N, D609N, D610N, D624N, D647N, D667N, D694N, D737N, D758N	not provided|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000580534	17	41197769	17	43045752	580534	574463	rs1567756588	NC_000017.11:43045751:C:T
NM_007294.4(BRCA1):c.5517G>T (p.Leu1839Phe)	BRCA1	L1839F, L735F, L1792F, L1860F, L1768F, L1796F, L1820F, L1837F, L1861F, L608F, L626F, L687F, L691F, L694F, L697F, L733F, L970F, L1670F, L1726F, L1728F, L1749F, L1771F, L1772F, L1795F, L1798F, L1819F, L1835F, L1836F, L1859F, L559F, L568F, L622F, L656F, L664F, L666F, L693F, L710F, L711F, L736F, L971F, L1542F, L1712F, L1750F, L1751F, L1769F, L1770F, L1790F, L1797F, L1812F, L1813F, L1834F, L1838F, L427F, L609F, L646F, L688F, L709F, L757F, L1543F, L1685F, L1710F, L1711F, L1727F, L1755F, L1767F, L1791F, L1811F, L623F, L627F, L647F, L648F, L654F, L665F, L668F, L669F, L689F, L695F, L696F, L732F, L734F, L758F	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867619	17	41197770	17	43045753	867619	853167	rs2050875063	NC_000017.11:43045752:C:A
NM_007294.4(BRCA1):c.5517G>C (p.Leu1839Phe)	BRCA1	L1839F, L735F, L1792F, L1860F, L1795F, L1797F, L1819F, L1836F, L609F, L623F, L646F, L654F, L656F, L666F, L668F, L691F, L695F, L697F, L711F, L757F, L970F, L1670F, L1710F, L1726F, L1728F, L1749F, L1767F, L1770F, L1790F, L1791F, L1811F, L1820F, L1834F, L626F, L627F, L664F, L669F, L688F, L693F, L696F, L709F, L732F, L734F, L1685F, L1711F, L1712F, L1751F, L1755F, L1768F, L1769F, L1798F, L1813F, L1837F, L1861F, L559F, L622F, L647F, L648F, L665F, L687F, L694F, L758F, L971F, L1542F, L1543F, L1727F, L1750F, L1771F, L1772F, L1796F, L1812F, L1835F, L1838F, L1859F, L427F, L568F, L608F, L689F, L710F, L733F, L736F	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867618	17	41197770	17	43045753	867618	853168	rs2050875063	NC_000017.11:43045752:C:G
NM_007294.4(BRCA1):c.5516T>A (p.Leu1839Ter)	BRCA1	L1839*, L1860*, L1792*, L735*, L1543*, L1726*, L1749*, L1790*, L1796*, L1797*, L1820*, L626*, L646*, L668*, L687*, L688*, L696*, L709*, L733*, L734*, L971*, L1542*, L1712*, L1728*, L1750*, L1769*, L1819*, L1837*, L427*, L559*, L623*, L627*, L664*, L665*, L694*, L697*, L710*, L732*, L736*, L757*, L1670*, L1751*, L1755*, L1768*, L1771*, L1772*, L1791*, L1795*, L1834*, L1836*, L568*, L608*, L622*, L647*, L648*, L666*, L689*, L691*, L970*, L1685*, L1710*, L1711*, L1727*, L1767*, L1770*, L1798*, L1811*, L1812*, L1813*, L1835*, L1838*, L1859*, L1861*, L609*, L654*, L656*, L669*, L693*, L695*, L711*, L758*	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867617	17	41197771	17	43045754	867617	853169	rs398122702	NC_000017.11:43045753:A:T
NM_007294.4(BRCA1):c.5516T>C (p.Leu1839Ser)	BRCA1	L1839S, L1792S, L735S, L1860S, L1728S, L1751S, L1770S, L1837S, L427S, L609S, L626S, L627S, L656S, L669S, L688S, L695S, L733S, L757S, L758S, L970S, L1542S, L1749S, L1767S, L1771S, L1772S, L1795S, L1797S, L1813S, L1820S, L1834S, L646S, L664S, L689S, L710S, L734S, L736S, L1670S, L1710S, L1711S, L1726S, L1768S, L1791S, L1819S, L1543S, L1685S, L1712S, L1727S, L1750S, L1755S, L1769S, L1790S, L1796S, L1798S, L1811S, L1812S, L1836S, L1838S, L608S, L623S, L647S, L648S, L654S, L665S, L668S, L687S, L691S, L697S, L709S, L971S, L1835S, L1859S, L1861S, L559S, L568S, L622S, L666S, L693S, L694S, L696S, L711S, L732S	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000091656	17	41197771	17	43045754	91656	97133	rs398122702	NC_000017.11:43045753:A:G
NM_007294.4(BRCA1):c.5515T>G (p.Leu1839Val)	BRCA1	L1839V, L1792V, L1860V, L735V, L1543V, L1728V, L1749V, L1750V, L1768V, L1769V, L1771V, L1772V, L1791V, L1813V, L568V, L609V, L626V, L654V, L664V, L687V, L696V, L697V, L709V, L711V, L971V, L1726V, L1790V, L1795V, L1797V, L1811V, L1835V, L1837V, L622V, L623V, L627V, L648V, L656V, L689V, L693V, L710V, L732V, L757V, L1542V, L1685V, L1711V, L1751V, L1770V, L1812V, L1819V, L1836V, L1859V, L427V, L559V, L647V, L665V, L666V, L669V, L688V, L733V, L736V, L970V, L1670V, L1710V, L1712V, L1727V, L1755V, L1767V, L1796V, L1798V, L1820V, L1834V, L1838V, L1861V, L608V, L646V, L668V, L691V, L694V, L695V, L734V, L758V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867616	17	41197772	17	43045755	867616	853170	rs2050875474	NC_000017.11:43045754:A:C
NM_007294.4(BRCA1):c.5515T>C (p.Leu1839=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864956	17	41197772	17	43045755	864956	853171	rs2050875474	NC_000017.11:43045754:A:G
NM_007294.4(BRCA1):c.5514G>C (p.Val1838=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864955	17	41197773	17	43045756	864955	853172	rs786201248	NC_000017.11:43045755:C:G
NM_007294.4(BRCA1):c.5514G>A (p.Val1838=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864954	17	41197773	17	43045756	864954	853173	rs786201248	NC_000017.11:43045755:C:T
NM_007294.4(BRCA1):c.5514G>T (p.Val1838=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000184051	17	41197773	17	43045756	184051	184868	rs786201248	NC_000017.11:43045755:C:A
NM_007294.4(BRCA1):c.5513T>C (p.Val1838Ala)	BRCA1	V1791A, V1838A, V1859A, V734A, V1748A, V1750A, V1754A, V1768A, V1797A, V1812A, V1835A, V1860A, V567A, V647A, V663A, V668A, V690A, V709A, V732A, V733A, V756A, V1669A, V1710A, V1711A, V1749A, V1766A, V1767A, V1769A, V1770A, V1790A, V1810A, V1834A, V426A, V607A, V625A, V646A, V692A, V735A, V970A, V1542A, V1726A, V1771A, V1789A, V1811A, V1833A, V1858A, V608A, V622A, V645A, V653A, V665A, V686A, V687A, V693A, V694A, V696A, V708A, V1541A, V1684A, V1709A, V1725A, V1727A, V1794A, V1795A, V1796A, V1818A, V1819A, V1836A, V1837A, V558A, V621A, V626A, V655A, V664A, V667A, V688A, V695A, V710A, V731A, V757A, V969A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864953	17	41197774	17	43045757	864953	853174	rs80357107	NC_000017.11:43045756:A:G
NM_007294.4(BRCA1):c.5513T>G (p.Val1838Gly)	BRCA1	V1838G, V1859G, V1791G, V734G, V1711G, V1726G, V1748G, V1767G, V1768G, V1790G, V1810G, V1811G, V1833G, V1858G, V1860G, V426G, V622G, V645G, V655G, V688G, V690G, V695G, V696G, V709G, V710G, V733G, V970G, V1669G, V1754G, V1770G, V1771G, V1797G, V1812G, V1836G, V607G, V621G, V647G, V692G, V694G, V731G, V1542G, V1684G, V1709G, V1749G, V1750G, V1789G, V1794G, V1795G, V1819G, V1834G, V626G, V664G, V667G, V668G, V708G, V757G, V969G, V1541G, V1710G, V1725G, V1727G, V1766G, V1769G, V1796G, V1818G, V1835G, V1837G, V558G, V567G, V608G, V625G, V646G, V653G, V663G, V665G, V686G, V687G, V693G, V732G, V735G, V756G	Breast-ovarian cancer, familial, susceptibility to, 1	Likely pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000254643	17	41197774	17	43045757	254643	249180	rs80357107	NC_000017.11:43045756:A:C
NM_007294.4(BRCA1):c.5513T>A (p.Val1838Glu)	BRCA1	V1838E, V1859E, V734E, V1791E, V1669E, V1684E, V1749E, V1750E, V1771E, V1789E, V1795E, V1797E, V1812E, V1858E, V426E, V607E, V625E, V645E, V646E, V668E, V687E, V695E, V756E, V969E, V1541E, V1725E, V1766E, V1770E, V1790E, V1794E, V1811E, V1819E, V1836E, V1837E, V558E, V621E, V626E, V647E, V653E, V655E, V688E, V709E, V731E, V733E, V735E, V1542E, V1711E, V1726E, V1727E, V1767E, V1768E, V1769E, V1796E, V1833E, V1834E, V1860E, V567E, V664E, V686E, V693E, V710E, V757E, V970E, V1709E, V1710E, V1748E, V1754E, V1810E, V1818E, V1835E, V608E, V622E, V663E, V665E, V667E, V690E, V692E, V694E, V696E, V708E, V732E	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055611	17	41197774	17	43045757	55611	70278	rs80357107	NC_000017.11:43045756:A:T
NM_007294.4(BRCA1):c.5512G>C (p.Val1838Leu)	BRCA1	V1791L, V734L, V1838L, V1859L, V1542L, V1684L, V1727L, V1748L, V1750L, V1754L, V1769L, V1771L, V1790L, V1796L, V1810L, V1833L, V1834L, V1836L, V1837L, V626L, V665L, V667L, V693L, V695L, V732L, V1541L, V1709L, V1710L, V1766L, V1767L, V1770L, V426L, V622L, V625L, V645L, V647L, V653L, V664L, V686L, V687L, V690L, V708L, V731L, V733L, V1669L, V1725L, V1749L, V1795L, V1819L, V608L, V621L, V646L, V663L, V668L, V692L, V710L, V757L, V1711L, V1726L, V1768L, V1789L, V1794L, V1797L, V1811L, V1812L, V1818L, V1835L, V1858L, V1860L, V558L, V567L, V607L, V655L, V688L, V694L, V696L, V709L, V735L, V756L, V969L, V970L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869002	17	41197775	17	43045758	869002	853175	rs730881501	NC_000017.11:43045757:C:G
NM_007294.4(BRCA1):c.5512G>T (p.Val1838Leu)	BRCA1	V1838L, V1791L, V734L, V1859L, V1542L, V1725L, V1750L, V1771L, V1811L, V1837L, V1860L, V663L, V668L, V693L, V695L, V708L, V731L, V732L, V1726L, V1768L, V1770L, V1796L, V1797L, V1812L, V1818L, V1834L, V1835L, V1836L, V567L, V607L, V608L, V621L, V645L, V655L, V686L, V687L, V688L, V694L, V733L, V1541L, V1669L, V1684L, V1709L, V1727L, V1748L, V1749L, V1754L, V1766L, V1789L, V1810L, V1819L, V426L, V622L, V626L, V667L, V692L, V696L, V710L, V735L, V756L, V969L, V970L, V1710L, V1711L, V1767L, V1769L, V1790L, V1794L, V1795L, V1833L, V1858L, V558L, V625L, V646L, V647L, V653L, V664L, V665L, V690L, V709L, V757L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000184981	17	41197775	17	43045758	184981	184869	rs730881501	NC_000017.11:43045757:C:A
NM_007294.4(BRCA1):c.5512G>A (p.Val1838Met)	BRCA1	V1838M, V1859M, V734M, V1791M, V1669M, V1710M, V1754M, V1769M, V1835M, V1837M, V567M, V607M, V608M, V622M, V647M, V667M, V690M, V695M, V732M, V970M, V1541M, V1684M, V1711M, V1726M, V1750M, V1770M, V1790M, V1796M, V1797M, V1819M, V1834M, V1836M, V626M, V645M, V653M, V655M, V663M, V664M, V668M, V686M, V688M, V692M, V694M, V710M, V969M, V1542M, V1709M, V1725M, V1727M, V1748M, V1768M, V1789M, V1794M, V1811M, V1818M, V621M, V687M, V693M, V708M, V731M, V733M, V735M, V757M, V1749M, V1766M, V1767M, V1771M, V1795M, V1810M, V1812M, V1833M, V1858M, V1860M, V426M, V558M, V625M, V646M, V665M, V696M, V709M, V756M	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2022)	criteria provided, conflicting interpretations	VCV000182173	17	41197775	17	43045758	182173	180813	rs730881501	NC_000017.11:43045757:C:T
NM_007294.4(BRCA1):c.5511G>C (p.Trp1837Cys)	BRCA1	W1837C, W1790C, W733C, W1858C, W1540C, W1709C, W1724C, W1753C, W1766C, W1788C, W1789C, W1796C, W1833C, W566C, W689C, W691C, W708C, W731C, W755C, W968C, W1541C, W1726C, W1748C, W1767C, W1795C, W1809C, W1817C, W1818C, W1857C, W1859C, W621C, W662C, W663C, W666C, W693C, W694C, W707C, W709C, W734C, W969C, W1668C, W1683C, W1725C, W1747C, W1770C, W1793C, W1810C, W1832C, W1835C, W645C, W646C, W664C, W695C, W732C, W756C, W1708C, W1710C, W1749C, W1765C, W1768C, W1769C, W1794C, W1811C, W1834C, W1836C, W425C, W557C, W606C, W607C, W620C, W624C, W625C, W644C, W652C, W654C, W667C, W685C, W686C, W687C, W692C, W730C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000421244	17	41197776	17	43045759	421244	409942	rs80356914	NC_000017.11:43045758:C:G
NM_007294.4(BRCA1):c.5511G>A (p.Trp1837Ter)	BRCA1	W1837*, W1790*, W1858*, W733*, W1668*, W1709*, W1710*, W1724*, W1747*, W1766*, W1767*, W1768*, W1796*, W1811*, W1833*, W566*, W606*, W624*, W646*, W663*, W687*, W695*, W707*, W709*, W730*, W734*, W969*, W1540*, W1725*, W1770*, W1788*, W1836*, W607*, W620*, W625*, W644*, W664*, W685*, W691*, W692*, W708*, W756*, W968*, W1749*, W1769*, W1795*, W1832*, W1857*, W1859*, W557*, W654*, W662*, W666*, W693*, W694*, W731*, W1541*, W1683*, W1708*, W1726*, W1748*, W1753*, W1765*, W1789*, W1793*, W1794*, W1809*, W1810*, W1817*, W1818*, W1834*, W1835*, W425*, W621*, W645*, W652*, W667*, W686*, W689*, W732*, W755*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055609	17	41197776	17	43045759	55609	70276	rs80356914	NC_000017.11:43045758:C:T
NM_007294.4(BRCA1):c.5511G>T (p.Trp1837Cys)	BRCA1	W1837C, W1790C, W733C, W1858C, W1541C, W1708C, W1724C, W1725C, W1726C, W1768C, W1788C, W1793C, W1809C, W1811C, W1818C, W606C, W607C, W646C, W652C, W654C, W662C, W663C, W664C, W667C, W686C, W689C, W692C, W695C, W734C, W755C, W756C, W1709C, W1710C, W1748C, W1749C, W1789C, W1794C, W1795C, W1835C, W1857C, W566C, W624C, W694C, W968C, W1683C, W1747C, W1765C, W1766C, W1769C, W1833C, W1834C, W557C, W620C, W625C, W644C, W685C, W691C, W707C, W708C, W709C, W730C, W1540C, W1668C, W1753C, W1767C, W1770C, W1796C, W1810C, W1817C, W1832C, W1836C, W1859C, W425C, W621C, W645C, W666C, W687C, W693C, W731C, W732C, W969C	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000037680	17	41197776	17	43045759	37680	46236	rs80356914	NC_000017.11:43045758:C:A
NM_007294.4(BRCA1):c.5510G>T (p.Trp1837Leu)	BRCA1	W1837L, W733L, W1858L, W1790L, W1668L, W1724L, W1725L, W1748L, W1749L, W1766L, W1818L, W1832L, W1835L, W1857L, W425L, W566L, W645L, W646L, W663L, W692L, W693L, W730L, W731L, W969L, W1541L, W1683L, W1708L, W1710L, W1788L, W1789L, W1795L, W1810L, W557L, W621L, W652L, W662L, W666L, W685L, W689L, W695L, W707L, W708L, W968L, W1540L, W1709L, W1726L, W1765L, W1768L, W1769L, W1770L, W1817L, W1833L, W1834L, W606L, W624L, W625L, W667L, W709L, W734L, W755L, W1747L, W1753L, W1767L, W1793L, W1794L, W1796L, W1809L, W1811L, W1836L, W1859L, W607L, W620L, W644L, W654L, W664L, W686L, W687L, W691L, W694L, W732L, W756L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869001	17	41197777	17	43045760	869001	853176	rs80357307	NC_000017.11:43045759:C:A
NM_007294.4(BRCA1):c.5510G>C (p.Trp1837Ser)	BRCA1	W1790S, W1837S, W1858S, W733S, W1683S, W1710S, W1724S, W1726S, W1768S, W1794S, W1832S, W1833S, W1857S, W557S, W566S, W624S, W625S, W645S, W652S, W662S, W687S, W691S, W694S, W695S, W709S, W730S, W732S, W756S, W1708S, W1725S, W1749S, W1767S, W1770S, W1788S, W1810S, W1818S, W1834S, W1859S, W606S, W607S, W644S, W664S, W685S, W693S, W708S, W731S, W734S, W755S, W1540S, W1747S, W1748S, W1795S, W1796S, W1809S, W1817S, W1835S, W646S, W666S, W689S, W692S, W707S, W968S, W1541S, W1668S, W1709S, W1753S, W1765S, W1766S, W1769S, W1789S, W1793S, W1811S, W1836S, W425S, W620S, W621S, W654S, W663S, W667S, W686S, W969S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869000	17	41197777	17	43045760	869000	853177	rs80357307	NC_000017.11:43045759:C:G
NM_007294.4(BRCA1):c.5510G>A (p.Trp1837Ter)	BRCA1	W1837*, W733*, W1858*, W1790*, W1708*, W1709*, W1725*, W1747*, W1768*, W1796*, W1811*, W1833*, W620*, W621*, W624*, W645*, W664*, W666*, W667*, W687*, W695*, W707*, W708*, W730*, W1668*, W1748*, W1749*, W1766*, W1769*, W1789*, W1817*, W1836*, W1857*, W425*, W606*, W663*, W731*, W756*, W968*, W969*, W1541*, W1710*, W1724*, W1726*, W1765*, W1770*, W1788*, W1793*, W1794*, W1809*, W1810*, W1834*, W1859*, W566*, W607*, W625*, W644*, W654*, W662*, W686*, W689*, W692*, W732*, W755*, W1540*, W1683*, W1753*, W1767*, W1795*, W1818*, W1832*, W1835*, W557*, W646*, W652*, W685*, W691*, W693*, W694*, W709*, W734*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055608	17	41197777	17	43045760	55608	70275	rs80357307	NC_000017.11:43045759:C:T
NM_007294.4(BRCA1):c.5509T>A (p.Trp1837Arg)	BRCA1	W1790R, W733R, W1837R, W1858R, W1540R, W1708R, W1725R, W1747R, W1748R, W1793R, W1795R, W1796R, W1811R, W1835R, W557R, W566R, W646R, W662R, W666R, W685R, W687R, W730R, W734R, W755R, W756R, W1541R, W1710R, W1726R, W1765R, W1766R, W1769R, W1770R, W1809R, W1817R, W1818R, W1859R, W625R, W645R, W664R, W667R, W689R, W692R, W694R, W969R, W1668R, W1683R, W1709R, W1724R, W1749R, W1753R, W1768R, W1788R, W1789R, W1833R, W1834R, W1836R, W621R, W644R, W686R, W695R, W708R, W968R, W663R, W691R, W693R, W707R, W709R, W731R, W732R, W1767R, W1794R, W1810R, W1832R, W1857R, W425R, W606R, W607R, W620R, W624R, W652R, W654R	Hereditary breast ovarian cancer syndrome	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV000853483	17	41197778	17	43045761	853483	845361	rs80356959	NC_000017.11:43045760:A:T
NM_007294.4(BRCA1):c.5509T>G (p.Trp1837Gly)	BRCA1	W1837G, W1790G, W1858G, W733G, W1541G, W1710G, W1725G, W1749G, W1753G, W1765G, W1768G, W1770G, W1789G, W606G, W624G, W625G, W689G, W691G, W693G, W707G, W730G, W731G, W732G, W755G, W1540G, W1708G, W1726G, W1747G, W1769G, W1788G, W1810G, W1811G, W1817G, W1834G, W1835G, W620G, W621G, W644G, W652G, W666G, W667G, W694G, W708G, W734G, W756G, W969G, W1683G, W1724G, W1766G, W1794G, W1796G, W1836G, W1857G, W607G, W663G, W664G, W686G, W687G, W692G, W709G, W1668G, W1709G, W1748G, W1767G, W1793G, W1795G, W1809G, W1818G, W1832G, W1833G, W1859G, W425G, W557G, W566G, W645G, W646G, W654G, W662G, W685G, W695G, W968G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000055607	17	41197778	17	43045761	55607	70274	rs80356959	NC_000017.11:43045760:A:C
NM_007294.4(BRCA1):c.5509T>C (p.Trp1837Arg)	BRCA1	W1837R, W733R, W1858R, W1790R, W1540R, W1541R, W1725R, W1747R, W1766R, W1768R, W1794R, W1817R, W425R, W621R, W624R, W625R, W646R, W662R, W663R, W685R, W691R, W707R, W731R, W1668R, W1683R, W1724R, W1765R, W1770R, W1789R, W1795R, W1796R, W1809R, W1810R, W1832R, W1857R, W1859R, W557R, W606R, W666R, W667R, W687R, W692R, W730R, W734R, W1708R, W1709R, W1710R, W1726R, W1767R, W1788R, W1818R, W1833R, W566R, W607R, W644R, W652R, W664R, W686R, W693R, W694R, W695R, W708R, W732R, W1748R, W1749R, W1753R, W1769R, W1793R, W1811R, W1834R, W1835R, W1836R, W620R, W645R, W654R, W689R, W709R, W755R, W756R, W968R, W969R	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037679	17	41197778	17	43045761	37679	46235	rs80356959	NC_000017.11:43045760:A:G
NM_007294.4(BRCA1):c.5508G>T (p.Glu1836Asp)	BRCA1	E732D, E1789D, E1836D, E1857D, E1539D, E1707D, E1724D, E1725D, E1747D, E1748D, E1766D, E1767D, E1787D, E1792D, E1831D, E1832D, E424D, E556D, E606D, E624D, E645D, E653D, E666D, E693D, E729D, E730D, E1540D, E1682D, E1723D, E1752D, E1788D, E1794D, E1809D, E1810D, E1817D, E1833D, E1834D, E623D, E684D, E685D, E686D, E688D, E690D, E707D, E708D, E967D, E1667D, E1764D, E1793D, E1795D, E1816D, E1835D, E619D, E644D, E661D, E663D, E694D, E706D, E754D, E755D, E1768D, E1769D, E1808D, E1856D, E1858D, E565D, E605D, E620D, E643D, E651D, E662D, E665D, E691D, E692D, E731D, E733D, E968D, E1708D, E1709D, E1746D, E1765D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868607	17	41197779	17	43045762	868607	853178	rs2050877902	NC_000017.11:43045761:C:A
NM_007294.4(BRCA1):c.5508G>C (p.Glu1836Asp)	BRCA1	E1836D, E732D, E1789D, E1857D, E1539D, E1540D, E1667D, E1707D, E1746D, E1747D, E1748D, E1752D, E1793D, E1817D, E565D, E620D, E644D, E661D, E663D, E665D, E691D, E694D, E708D, E729D, E755D, E1724D, E1764D, E1766D, E1795D, E1831D, E1834D, E556D, E606D, E651D, E653D, E662D, E688D, E690D, E706D, E730D, E733D, E967D, E968D, E1709D, E1723D, E1788D, E1794D, E1809D, E1833D, E1856D, E1858D, E424D, E619D, E624D, E645D, E666D, E684D, E685D, E707D, E754D, E1682D, E1708D, E1725D, E1765D, E1767D, E1768D, E1769D, E1787D, E1792D, E1808D, E1810D, E1816D, E1832D, E1835D, E605D, E623D, E643D, E686D, E692D, E693D, E731D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868606	17	41197779	17	43045762	868606	853179	rs2050877902	NC_000017.11:43045761:C:G
NM_007294.4(BRCA1):c.5508G>A (p.Glu1836=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000868605	17	41197779	17	43045762	868605	853180	rs2050877902	NC_000017.11:43045761:C:T
NM_007294.4(BRCA1):c.5507A>T (p.Glu1836Val)	BRCA1	E1857V, E1789V, E732V, E1836V, E1539V, E1667V, E1707V, E1724V, E1764V, E1767V, E1768V, E1787V, E1788V, E1816V, E606V, E624V, E651V, E661V, E662V, E690V, E706V, E729V, E730V, E754V, E967V, E1682V, E1723V, E1752V, E1765V, E1795V, E1808V, E1831V, E1833V, E1835V, E1858V, E556V, E620V, E643V, E645V, E663V, E684V, E686V, E694V, E731V, E1540V, E1708V, E1746V, E1766V, E1769V, E1792V, E1793V, E1794V, E1817V, E1856V, E424V, E644V, E653V, E665V, E685V, E691V, E692V, E733V, E968V, E1709V, E1725V, E1747V, E1748V, E1809V, E1810V, E1832V, E1834V, E565V, E605V, E619V, E623V, E666V, E688V, E693V, E707V, E708V, E755V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868604	17	41197780	17	43045763	868604	853181	rs2050878133	NC_000017.11:43045762:T:A
NM_007294.4(BRCA1):c.5507A>G (p.Glu1836Gly)	BRCA1	E732G, E1857G, E1789G, E1836G, E1539G, E1708G, E1725G, E1746G, E1747G, E1792G, E424G, E565G, E663G, E688G, E706G, E730G, E754G, E755G, E1667G, E1723G, E1768G, E1788G, E1795G, E1816G, E1832G, E556G, E605G, E606G, E644G, E662G, E666G, E685G, E690G, E691G, E694G, E707G, E731G, E733G, E967G, E968G, E1540G, E1707G, E1724G, E1764G, E1767G, E1787G, E1794G, E1808G, E1810G, E1817G, E1831G, E1833G, E1835G, E1856G, E619G, E623G, E624G, E643G, E651G, E653G, E684G, E686G, E693G, E708G, E729G, E1682G, E1709G, E1748G, E1752G, E1765G, E1766G, E1769G, E1793G, E1809G, E1834G, E1858G, E620G, E645G, E661G, E665G, E692G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868603	17	41197780	17	43045763	868603	853182	rs2050878133	NC_000017.11:43045762:T:C
NM_007294.4(BRCA1):c.5507A>C (p.Glu1836Ala)	BRCA1	E732A, E1789A, E1836A, E1857A, E1707A, E1747A, E1748A, E1765A, E1793A, E1794A, E1817A, E1832A, E1835A, E619A, E623A, E644A, E665A, E666A, E690A, E754A, E755A, E1709A, E1725A, E1787A, E1792A, E1810A, E1833A, E1856A, E565A, E1764A, E1766A, E1768A, E1769A, E1788A, E1808A, E1816A, E424A, E556A, E605A, E651A, E662A, E688A, E708A, E968A, E620A, E624A, E643A, E661A, E685A, E686A, E692A, E693A, E706A, E729A, E730A, E733A, E1682A, E1708A, E1723A, E1539A, E1540A, E1667A, E1724A, E1746A, E1752A, E1767A, E1795A, E1809A, E1831A, E1834A, E1858A, E606A, E645A, E653A, E663A, E684A, E691A, E694A, E707A, E731A, E967A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867611	17	41197780	17	43045763	867611	853183	rs2050878133	NC_000017.11:43045762:T:G
NM_007294.4(BRCA1):c.5506G>C (p.Glu1836Gln)	BRCA1	E1857Q, E1789Q, E1836Q, E732Q, E1682Q, E1724Q, E1747Q, E1748Q, E1769Q, E1792Q, E1795Q, E1834Q, E424Q, E556Q, E605Q, E623Q, E644Q, E685Q, E706Q, E707Q, E708Q, E754Q, E1709Q, E1766Q, E1787Q, E1793Q, E1794Q, E1808Q, E1831Q, E1833Q, E1856Q, E1858Q, E606Q, E643Q, E662Q, E686Q, E691Q, E693Q, E730Q, E968Q, E1539Q, E1667Q, E1707Q, E1725Q, E1764Q, E1768Q, E1810Q, E1816Q, E1817Q, E1835Q, E565Q, E619Q, E651Q, E653Q, E663Q, E684Q, E729Q, E733Q, E967Q, E1540Q, E1708Q, E1723Q, E1746Q, E1752Q, E1765Q, E1767Q, E1788Q, E1809Q, E1832Q, E620Q, E624Q, E645Q, E661Q, E665Q, E666Q, E688Q, E690Q, E692Q, E694Q, E731Q, E755Q	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867610	17	41197781	17	43045764	867610	853184	rs80356942	NC_000017.11:43045763:C:G
NM_007294.4(BRCA1):c.5506G>T (p.Glu1836Ter)	BRCA1	E1836*, E732*, E1857*, E1789*, E1539*, E1708*, E1709*, E1746*, E1747*, E1764*, E1787*, E1793*, E1832*, E424*, E565*, E619*, E645*, E651*, E663*, E690*, E708*, E733*, E1667*, E1724*, E1725*, E1752*, E1765*, E1767*, E1788*, E1816*, E1831*, E1834*, E1858*, E620*, E623*, E624*, E653*, E684*, E686*, E692*, E706*, E707*, E729*, E967*, E1540*, E1707*, E1766*, E1768*, E1792*, E1795*, E1809*, E1817*, E556*, E605*, E643*, E644*, E662*, E685*, E688*, E691*, E731*, E755*, E968*, E1682*, E1723*, E1748*, E1769*, E1794*, E1808*, E1810*, E1833*, E1835*, E1856*, E606*, E661*, E665*, E666*, E693*, E694*, E730*, E754*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055606	17	41197781	17	43045764	55606	70273	rs80356942	NC_000017.11:43045763:C:A
NM_007294.4(BRCA1):c.5506G>A (p.Glu1836Lys)	BRCA1	E1836K, E1789K, E1857K, E732K, E1539K, E1667K, E1724K, E1747K, E1765K, E1769K, E1788K, E1792K, E1816K, E1817K, E1835K, E1856K, E644K, E661K, E684K, E686K, E690K, E731K, E967K, E968K, E1540K, E1709K, E1725K, E1767K, E1832K, E1834K, E619K, E643K, E665K, E666K, E688K, E691K, E693K, E694K, E708K, E729K, E754K, E1707K, E1723K, E1748K, E1752K, E1766K, E1768K, E1793K, E1795K, E1808K, E1810K, E1831K, E1833K, E1858K, E424K, E556K, E605K, E606K, E623K, E645K, E653K, E662K, E706K, E707K, E755K, E1682K, E1708K, E1746K, E1764K, E1787K, E1794K, E1809K, E565K, E620K, E624K, E651K, E663K, E685K, E692K, E730K, E733K	Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|not provided|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jan 19, 2023)	criteria provided, multiple submitters, no conflicts	VCV000055605	17	41197781	17	43045764	55605	70272	rs80356942	NC_000017.11:43045763:C:T
NM_007294.4(BRCA1):c.5505A>T (p.Arg1835=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867609	17	41197782	17	43045765	867609	853185	rs2050879074	NC_000017.11:43045764:T:A
NM_007294.4(BRCA1):c.5505A>G (p.Arg1835=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867608	17	41197782	17	43045765	867608	853186	rs2050879074	NC_000017.11:43045764:T:C
NM_007294.4(BRCA1):c.5505A>C (p.Arg1835=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867607	17	41197782	17	43045765	867607	853187	rs2050879074	NC_000017.11:43045764:T:G
NM_007294.4(BRCA1):c.5504G>T (p.Arg1835Leu)	BRCA1	R1788L, R731L, R1835L, R1856L, R1707L, R1724L, R1747L, R1787L, R1808L, R1831L, R1832L, R1834L, R1857L, R618L, R623L, R650L, R661L, R684L, R706L, R728L, R753L, R754L, R1539L, R1722L, R1765L, R1768L, R1786L, R1794L, R1807L, R1815L, R423L, R564L, R604L, R605L, R622L, R642L, R644L, R652L, R660L, R683L, R687L, R691L, R692L, R707L, R729L, R732L, R967L, R1666L, R1746L, R1751L, R1791L, R1830L, R619L, R643L, R662L, R664L, R665L, R685L, R689L, R1538L, R1681L, R1706L, R1708L, R1723L, R1745L, R1763L, R1764L, R1766L, R1767L, R1792L, R1793L, R1809L, R1816L, R1833L, R1855L, R555L, R690L, R693L, R705L, R730L, R966L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867606	17	41197783	17	43045766	867606	853188	rs273902776	NC_000017.11:43045765:C:A
NM_007294.4(BRCA1):c.5504G>C (p.Arg1835Pro)	BRCA1	R1835P, R1788P, R731P, R1856P, R1539P, R1666P, R1708P, R1745P, R1765P, R1766P, R1831P, R1832P, R423P, R564P, R665P, R684P, R687P, R691P, R692P, R707P, R730P, R732P, R966P, R1706P, R1722P, R1747P, R1751P, R1763P, R1768P, R1786P, R1791P, R1792P, R1793P, R1808P, R1809P, R1830P, R1855P, R604P, R605P, R618P, R619P, R642P, R643P, R660P, R683P, R693P, R705P, R753P, R967P, R1707P, R1807P, R1815P, R1816P, R1834P, R1857P, R623P, R652P, R662P, R664P, R685P, R728P, R754P, R1538P, R1681P, R1723P, R1724P, R1746P, R1764P, R1767P, R1787P, R1794P, R1833P, R555P, R622P, R644P, R650P, R661P, R689P, R690P, R706P, R729P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified	Uncertain significance(Last reviewed: Feb 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000182172	17	41197783	17	43045766	182172	180814	rs273902776	NC_000017.11:43045765:C:G
NM_007294.4(BRCA1):c.5504G>A (p.Arg1835Gln)	BRCA1	R1835Q, R731Q, R1788Q, R1856Q, R1707Q, R1751Q, R1763Q, R1787Q, R1793Q, R1808Q, R1831Q, R1833Q, R1834Q, R555Q, R604Q, R622Q, R643Q, R644Q, R650Q, R664Q, R684Q, R690Q, R692Q, R705Q, R730Q, R753Q, R966Q, R1538Q, R1765Q, R1766Q, R1768Q, R1794Q, R1807Q, R1809Q, R1855Q, R423Q, R564Q, R652Q, R662Q, R687Q, R754Q, R967Q, R1539Q, R1681Q, R1706Q, R1708Q, R1722Q, R1723Q, R1724Q, R1747Q, R1767Q, R1786Q, R1815Q, R1832Q, R1857Q, R623Q, R642Q, R683Q, R685Q, R691Q, R693Q, R706Q, R728Q, R732Q, R1666Q, R1745Q, R1746Q, R1764Q, R1791Q, R1792Q, R1816Q, R1830Q, R605Q, R618Q, R619Q, R660Q, R661Q, R665Q, R689Q, R707Q, R729Q	not provided|not specified|Breast neoplasm|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2022)	criteria provided, conflicting interpretations	VCV000055604	17	41197783	17	43045766	55604	70271	rs273902776	NC_000017.11:43045765:C:T
NM_007294.4(BRCA1):c.5503C>G (p.Arg1835Gly)	BRCA1	R1856G, R731G, R1788G, R1835G, R1538G, R1707G, R1722G, R1723G, R1747G, R1767G, R1768G, R1794G, R1807G, R1815G, R1833G, R555G, R604G, R605G, R623G, R650G, R665G, R685G, R706G, R728G, R754G, R966G, R1724G, R1751G, R1764G, R1787G, R1816G, R1830G, R1831G, R1834G, R564G, R642G, R652G, R661G, R683G, R707G, R729G, R732G, R753G, R1539G, R1681G, R1746G, R1765G, R1791G, R1792G, R1808G, R1809G, R1832G, R1855G, R1857G, R618G, R644G, R684G, R689G, R690G, R691G, R693G, R705G, R730G, R967G, R1708G, R1745G, R1763G, R1766G, R1786G, R1793G, R423G, R619G, R622G, R643G, R660G, R662G, R664G, R687G, R692G, R1666G, R1706G	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, single submitter	VCV000864945	17	41197784	17	43045767	864945	853189	rs41293465	NC_000017.11:43045766:G:C
NM_007294.4(BRCA1):c.5503C>A (p.Arg1835=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864944	17	41197784	17	43045767	864944	853190	rs41293465	NC_000017.11:43045766:G:T
NM_007294.4(BRCA1):c.5503C>T (p.Arg1835Ter)	BRCA1	R1835*, R1856*, R1788*, R731*, R1539*, R1681*, R1706*, R1708*, R1764*, R1808*, R1809*, R1857*, R604*, R605*, R644*, R661*, R687*, R689*, R705*, R753*, R754*, R1666*, R1722*, R1723*, R1745*, R1747*, R1763*, R1766*, R1767*, R1807*, R1816*, R1831*, R1834*, R555*, R564*, R619*, R622*, R623*, R652*, R683*, R684*, R691*, R693*, R706*, R1538*, R1707*, R1724*, R1765*, R1787*, R1791*, R1793*, R1794*, R1815*, R1830*, R1855*, R618*, R642*, R643*, R660*, R662*, R664*, R685*, R729*, R966*, R1746*, R1751*, R1768*, R1786*, R1792*, R1832*, R1833*, R423*, R650*, R665*, R690*, R692*, R707*, R728*, R730*, R732*, R967*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000055601	17	41197784	17	43045767	55601	70268	rs41293465	NC_000017.11:43045766:G:A
NM_007294.4(BRCA1):c.5502C>G (p.Thr1834=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864943	17	41197785	17	43045768	864943	853191	rs1057520459	NC_000017.11:43045767:G:C
NM_007294.4(BRCA1):c.5502C>A (p.Thr1834=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864942	17	41197785	17	43045768	864942	853192	rs1057520459	NC_000017.11:43045767:G:T
NM_007294.4(BRCA1):c.5502C>T (p.Thr1834=)	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Aug 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000379005	17	41197785	17	43045768	379005	378220	rs1057520459	NC_000017.11:43045767:G:A
NM_007294.4(BRCA1):c.5501C>G (p.Thr1834Ser)	BRCA1	T730S, T1834S, T1787S, T1855S, T1680S, T1706S, T1707S, T1721S, T1762S, T1766S, T1806S, T1807S, T1808S, T1814S, T1830S, T554S, T603S, T604S, T686S, T688S, T706S, T727S, T729S, T731S, T966S, T1538S, T1765S, T1790S, T1792S, T1832S, T1833S, T617S, T621S, T643S, T659S, T661S, T683S, T691S, T705S, T728S, T1722S, T1723S, T1744S, T1746S, T1764S, T1786S, T1815S, T1856S, T641S, T642S, T649S, T664S, T682S, T690S, T704S, T752S, T753S, T965S, T1537S, T1665S, T1705S, T1745S, T1750S, T1763S, T1767S, T1785S, T1791S, T1793S, T1829S, T1831S, T1854S, T422S, T563S, T618S, T622S, T651S, T660S, T663S, T684S, T689S, T692S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868991	17	41197786	17	43045769	868991	853193	rs730881500	NC_000017.11:43045768:G:C
NM_007294.4(BRCA1):c.5501C>A (p.Thr1834Asn)	BRCA1	T1834N, T1855N, T1787N, T730N, T1538N, T1744N, T1767N, T1785N, T1792N, T1807N, T1815N, T563N, T617N, T641N, T649N, T659N, T663N, T688N, T692N, T706N, T727N, T966N, T1705N, T1706N, T1722N, T1746N, T1764N, T1829N, T1830N, T1831N, T1856N, T554N, T604N, T618N, T651N, T660N, T690N, T729N, T731N, T965N, T1537N, T1665N, T1707N, T1721N, T1723N, T1763N, T1766N, T1786N, T1790N, T1793N, T1806N, T1854N, T422N, T642N, T643N, T661N, T683N, T684N, T686N, T691N, T705N, T753N, T1680N, T1745N, T1750N, T1762N, T1765N, T1791N, T1808N, T1814N, T1832N, T1833N, T603N, T621N, T622N, T664N, T682N, T689N, T704N, T728N, T752N	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV000840931	17	41197786	17	43045769	840931	845362	rs730881500	NC_000017.11:43045768:G:T
NM_007294.4(BRCA1):c.5501C>T (p.Thr1834Ile)	BRCA1	T1834I, T730I, T1787I, T1855I, T664I, T691I, T692I, T705I, T1537I, T1707I, T1722I, T1723I, T1765I, T1785I, T1793I, T1808I, T1830I, T1831I, T554I, T563I, T618I, T643I, T649I, T661I, T683I, T684I, T689I, T728I, T729I, T753I, T1680I, T1721I, T1744I, T1746I, T1790I, T1806I, T1829I, T1832I, T1854I, T621I, T641I, T651I, T1706I, T1750I, T1763I, T1767I, T1786I, T1792I, T1856I, T422I, T603I, T604I, T642I, T659I, T660I, T688I, T690I, T704I, T706I, T731I, T965I, T966I, T1764I, T1766I, T1791I, T1807I, T1814I, T1815I, T1833I, T617I, T622I, T663I, T682I, T686I, T727I, T752I, T1538I, T1665I, T1705I, T1745I, T1762I	not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2023)	criteria provided, conflicting interpretations	VCV000182171	17	41197786	17	43045769	182171	180815	rs730881500	NC_000017.11:43045768:G:A
NM_007294.4(BRCA1):c.5500A>T (p.Thr1834Ser)	BRCA1	T1722S, T1745S, T1762S, T1763S, T1767S, T1785S, T1806S, T1807S, T1814S, T1832S, T1854S, T422S, T622S, T641S, T649S, T659S, T661S, T682S, T690S, T727S, T730S, T1787S, T1834S, T1855S, T1680S, T1705S, T1765S, T1766S, T1786S, T1792S, T1793S, T1815S, T1856S, T617S, T664S, T689S, T691S, T704S, T706S, T1538S, T1707S, T1721S, T1723S, T1750S, T1790S, T1791S, T1808S, T1829S, T1830S, T1831S, T1833S, T563S, T603S, T604S, T618S, T621S, T642S, T660S, T663S, T684S, T686S, T688S, T692S, T728S, T729S, T752S, T753S, T965S, T1665S, T1706S, T1744S, T1746S, T1764S, T554S, T643S, T651S, T683S, T705S, T731S, T966S, T1537S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868990	17	41197787	17	43045770	868990	853194	rs2050880456	NC_000017.11:43045769:T:A
NM_007294.4(BRCA1):c.5500A>G (p.Thr1834Ala)	BRCA1	T1834A, T1855A, T1787A, T730A, T1537A, T1538A, T1680A, T1721A, T1744A, T1745A, T1765A, T1791A, T1806A, T1829A, T1833A, T1854A, T621A, T651A, T664A, T682A, T683A, T689A, T690A, T691A, T692A, T727A, T729A, T752A, T966A, T1707A, T1722A, T1750A, T1762A, T1764A, T1767A, T1807A, T1815A, T1830A, T618A, T641A, T649A, T660A, T661A, T684A, T686A, T688A, T704A, T965A, T1665A, T1723A, T1746A, T1763A, T1786A, T1790A, T1814A, T1831A, T1832A, T617A, T622A, T643A, T663A, T753A, T1705A, T1706A, T1766A, T1785A, T1792A, T1793A, T1808A, T1856A, T422A, T554A, T563A, T603A, T604A, T642A, T659A, T705A, T706A, T728A, T731A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868989	17	41197787	17	43045770	868989	853195	rs2050880456	NC_000017.11:43045769:T:C
NM_007294.4(BRCA1):c.5500A>C (p.Thr1834Pro)	BRCA1	T1787P, T1834P, T730P, T1855P, T1763P, T1785P, T1792P, T1793P, T1807P, T1829P, T1831P, T422P, T563P, T659P, T692P, T729P, T1723P, T1750P, T1762P, T1765P, T1786P, T1790P, T1791P, T1854P, T604P, T618P, T643P, T651P, T660P, T686P, T690P, T753P, T1705P, T1707P, T1745P, T1764P, T1767P, T1806P, T1814P, T1815P, T1830P, T1832P, T1833P, T603P, T617P, T621P, T622P, T649P, T661P, T682P, T683P, T684P, T704P, T705P, T706P, T727P, T728P, T731P, T752P, T1537P, T1538P, T1665P, T1680P, T1706P, T1721P, T1722P, T1744P, T1746P, T1766P, T1808P, T1856P, T554P, T641P, T642P, T663P, T664P, T688P, T689P, T691P, T965P, T966P	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868988	17	41197787	17	43045770	868988	853196	rs2050880456	NC_000017.11:43045769:T:G
NM_007294.4(BRCA1):c.5499G>T (p.Val1833=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868987	17	41197788	17	43045771	868987	853197	rs2050880700	NC_000017.11:43045770:C:A
NM_007294.4(BRCA1):c.5499G>C (p.Val1833=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868986	17	41197788	17	43045771	868986	853198	rs2050880700	NC_000017.11:43045770:C:G
NM_007294.4(BRCA1):c.5499G>A (p.Val1833=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868597	17	41197788	17	43045771	868597	853199	rs2050880700	NC_000017.11:43045770:C:T
NM_007294.4(BRCA1):c.5498T>G (p.Val1833Gly)	BRCA1	V1679G, V1749G, V1762G, V1807G, V1814G, V1830G, V1854G, V1855G, V421G, V562G, V650G, V659G, V685G, V690G, V703G, V726G, V964G, V965G, V1537G, V1664G, V1704G, V1705G, V1706G, V1720G, V1744G, V1761G, V1790G, V1829G, V1831G, V616G, V617G, V620G, V621G, V642G, V662G, V687G, V730G, V1536G, V1722G, V1745G, V1763G, V1764G, V1765G, V1784G, V1785G, V1786G, V1789G, V1791G, V1828G, V1832G, V1853G, V553G, V648G, V660G, V663G, V683G, V688G, V689G, V704G, V729G, V1721G, V1743G, V1766G, V1792G, V1805G, V1806G, V1813G, V1833G, V602G, V603G, V640G, V641G, V658G, V681G, V682G, V691G, V705G, V727G, V728G, V751G, V752G	Hereditary breast ovarian cancer syndrome	Likely pathogenic(Last reviewed: May 9, 2022)	criteria provided, single submitter	VCV002135737	17	41197789	17	43045772	2135737	2188992		NC_000017.11:43045771:A:C
NM_007294.4(BRCA1):c.5498T>A (p.Val1833Glu)	BRCA1	V1854E, V1786E, V1833E, V729E, V1722E, V1763E, V1764E, V1784E, V1807E, V1813E, V1828E, V1829E, V1830E, V1832E, V642E, V648E, V662E, V704E, V705E, V726E, V728E, V1706E, V1766E, V1805E, V1853E, V421E, V603E, V617E, V621E, V650E, V660E, V687E, V690E, V752E, V964E, V965E, V1679E, V1720E, V1744E, V1745E, V1749E, V1762E, V1785E, V1790E, V1791E, V1792E, V1831E, V1855E, V553E, V602E, V640E, V641E, V658E, V663E, V683E, V688E, V689E, V691E, V730E, V751E, V1536E, V1664E, V1704E, V1705E, V1765E, V1537E, V1721E, V1743E, V1761E, V1789E, V1806E, V1814E, V562E, V616E, V620E, V659E, V681E, V682E, V685E, V703E, V727E	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868596	17	41197789	17	43045772	868596	853200	rs587782340	NC_000017.11:43045771:A:T
NM_007294.4(BRCA1):c.5498T>C (p.Val1833Ala)	BRCA1	V1833A, V1854A, V729A, V1786A, V1536A, V1537A, V1664A, V1706A, V1749A, V1763A, V1764A, V1807A, V1813A, V1855A, V421A, V553A, V603A, V727A, V1705A, V1743A, V1744A, V1765A, V1784A, V1789A, V1791A, V1805A, V1831A, V616A, V641A, V648A, V650A, V658A, V663A, V681A, V683A, V688A, V705A, V726A, V728A, V1704A, V1721A, V1745A, V1762A, V1766A, V1785A, V1790A, V1806A, V1829A, V1830A, V1853A, V620A, V621A, V659A, V660A, V682A, V687A, V703A, V704A, V751A, V964A, V1679A, V1720A, V1722A, V1761A, V1792A, V1814A, V1828A, V1832A, V562A, V602A, V617A, V640A, V642A, V662A, V685A, V689A, V690A, V691A, V730A, V752A, V965A	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jul 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000142256	17	41197789	17	43045772	142256	151970	rs587782340	NC_000017.11:43045771:A:G
NM_007294.4(BRCA1):c.5497G>C (p.Val1833Leu)	BRCA1	V1854L, V729L, V1786L, V1833L, V1537L, V1704L, V1720L, V1743L, V1744L, V1762L, V1790L, V1791L, V1807L, V1813L, V1831L, V1853L, V562L, V648L, V658L, V660L, V681L, V682L, V705L, V727L, V751L, V1664L, V1705L, V1721L, V1784L, V1789L, V1792L, V1805L, V1806L, V1830L, V1855L, V553L, V602L, V616L, V617L, V642L, V659L, V662L, V687L, V689L, V726L, V730L, V752L, V1536L, V1679L, V1745L, V1749L, V1764L, V1765L, V1828L, V421L, V620L, V621L, V641L, V685L, V690L, V965L, V1706L, V1722L, V1761L, V1763L, V1766L, V1785L, V1814L, V1829L, V1832L, V603L, V640L, V650L, V663L, V683L, V688L, V691L, V703L, V704L, V728L, V964L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868595	17	41197790	17	43045773	868595	853201	rs80357268	NC_000017.11:43045772:C:G
NM_007294.4(BRCA1):c.5497G>A (p.Val1833Met)	BRCA1	V1833M, V1854M, V729M, V1786M, V1536M, V1722M, V1745M, V1761M, V1763M, V1764M, V1765M, V1784M, V1790M, V1807M, V1828M, V1830M, V1831M, V1853M, V553M, V617M, V621M, V642M, V659M, V683M, V689M, V703M, V704M, V752M, V965M, V1537M, V1664M, V1679M, V1720M, V1721M, V1749M, V1813M, V1829M, V1855M, V603M, V640M, V660M, V726M, V964M, V1706M, V1743M, V1744M, V1785M, V1789M, V1806M, V1814M, V1832M, V421M, V602M, V616M, V650M, V663M, V682M, V727M, V751M, V1704M, V1705M, V1762M, V1766M, V1791M, V1792M, V1805M, V562M, V620M, V641M, V648M, V658M, V662M, V681M, V685M, V687M, V688M, V690M, V691M, V705M, V728M, V730M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2022)	criteria provided, multiple submitters, no conflicts	VCV000055598	17	41197790	17	43045773	55598	70265	rs80357268	NC_000017.11:43045772:C:T
NM_007294.4(BRCA1):c.5496G>A (p.Val1832=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427255	17	41197791	17	43045774	427255	416421	rs1131692070	NC_000017.11:43045773:C:T
NM_007294.4(BRCA1):c.5495T>G (p.Val1832Gly)	BRCA1	V1785G, V1832G, V1853G, V728G, V1703G, V1742G, V1760G, V1764G, V1804G, V1806G, V1812G, V1813G, V1827G, V639G, V657G, V659G, V682G, V684G, V687G, V690G, V703G, V725G, V750G, V1536G, V1663G, V1678G, V1705G, V1719G, V1721G, V1743G, V1761G, V1830G, V420G, V552G, V561G, V602G, V615G, V616G, V619G, V640G, V641G, V658G, V662G, V702G, V726G, V727G, V1720G, V1744G, V1748G, V1788G, V1789G, V1790G, V1791G, V1828G, V1829G, V1852G, V1854G, V647G, V680G, V681G, V688G, V689G, V704G, V729G, V751G, V1535G, V1704G, V1762G, V1763G, V1765G, V1783G, V1784G, V1805G, V1831G, V601G, V620G, V649G, V661G, V686G, V963G, V964G	not provided	Uncertain significance	no assertion criteria provided	VCV000868594	17	41197792	17	43045775	868594	853202	rs749290001	NC_000017.11:43045774:A:C
NM_007294.4(BRCA1):c.5495T>C (p.Val1832Ala)	BRCA1	V1785A, V1832A, V728A, V1853A, V1535A, V1705A, V1742A, V1764A, V1784A, V1790A, V1805A, V1813A, V1852A, V1854A, V420A, V602A, V615A, V658A, V681A, V687A, V688A, V727A, V963A, V1804A, V1806A, V1827A, V1828A, V1831A, V639A, V640A, V682A, V689A, V690A, V702A, V729A, V750A, V751A, V964A, V1663A, V1704A, V1719A, V1721A, V1743A, V1789A, V1830A, V561A, V616A, V620A, V641A, V659A, V661A, V684A, V703A, V704A, V725A, V726A, V1536A, V1703A, V1744A, V1760A, V1761A, V1762A, V1763A, V1765A, V1791A, V1678A, V1720A, V1748A, V1783A, V1788A, V1812A, V1829A, V552A, V601A, V619A, V647A, V649A, V657A, V662A, V680A, V686A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868593	17	41197792	17	43045775	868593	853203	rs749290001	NC_000017.11:43045774:A:G
NM_007294.4(BRCA1):c.5494G>A (p.Val1832Met)	BRCA1	V1785M, V1832M, V1853M, V728M, V750M, V751M, V1535M, V1536M, V1705M, V1744M, V1760M, V1761M, V1765M, V1784M, V1791M, V1806M, V1828M, V1829M, V1830M, V552M, V619M, V620M, V647M, V680M, V684M, V686M, V687M, V702M, V725M, V1663M, V1678M, V1704M, V1743M, V1748M, V1783M, V561M, V602M, V639M, V682M, V688M, V689M, V704M, V963M, V964M, V1719M, V1742M, V1762M, V1789M, V1804M, V1805M, V1852M, V1854M, V420M, V601M, V616M, V641M, V659M, V661M, V662M, V727M, V1703M, V1720M, V1721M, V1763M, V1764M, V1788M, V1790M, V1812M, V1813M, V1827M, V1831M, V615M, V640M, V649M, V657M, V658M, V681M, V690M, V703M, V726M, V729M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Oct 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV001171791	17	41197793	17	43045776	1171791	1161351		NC_000017.11:43045775:C:T
NM_007294.4(BRCA1):c.5494G>C (p.Val1832Leu)	BRCA1	V728L, V1832L, V1853L, V1785L, V1535L, V1721L, V1742L, V1762L, V1791L, V1805L, V1806L, V1813L, V1852L, V420L, V561L, V601L, V602L, V615L, V640L, V681L, V682L, V690L, V725L, V726L, V750L, V1663L, V1678L, V1744L, V1765L, V1828L, V1829L, V1854L, V647L, V659L, V661L, V680L, V686L, V688L, V963L, V964L, V1705L, V1719L, V1720L, V1748L, V1760L, V1783L, V1784L, V1788L, V1804L, V1831L, V552L, V616L, V619L, V639L, V657L, V684L, V703L, V727L, V729L, V1536L, V1703L, V1704L, V1743L, V1761L, V1763L, V1764L, V1789L, V1790L, V1812L, V1827L, V1830L, V620L, V641L, V649L, V658L, V662L, V687L, V689L, V702L, V704L, V751L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868592	17	41197793	17	43045776	868592	853204	rs2050882095	NC_000017.11:43045775:C:G
NM_007294.4(BRCA1):c.5493T>G (p.Pro1831=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867600	17	41197794	17	43045777	867600	853205	rs2050882264	NC_000017.11:43045776:A:C
NM_007294.4(BRCA1):c.5493T>C (p.Pro1831=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: May 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000867599	17	41197794	17	43045777	867599	853206	rs2050882264	NC_000017.11:43045776:A:G
NM_007294.4(BRCA1):c.5493T>A (p.Pro1831=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867598	17	41197794	17	43045777	867598	853207	rs2050882264	NC_000017.11:43045776:A:T
NM_007294.4(BRCA1):c.5492C>T (p.Pro1831Leu)	BRCA1	P1784L, P727L, P1852L, P1831L, P1535L, P1662L, P1720L, P1741L, P1783L, P551L, P560L, P600L, P638L, P656L, P685L, P686L, P687L, P725L, P749L, P750L, P962L, P1747L, P1760L, P1782L, P1789L, P1790L, P1804L, P1812L, P1829L, P1851L, P419L, P618L, P661L, P680L, P701L, P963L, P1534L, P1677L, P1703L, P1719L, P1742L, P1743L, P1761L, P1763L, P1764L, P1803L, P1805L, P1827L, P601L, P614L, P615L, P639L, P657L, P658L, P660L, P679L, P681L, P689L, P726L, P1702L, P1704L, P1718L, P1759L, P1762L, P1787L, P1788L, P1811L, P1826L, P1828L, P1830L, P1853L, P619L, P640L, P646L, P648L, P683L, P688L, P702L, P703L, P724L, P728L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867597	17	41197795	17	43045778	867597	853208	rs587782778	NC_000017.11:43045777:G:A
NM_007294.4(BRCA1):c.5492C>A (p.Pro1831His)	BRCA1	P1784H, P1852H, P727H, P1831H, P1703H, P1704H, P1718H, P1747H, P1760H, P1762H, P1788H, P1789H, P1804H, P1826H, P1830H, P615H, P638H, P639H, P656H, P701H, P728H, P1702H, P1720H, P1743H, P1759H, P1782H, P1783H, P1787H, P1811H, P1812H, P1827H, P560H, P619H, P640H, P657H, P658H, P660H, P661H, P680H, P683H, P685H, P749H, P750H, P1534H, P1677H, P1741H, P1761H, P1764H, P1803H, P1829H, P1851H, P419H, P600H, P614H, P681H, P703H, P724H, P725H, P962H, P1535H, P1662H, P1719H, P1742H, P1763H, P1790H, P1805H, P1828H, P1853H, P551H, P601H, P618H, P646H, P648H, P679H, P686H, P687H, P688H, P689H, P702H, P726H, P963H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867596	17	41197795	17	43045778	867596	853209	rs587782778	NC_000017.11:43045777:G:T
NM_007294.4(BRCA1):c.5492C>G (p.Pro1831Arg)	BRCA1	P1831R, P1852R, P727R, P1784R, P1702R, P1790R, P1828R, P1829R, P601R, P640R, P646R, P660R, P661R, P679R, P701R, P703R, P726R, P962R, P1704R, P1718R, P1719R, P1742R, P1743R, P1783R, P1788R, P1803R, P1830R, P1851R, P614R, P648R, P683R, P702R, P725R, P749R, P750R, P1534R, P1535R, P1677R, P1759R, P1761R, P1764R, P1789R, P1804R, P1811R, P1812R, P1826R, P1827R, P1853R, P657R, P658R, P680R, P685R, P687R, P688R, P689R, P724R, P1662R, P1703R, P1720R, P1741R, P1747R, P1760R, P1762R, P1763R, P1782R, P1787R, P1805R, P419R, P551R, P560R, P600R, P615R, P618R, P619R, P638R, P639R, P656R, P681R, P686R, P728R, P963R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2022)	criteria provided, conflicting interpretations	VCV000142865	17	41197795	17	43045778	142865	152579	rs587782778	NC_000017.11:43045777:G:C
NM_007294.4(BRCA1):c.5491C>T (p.Pro1831Ser)	BRCA1	P1852S, P727S, P1784S, P1831S, P1662S, P1702S, P1704S, P1719S, P1720S, P1741S, P1761S, P1764S, P1787S, P1805S, P1811S, P1827S, P419S, P560S, P618S, P619S, P638S, P639S, P640S, P656S, P657S, P687S, P689S, P702S, P724S, P726S, P728S, P749S, P750S, P962S, P1534S, P1677S, P1703S, P1718S, P1760S, P1783S, P1789S, P1828S, P679S, P686S, P688S, P963S, P1535S, P1759S, P1762S, P1763S, P1782S, P1788S, P1790S, P1803S, P1829S, P1830S, P551S, P601S, P614S, P646S, P648S, P658S, P660S, P681S, P1742S, P1743S, P1747S, P1804S, P1812S, P1826S, P1851S, P1853S, P600S, P615S, P661S, P680S, P683S, P685S, P701S, P703S, P725S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867595	17	41197796	17	43045779	867595	853210	rs768239314	NC_000017.11:43045778:G:A
NM_007294.4(BRCA1):c.5491C>G (p.Pro1831Ala)	BRCA1	P1784A, P1831A, P1852A, P727A, P1677A, P1719A, P1763A, P1787A, P1789A, P1804A, P1826A, P1827A, P1828A, P600A, P618A, P619A, P656A, P657A, P683A, P688A, P702A, P962A, P1534A, P1535A, P1718A, P1720A, P1747A, P1762A, P1764A, P1783A, P1803A, P1812A, P1829A, P1853A, P601A, P638A, P680A, P685A, P689A, P728A, P1702A, P1743A, P1760A, P1761A, P1782A, P1788A, P1790A, P1805A, P1851A, P419A, P639A, P660A, P661A, P679A, P686A, P687A, P750A, P963A, P1662A, P1703A, P1704A, P1741A, P1742A, P1759A, P1811A, P1830A, P551A, P560A, P614A, P615A, P640A, P646A, P648A, P658A, P681A, P701A, P703A, P724A, P725A, P726A, P749A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867594	17	41197796	17	43045779	867594	853211	rs768239314	NC_000017.11:43045778:G:C
NM_007294.4(BRCA1):c.5491C>A (p.Pro1831Thr)	BRCA1	P727T, P1784T, P1852T, P1831T, P639T, P683T, P687T, P688T, P689T, P703T, P725T, P750T, P962T, P1534T, P1662T, P1677T, P1702T, P1718T, P1741T, P1747T, P1761T, P1787T, P1790T, P1803T, P1811T, P1827T, P1828T, P1853T, P600T, P619T, P1719T, P1720T, P1762T, P1764T, P1788T, P1804T, P1805T, P1812T, P1826T, P551T, P601T, P614T, P658T, P660T, P681T, P726T, P728T, P963T, P1703T, P1759T, P1782T, P1789T, P1829T, P1830T, P419T, P615T, P638T, P640T, P646T, P648T, P656T, P680T, P685T, P702T, P1535T, P1704T, P1742T, P1743T, P1760T, P1763T, P1783T, P1851T, P560T, P618T, P657T, P661T, P679T, P686T, P701T, P724T, P749T	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864938	17	41197796	17	43045779	864938	853212	rs768239314	NC_000017.11:43045778:G:T
NM_007294.4(BRCA1):c.5490A>T (p.Ala1830=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864937	17	41197797	17	43045780	864937	853213	rs2050883369	NC_000017.11:43045779:T:A
NM_007294.4(BRCA1):c.5490A>G (p.Ala1830=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864936	17	41197797	17	43045780	864936	853214	rs2050883369	NC_000017.11:43045779:T:C
NM_007294.4(BRCA1):c.5490A>C (p.Ala1830=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864935	17	41197797	17	43045780	864935	853215	rs2050883369	NC_000017.11:43045779:T:G
NM_007294.4(BRCA1):c.5489C>T (p.Ala1830Val)	BRCA1	A1851V, A1830V, A726V, A1783V, A1533V, A1534V, A1676V, A1701V, A1740V, A1746V, A1762V, A1781V, A1786V, A1828V, A418V, A599V, A617V, A679V, A684V, A687V, A688V, A724V, A961V, A1702V, A1761V, A1763V, A1782V, A1787V, A1811V, A1825V, A1826V, A1850V, A614V, A618V, A639V, A647V, A659V, A660V, A678V, A701V, A748V, A962V, A1717V, A1718V, A1719V, A1741V, A1759V, A1788V, A1789V, A1802V, A1804V, A1810V, A1827V, A1829V, A1852V, A600V, A613V, A637V, A655V, A656V, A682V, A685V, A700V, A702V, A749V, A1661V, A1703V, A1742V, A1758V, A1760V, A1803V, A550V, A559V, A638V, A645V, A657V, A680V, A686V, A723V, A725V, A727V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864934	17	41197798	17	43045781	864934	853216	rs2050883748	NC_000017.11:43045780:G:A
NM_007294.4(BRCA1):c.5489C>G (p.Ala1830Gly)	BRCA1	A1830G, A1851G, A1783G, A726G, A1718G, A1758G, A1759G, A1782G, A1788G, A1802G, A1803G, A1825G, A1829G, A550G, A559G, A599G, A613G, A638G, A656G, A659G, A660G, A678G, A679G, A687G, A701G, A727G, A1534G, A1701G, A1703G, A1717G, A1719G, A1740G, A1761G, A1811G, A1826G, A1827G, A1852G, A418G, A614G, A617G, A645G, A655G, A657G, A680G, A684G, A686G, A723G, A725G, A748G, A1661G, A1702G, A1742G, A1746G, A1760G, A1781G, A1787G, A1810G, A637G, A639G, A682G, A685G, A688G, A724G, A961G, A1533G, A1676G, A1741G, A1762G, A1763G, A1786G, A1789G, A1804G, A1828G, A1850G, A600G, A618G, A647G, A700G, A702G, A749G, A962G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864933	17	41197798	17	43045781	864933	853217	rs2050883748	NC_000017.11:43045780:G:C
NM_007294.4(BRCA1):c.5489C>A (p.Ala1830Glu)	BRCA1	A1783E, A1851E, A726E, A1830E, A1701E, A1741E, A1742E, A1758E, A1759E, A1786E, A1787E, A1811E, A559E, A618E, A682E, A685E, A702E, A723E, A724E, A749E, A962E, A1534E, A1676E, A1717E, A1746E, A1760E, A1781E, A1782E, A1852E, A645E, A656E, A659E, A660E, A678E, A684E, A686E, A687E, A748E, A961E, A1661E, A1703E, A1740E, A1762E, A1789E, A1802E, A1810E, A1826E, A1828E, A1850E, A599E, A613E, A638E, A639E, A647E, A657E, A688E, A727E, A1533E, A1702E, A1718E, A1719E, A1761E, A1763E, A1788E, A1803E, A1804E, A1825E, A1827E, A1829E, A418E, A550E, A600E, A614E, A617E, A637E, A655E, A679E, A680E, A700E, A701E, A725E	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864932	17	41197798	17	43045781	864932	853218	rs2050883748	NC_000017.11:43045780:G:T
NM_007294.4(BRCA1):c.5488G>C (p.Ala1830Pro)	BRCA1	A1830P, A1851P, A1783P, A726P, A1534P, A1661P, A1676P, A1740P, A1760P, A1762P, A1789P, A1802P, A1803P, A1826P, A1828P, A1850P, A550P, A613P, A637P, A638P, A647P, A679P, A682P, A688P, A702P, A962P, A1746P, A1804P, A1810P, A1852P, A418P, A617P, A684P, A701P, A724P, A725P, A727P, A749P, A1702P, A1703P, A1717P, A1718P, A1719P, A1741P, A1758P, A1759P, A1761P, A1781P, A1786P, A1787P, A1829P, A559P, A618P, A639P, A657P, A659P, A660P, A678P, A680P, A686P, A700P, A961P, A1533P, A1701P, A1742P, A1763P, A1782P, A1788P, A1811P, A1825P, A1827P, A599P, A600P, A614P, A645P, A655P, A656P, A685P, A687P, A723P, A748P	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868984	17	41197799	17	43045782	868984	853220	rs80357393	NC_000017.11:43045781:C:G
NM_007294.4(BRCA1):c.5488G>T (p.Ala1830Ser)	BRCA1	A1830S, A1783S, A726S, A1851S, A1701S, A1717S, A1718S, A1742S, A1758S, A1760S, A1802S, A1803S, A1804S, A600S, A617S, A618S, A637S, A655S, A688S, A701S, A723S, A725S, A748S, A1534S, A1661S, A1702S, A1761S, A1786S, A1789S, A1825S, A1827S, A1828S, A599S, A639S, A678S, A679S, A684S, A685S, A686S, A687S, A724S, A727S, A749S, A1746S, A1759S, A1762S, A1763S, A1781S, A1782S, A1788S, A1826S, A1829S, A1850S, A1852S, A550S, A614S, A656S, A657S, A680S, A962S, A1703S, A1719S, A1740S, A1741S, A1787S, A1810S, A1811S, A418S, A559S, A613S, A638S, A645S, A647S, A659S, A660S, A682S, A700S, A702S, A961S, A1533S, A1676S	Ovarian cancer	Likely pathogenic(Last reviewed: Jan 1, 2022)	criteria provided, single submitter	VCV000864931	17	41197799	17	43045782	864931	853219	rs80357393	NC_000017.11:43045781:C:A
NM_007294.4(BRCA1):c.5488G>A (p.Ala1830Thr)	BRCA1	A1830T, A726T, A1851T, A1783T, A1661T, A1676T, A1703T, A1717T, A1740T, A1742T, A1762T, A1850T, A600T, A613T, A618T, A645T, A660T, A682T, A684T, A723T, A724T, A962T, A1533T, A1701T, A1741T, A1746T, A1759T, A1761T, A1787T, A1828T, A1852T, A599T, A614T, A657T, A659T, A686T, A702T, A725T, A748T, A1702T, A1718T, A1758T, A1760T, A1763T, A1781T, A1786T, A1788T, A1810T, A1825T, A1827T, A1829T, A418T, A550T, A617T, A637T, A639T, A655T, A679T, A680T, A685T, A687T, A700T, A749T, A1534T, A1719T, A1782T, A1789T, A1802T, A1803T, A1804T, A1811T, A1826T, A559T, A638T, A647T, A656T, A678T, A688T, A701T, A727T, A961T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 20, 2022)	criteria provided, conflicting interpretations	VCV000055594	17	41197799	17	43045782	55594	70261	rs80357393	NC_000017.11:43045781:C:T
NM_007294.4(BRCA1):c.5487G>T (p.Glu1829Asp)	BRCA1	E1829D, E1850D, E725D, E1782D, E1532D, E1701D, E1702D, E1718D, E1739D, E1745D, E1759D, E1781D, E1803D, E1825D, E1851D, E636D, E655D, E677D, E681D, E683D, E700D, E723D, E1533D, E1716D, E1741D, E1760D, E1762D, E1780D, E1787D, E1801D, E1802D, E1809D, E1827D, E558D, E599D, E612D, E617D, E644D, E646D, E678D, E684D, E685D, E724D, E726D, E747D, E1660D, E1675D, E1717D, E1758D, E1761D, E1785D, E1788D, E1810D, E1824D, E1826D, E1828D, E613D, E616D, E638D, E656D, E658D, E659D, E679D, E686D, E701D, E722D, E961D, E1700D, E1740D, E1757D, E1786D, E1849D, E417D, E549D, E598D, E637D, E654D, E687D, E699D, E748D, E960D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868983	17	41197800	17	43045783	868983	853221	rs2050884436	NC_000017.11:43045782:C:A
NM_007294.4(BRCA1):c.5487G>C (p.Glu1829Asp)	BRCA1	E1829D, E1850D, E725D, E1782D, E1660D, E1716D, E1717D, E1741D, E1758D, E1780D, E1827D, E417D, E558D, E599D, E613D, E636D, E638D, E655D, E677D, E678D, E679D, E686D, E699D, E722D, E723D, E748D, E961D, E1700D, E1701D, E1718D, E1745D, E1757D, E1781D, E1786D, E1787D, E1803D, E1824D, E549D, E612D, E617D, E637D, E646D, E656D, E658D, E683D, E684D, E685D, E687D, E700D, E726D, E960D, E1739D, E1761D, E1762D, E1785D, E1788D, E1809D, E1810D, E1828D, E616D, E654D, E681D, E747D, E1532D, E1533D, E1675D, E1702D, E1740D, E1759D, E1760D, E1801D, E1802D, E1825D, E1826D, E1849D, E1851D, E598D, E644D, E659D, E701D, E724D	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000868982	17	41197800	17	43045783	868982	853222	rs2050884436	NC_000017.11:43045782:C:G
NM_007294.4(BRCA1):c.5487G>A (p.Glu1829=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000868981	17	41197800	17	43045783	868981	853223	rs2050884436	NC_000017.11:43045782:C:T
NM_007294.4(BRCA1):c.888A>C (p.Arg296Ser)	BRCA1	R249S, R254S, R270S, R128S, R168S, R185S, R269S, R295S, R296S, R169S, R184S, R208S, R225S, R228S, R229S, R293S, R207S, R226S, R248S, R255S	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001764975	17	41246660	17	43094643	1764975	1824469		NC_000017.11:43094642:T:G
NM_007294.4(BRCA1):c.888A>G (p.Arg296=)	BRCA1		Malignant tumor of breast	Likely benign	no assertion criteria provided	VCV000433695	17	41246660	17	43094643	433695	427563	rs1555592914	NC_000017.11:43094642:T:C
NM_007294.4(BRCA1):c.887G>C (p.Arg296Thr)	BRCA1	R168T, R169T, R184T, R225T, R228T, R248T, R249T, R293T, R296T, R128T, R208T, R226T, R269T, R270T, R207T, R229T, R254T, R255T, R295T, R185T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV002017000	17	41246661	17	43094644	2017000	2068510		NC_000017.11:43094643:C:G
NM_007294.4(BRCA1):c.886A>T (p.Arg296Ter)	BRCA1	R296*, R249*, R248*, R269*, R169*, R208*, R226*, R293*, R184*, R185*, R207*, R229*, R254*, R270*, R128*, R168*, R225*, R228*, R255*, R295*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	VCV000431203	17	41246662	17	43094645	431203	424859	rs748675395	NC_000017.11:43094644:T:A
NM_007294.4(BRCA1):c.886A>G (p.Arg296Gly)	BRCA1	R296G, R249G, R184G, R228G, R254G, R169G, R207G, R226G, R270G, R295G, R208G, R248G, R269G, R128G, R168G, R185G, R225G, R229G, R255G, R293G	not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000431183	17	41246662	17	43094645	431183	424715	rs748675395	NC_000017.11:43094644:T:C
NM_007294.4(BRCA1):c.885C>G (p.Asp295Glu)	BRCA1	D248E, D295E, D167E, D184E, D227E, D269E, D247E, D254E, D268E, D127E, D183E, D206E, D207E, D224E, D228E, D253E, D292E, D168E, D225E, D294E	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000845638	17	41246663	17	43094646	845638	845456	rs1060504557	NC_000017.11:43094645:G:C
NM_007294.4(BRCA1):c.885C>T (p.Asp295=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Mar 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000415552	17	41246663	17	43094646	415552	402118	rs1060504557	NC_000017.11:43094645:G:A
NM_007294.4(BRCA1):c.884A>G (p.Asp295Gly)	BRCA1	D295G, D248G, D224G, D292G, D127G, D183G, D184G, D207G, D269G, D167G, D228G, D254G, D294G, D168G, D206G, D225G, D227G, D247G, D253G, D268G	not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000233188	17	41246664	17	43094647	233188	236154	rs772684048	NC_000017.11:43094646:T:C
NM_007294.4(BRCA1):c.883G>T (p.Asp295Tyr)	BRCA1	D248Y, D295Y, D127Y, D184Y, D224Y, D225Y, D253Y, D292Y, D167Y, D168Y, D183Y, D227Y, D247Y, D268Y, D294Y, D207Y, D228Y, D206Y, D254Y, D269Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001058491	17	41246665	17	43094648	1058491	1050319		NC_000017.11:43094647:C:A
NM_007294.4(BRCA1):c.881A>G (p.Lys294Arg)	BRCA1	K294R, K247R, K126R, K167R, K183R, K246R, K268R, K293R, K205R, K227R, K206R, K223R, K252R, K291R, K166R, K182R, K224R, K226R, K253R, K267R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000531293	17	41246667	17	43094650	531293	531327	rs1555592934	NC_000017.11:43094649:T:C
NM_007294.4(BRCA1):c.880A>G (p.Lys294Glu)	BRCA1	K294E, K247E, K126E, K183E, K252E, K253E, K167E, K182E, K205E, K206E, K267E, K293E, K224E, K227E, K246E, K268E, K291E, K166E, K223E, K226E	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000629376	17	41246668	17	43094651	629376	618688	rs1567801705	NC_000017.11:43094650:T:C
NM_007294.4(BRCA1):c.879T>C (p.Thr293=)	BRCA1		Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 13, 2021)	criteria provided, conflicting interpretations	VCV001692986	17	41246669	17	43094652	1692986	1685426		NC_000017.11:43094651:A:G
NM_007294.4(BRCA1):c.879T>G (p.Thr293=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427356	17	41246669	17	43094652	427356	416515	rs139433219	NC_000017.11:43094651:A:C
NM_007294.4(BRCA1):c.878C>G (p.Thr293Ser)	BRCA1	T293S, T246S, T205S, T252S, T165S, T166S, T181S, T223S, T225S, T226S, T245S, T266S, T290S, T125S, T204S, T251S, T267S, T182S, T222S, T292S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000570469	17	41246670	17	43094653	570469	571209	rs747172803	NC_000017.11:43094652:G:C
NM_007294.4(BRCA1):c.878C>T (p.Thr293Ile)	BRCA1	T293I, T246I, T223I, T245I, T292I, T166I, T181I, T182I, T204I, T225I, T251I, T267I, T290I, T125I, T222I, T226I, T252I, T165I, T205I, T266I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000491193	17	41246670	17	43094653	491193	484952	rs747172803	NC_000017.11:43094652:G:A
NM_007294.4(BRCA1):c.877A>C (p.Thr293Pro)	BRCA1	T293P, T246P, T165P, T182P, T204P, T205P, T226P, T125P, T166P, T181P, T223P, T252P, T222P, T251P, T266P, T267P, T225P, T245P, T290P, T292P	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000489738	17	41246671	17	43094654	489738	482984	rs1555592945	NC_000017.11:43094653:T:G
NM_007294.4(BRCA1):c.876C>T (p.Leu292=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427344	17	41246672	17	43094655	427344	416516	rs771001707	NC_000017.11:43094654:G:A
NM_007294.4(BRCA1):c.871T>G (p.Leu291Val)	BRCA1	L179V, L223V, L265V, L163V, L164V, L180V, L202V, L220V, L221V, L244V, L291V, L123V, L203V, L224V, L250V, L264V, L290V, L243V, L249V, L288V	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001764447	17	41246677	17	43094660	1764447	1817574		NC_000017.11:43094659:A:C
NM_007294.4(BRCA1):c.869T>C (p.Leu290Ser)	BRCA1	L290S, L243S, L162S, L179S, L202S, L220S, L248S, L122S, L219S, L223S, L263S, L289S, L178S, L201S, L242S, L249S, L264S, L163S, L222S, L287S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000572126	17	41246679	17	43094662	572126	574490	rs730881468	NC_000017.11:43094661:A:G
NM_007294.4(BRCA1):c.869T>A (p.Leu290Ter)	BRCA1	L290*, L243*, L223*, L242*, L249*, L264*, L287*, L162*, L220*, L248*, L122*, L163*, L201*, L202*, L222*, L263*, L178*, L179*, L219*, L289*	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000371981	17	41246679	17	43094662	371981	358942	rs730881468	NC_000017.11:43094661:A:T
NM_007294.4(BRCA1):c.869T>G (p.Leu290Ter)	BRCA1	L290*, L243*, L162*, L220*, L248*, L163*, L201*, L202*, L219*, L179*, L223*, L249*, L263*, L264*, L287*, L122*, L178*, L222*, L242*, L289*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000182128	17	41246679	17	43094662	182128	180883	rs730881468	NC_000017.11:43094661:A:C
NM_007294.4(BRCA1):c.866G>C (p.Ser289Thr)	BRCA1	S242T, S289T, S178T, S218T, S219T, S222T, S288T, S121T, S248T, S262T, S161T, S286T, S162T, S177T, S200T, S201T, S221T, S241T, S247T, S263T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000849528	17	41246682	17	43094665	849528	845457	rs776999497	NC_000017.11:43094664:C:G
NM_007294.4(BRCA1):c.866G>A (p.Ser289Asn)	BRCA1	S289N, S242N, S161N, S219N, S221N, S222N, S241N, S262N, S263N, S288N, S201N, S218N, S121N, S162N, S178N, S200N, S247N, S248N, S286N, S177N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000441442	17	41246682	17	43094665	441442	435167	rs776999497	NC_000017.11:43094664:C:T
NM_007294.4(BRCA1):c.864C>T (p.Ser288=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 5, 2020)	criteria provided, single submitter	VCV001764168	17	41246684	17	43094667	1764168	1817296		NC_000017.11:43094666:G:A
NM_007294.4(BRCA1):c.863G>A (p.Ser288Asn)	BRCA1	S160N, S176N, S241N, S247N, S285N, S287N, S218N, S161N, S177N, S200N, S217N, S220N, S246N, S288N, S120N, S199N, S221N, S240N, S261N, S262N	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV002118389	17	41246685	17	43094668	2118389	2176171		NC_000017.11:43094667:C:T
NM_007294.4(BRCA1):c.862A>G (p.Ser288Gly)	BRCA1	S288G, S241G, S161G, S217G, S218G, S285G, S120G, S160G, S177G, S221G, S240G, S247G, S262G, S287G, S176G, S199G, S246G, S261G, S200G, S220G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000803419	17	41246686	17	43094669	803419	791773	rs1597879544	NC_000017.11:43094668:T:C
NM_007294.4(BRCA1):c.861C>A (p.Asn287Lys)	BRCA1	N159K, N217K, N246K, N284K, N119K, N175K, N198K, N199K, N216K, N219K, N245K, N287K, N176K, N220K, N261K, N286K, N160K, N239K, N240K, N260K	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001764054	17	41246687	17	43094670	1764054	1820917		NC_000017.11:43094669:G:T
NM_007294.4(BRCA1):c.861C>G (p.Asn287Lys)	BRCA1	N287K, N240K, N159K, N160K, N176K, N216K, N246K, N175K, N198K, N217K, N284K, N199K, N219K, N220K, N245K, N286K, N119K, N239K, N260K, N261K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000420773	17	41246687	17	43094670	420773	410022	rs1064794692	NC_000017.11:43094669:G:C
NM_007294.4(BRCA1):c.859A>G (p.Asn287Asp)	BRCA1	N240D, N287D, N119D, N199D, N246D, N260D, N261D, N286D, N175D, N216D, N220D, N239D, N284D, N159D, N217D, N245D, N160D, N176D, N198D, N219D	not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001330028	17	41246689	17	43094672	1330028	1320711		NC_000017.11:43094671:T:C
NM_007294.4(BRCA1):c.858G>A (p.Glu286=)	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Nov 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV001104640	17	41246690	17	43094673	1104640	1104889		NC_000017.11:43094672:C:T
NM_007294.4(BRCA1):c.856G>T (p.Glu286Ter)	BRCA1	E286*, E239*, E118*, E159*, E216*, E218*, E245*, E260*, E174*, E198*, E158*, E259*, E283*, E175*, E197*, E215*, E219*, E238*, E244*, E285*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000254382	17	41246692	17	43094675	254382	249161	rs886037980	NC_000017.11:43094674:C:A
NM_007294.4(BRCA1):c.854A>G (p.His285Arg)	BRCA1	H238R, H285R, H117R, H217R, H237R, H173R, H215R, H218R, H284R, H158R, H174R, H197R, H214R, H244R, H258R, H282R, H157R, H196R, H243R, H259R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001479741	17	41246694	17	43094677	1479741	1439464		NC_000017.11:43094676:T:C
NM_007294.4(BRCA1):c.854A>C (p.His285Pro)	BRCA1	H238P, H285P, H197P, H214P, H218P, H243P, H284P, H157P, H173P, H215P, H259P, H282P, H117P, H174P, H196P, H237P, H158P, H217P, H244P, H258P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001055953	17	41246694	17	43094677	1055953	1050320		NC_000017.11:43094676:T:G
NM_007294.4(BRCA1):c.852G>C (p.Gln284His)	BRCA1	Q237H, Q284H, Q213H, Q214H, Q281H, Q173H, Q116H, Q156H, Q195H, Q196H, Q243H, Q258H, Q216H, Q217H, Q242H, Q157H, Q172H, Q236H, Q257H, Q283H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000822538	17	41246696	17	43094679	822538	813878	rs1597879571	NC_000017.11:43094678:C:G
NM_007294.4(BRCA1):c.851A>G (p.Gln284Arg)	BRCA1	Q284R, Q237R, Q116R, Q172R, Q195R, Q196R, Q257R, Q281R, Q283R, Q214R, Q216R, Q217R, Q236R, Q242R, Q243R, Q156R, Q213R, Q258R, Q157R, Q173R	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|not specified|not provided|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000055739	17	41246697	17	43094680	55739	70406	rs80357039	NC_000017.11:43094679:T:C
NM_007294.4(BRCA1):c.850C>T (p.Gln284Ter)	BRCA1	Q284*, Q237*, Q157*, Q196*, Q214*, Q216*, Q243*, Q257*, Q281*, Q156*, Q217*, Q236*, Q173*, Q283*, Q116*, Q172*, Q195*, Q213*, Q242*, Q258*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	VCV000055738	17	41246698	17	43094681	55738	70405	rs397509330	NC_000017.11:43094680:G:A
NM_007294.4(BRCA1):c.849A>G (p.Leu283=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: May 28, 2021)	criteria provided, single submitter	VCV001610957	17	41246699	17	43094682	1610957	1585775		NC_000017.11:43094681:T:C
NM_007294.4(BRCA1):c.848T>C (p.Leu283Ser)	BRCA1	L236S, L283S, L172S, L194S, L195S, L212S, L213S, L242S, L155S, L156S, L215S, L241S, L256S, L280S, L115S, L171S, L216S, L235S, L257S, L282S	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001332672	17	41246700	17	43094683	1332672	1323390		NC_000017.11:43094682:A:G
NM_007294.4(BRCA1):c.848T>G (p.Leu283Ter)	BRCA1	L283*, L236*, L195*, L215*, L115*, L155*, L171*, L212*, L213*, L216*, L241*, L256*, L257*, L282*, L156*, L172*, L194*, L235*, L242*, L280*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	VCV000055737	17	41246700	17	43094683	55737	70404	rs273902792	NC_000017.11:43094682:A:C
NM_007294.4(BRCA1):c.848T>A (p.Leu283Ter)	BRCA1	L283*, L236*, L195*, L215*, L156*, L212*, L235*, L241*, L280*, L115*, L172*, L194*, L213*, L256*, L257*, L282*, L155*, L171*, L216*, L242*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055736	17	41246700	17	43094683	55736	70403	rs273902792	NC_000017.11:43094682:A:T
NM_007294.4(BRCA1):c.846A>T (p.Ser282=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 23, 2022)	criteria provided, single submitter	VCV001763483	17	41246702	17	43094685	1763483	1824207		NC_000017.11:43094684:T:A
NM_007294.4(BRCA1):c.845C>A (p.Ser282Ter)	BRCA1	S282*, S235*, S154*, S171*, S211*, S214*, S255*, S279*, S281*, S194*, S215*, S234*, S241*, S114*, S155*, S170*, S212*, S240*, S193*, S256*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	VCV000427236	17	41246703	17	43094686	427236	416229	rs786203027	NC_000017.11:43094685:G:T
NM_007294.4(BRCA1):c.845C>T (p.Ser282Leu)	BRCA1	S282L, S235L, S154L, S193L, S211L, S212L, S214L, S215L, S256L, S281L, S155L, S170L, S171L, S194L, S234L, S241L, S279L, S114L, S240L, S255L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000186539	17	41246703	17	43094686	186539	185091	rs786203027	NC_000017.11:43094685:G:A
NM_007294.4(BRCA1):c.844T>C (p.Ser282Pro)	BRCA1	S235P, S282P, S114P, S193P, S211P, S241P, S256P, S279P, S194P, S212P, S281P, S155P, S215P, S240P, S154P, S170P, S171P, S214P, S234P, S255P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000964205	17	41246704	17	43094687	964205	949960	rs2054037292	NC_000017.11:43094686:A:G
NM_007294.4(BRCA1):c.843C>T (p.Ser281=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000749991	17	41246705	17	43094688	749991	755877	rs1597879652	NC_000017.11:43094687:G:A
NM_007294.4(BRCA1):c.842G>A (p.Ser281Asn)	BRCA1	S154N, S169N, S210N, S211N, S240N, S254N, S280N, S281N, S113N, S153N, S213N, S214N, S234N, S239N, S170N, S192N, S193N, S255N, S233N, S278N	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001763350	17	41246706	17	43094689	1763350	1824074		NC_000017.11:43094688:C:T
NM_007294.4(BRCA1):c.842G>C (p.Ser281Thr)	BRCA1	S234T, S281T, S153T, S211T, S239T, S240T, S254T, S170T, S192T, S213T, S278T, S280T, S113T, S193T, S214T, S255T, S154T, S169T, S210T, S233T	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000822416	17	41246706	17	43094689	822416	813879	rs1567801816	NC_000017.11:43094688:C:G
NM_007294.4(BRCA1):c.841A>T (p.Ser281Cys)	BRCA1	S154C, S192C, S210C, S254C, S280C, S214C, S233C, S234C, S240C, S169C, S170C, S239C, S255C, S278C, S113C, S153C, S193C, S211C, S213C, S281C	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 9, 2022)	criteria provided, single submitter	VCV002450671	17	41246707	17	43094690	2450671	2423157		NC_000017.11:43094689:T:A
NM_007294.4(BRCA1):c.841A>G (p.Ser281Gly)	BRCA1	S281G, S234G, S113G, S153G, S254G, S255G, S170G, S233G, S239G, S280G, S210G, S240G, S154G, S169G, S192G, S193G, S211G, S213G, S214G, S278G	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000482900	17	41246707	17	43094690	482900	478845	rs1300771163	NC_000017.11:43094689:T:C
NM_007294.4(BRCA1):c.839C>A (p.Ala280Asp)	BRCA1	A280D, A233D, A209D, A232D, A239D, A253D, A112D, A152D, A168D, A169D, A210D, A213D, A238D, A254D, A279D, A153D, A192D, A212D, A277D, A191D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000842866	17	41246709	17	43094692	842866	845458	rs80357199	NC_000017.11:43094691:G:T
NM_007294.4(BRCA1):c.839C>G (p.Ala280Gly)	BRCA1	A280G, A233G, A152G, A153G, A212G, A253G, A168G, A192G, A209G, A213G, A112G, A232G, A279G, A169G, A191G, A210G, A238G, A239G, A254G, A277G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055731	17	41246709	17	43094692	55731	70398	rs80357199	NC_000017.11:43094691:G:C
NM_007294.4(BRCA1):c.837T>C (p.His279=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000224429	17	41246711	17	43094694	224429	226207	rs775477245	NC_000017.11:43094693:A:G
NM_007294.4(BRCA1):c.836A>T (p.His279Leu)	BRCA1	H279L, H232L, H167L, H191L, H278L, H208L, H211L, H231L, H190L, H111L, H151L, H168L, H209L, H237L, H238L, H253L, H152L, H212L, H252L, H276L	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000479199	17	41246712	17	43094695	479199	478782	rs80357482	NC_000017.11:43094694:T:A
NM_007294.4(BRCA1):c.836A>G (p.His279Arg)	BRCA1	H279R, H232R, H151R, H167R, H212R, H231R, H238R, H252R, H276R, H278R, H209R, H111R, H152R, H190R, H211R, H237R, H253R, H168R, H191R, H208R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000055730	17	41246712	17	43094695	55730	70397	rs80357482	NC_000017.11:43094694:T:C
NM_007294.4(BRCA1):c.835C>T (p.His279Tyr)	BRCA1	H232Y, H279Y, H111Y, H151Y, H167Y, H191Y, H209Y, H212Y, H152Y, H208Y, H237Y, H252Y, H190Y, H211Y, H231Y, H238Y, H253Y, H278Y, H168Y, H276Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000659023	17	41246713	17	43094696	659023	646044	rs1380919500	NC_000017.11:43094695:G:A
NM_007294.4(BRCA1):c.834T>A (p.Thr278=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV000822323	17	41246714	17	43094697	822323	813880	rs762956862	NC_000017.11:43094696:A:T
NM_007294.4(BRCA1):c.834T>G (p.Thr278=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000184380	17	41246714	17	43094697	184380	185092	rs762956862	NC_000017.11:43094696:A:C
NM_007294.4(BRCA1):c.833C>T (p.Thr278Ile)	BRCA1	T231I, T278I, T166I, T190I, T230I, T150I, T208I, T236I, T277I, T110I, T189I, T210I, T211I, T251I, T275I, T151I, T167I, T207I, T237I, T252I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001442869	17	41246715	17	43094698	1442869	1371756		NC_000017.11:43094697:G:A
NM_007294.4(BRCA1):c.829A>C (p.Asn277His)	BRCA1	N230H, N277H, N209H, N235H, N236H, N251H, N189H, N206H, N207H, N149H, N165H, N166H, N188H, N210H, N250H, N274H, N109H, N150H, N229H, N276H	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001021564	17	41246719	17	43094702	1021564	1012786	rs2054040121	NC_000017.11:43094701:T:G
NM_007294.4(BRCA1):c.829A>G (p.Asn277Asp)	BRCA1	N277D, N230D, N250D, N251D, N149D, N150D, N188D, N209D, N229D, N236D, N165D, N206D, N166D, N189D, N276D, N109D, N207D, N210D, N235D, N274D	not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000926725	17	41246719	17	43094702	926725	913969	rs2054040121	NC_000017.11:43094701:T:C
NM_007294.4(BRCA1):c.828A>G (p.Thr276=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000184319	17	41246720	17	43094703	184319	185093	rs186274774	NC_000017.11:43094702:T:C
NM_007294.4(BRCA1):c.827C>T (p.Thr276Ile)	BRCA1	T108I, T148I, T149I, T164I, T165I, T187I, T188I, T205I, T206I, T208I, T209I, T228I, T229I, T234I, T235I, T249I, T250I, T273I, T275I, T276I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001709638	17	41246721	17	43094704	1709638	1707992		NC_000017.11:43094703:G:A
NM_007294.4(BRCA1):c.827C>A (p.Thr276Lys)	BRCA1	T276K, T229K, T148K, T206K, T209K, T234K, T273K, T149K, T165K, T235K, T249K, T108K, T187K, T188K, T228K, T250K, T275K, T164K, T205K, T208K	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000252891	17	41246721	17	43094704	252891	247292	rs80357436	NC_000017.11:43094703:G:T
NM_007294.4(BRCA1):c.827C>G (p.Thr276Arg)	BRCA1	T276R, T229R, T149R, T209R, T250R, T164R, T205R, T208R, T234R, T148R, T165R, T188R, T235R, T275R, T108R, T187R, T206R, T228R, T249R, T273R	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037706	17	41246721	17	43094704	37706	46262	rs80357436	NC_000017.11:43094703:G:C
NM_007294.4(BRCA1):c.825C>T (p.Gly275=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000055727	17	41246723	17	43094706	55727	70394	rs397509328	NC_000017.11:43094705:G:A
NM_007294.4(BRCA1):c.824G>A (p.Gly275Asp)	BRCA1	G275D, G228D, G248D, G274D, G164D, G227D, G272D, G147D, G187D, G204D, G207D, G234D, G249D, G107D, G148D, G163D, G208D, G233D, G186D, G205D	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055726	17	41246724	17	43094707	55726	70393	rs397509327	NC_000017.11:43094706:C:T
NM_007294.4(BRCA1):c.823G>A (p.Gly275Ser)	BRCA1	G275S, G228S, G205S, G272S, G107S, G148S, G164S, G186S, G207S, G208S, G234S, G249S, G187S, G204S, G233S, G274S, G147S, G163S, G227S, G248S	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055725	17	41246725	17	43094708	55725	70392	rs8176153	NC_000017.11:43094707:C:T
NM_007294.4(BRCA1):c.822T>A (p.Cys274Ter)	BRCA1	C274*, C227*, C106*, C206*, C207*, C248*, C271*, C146*, C162*, C226*, C233*, C163*, C185*, C204*, C232*, C273*, C147*, C186*, C203*, C247*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055724	17	41246726	17	43094709	55724	70391	rs80357331	NC_000017.11:43094708:A:T
NM_007294.4(BRCA1):c.821G>A (p.Cys274Tyr)	BRCA1	C227Y, C274Y, C106Y, C147Y, C226Y, C247Y, C271Y, C163Y, C203Y, C233Y, C185Y, C204Y, C248Y, C273Y, C146Y, C162Y, C186Y, C206Y, C207Y, C232Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000664275	17	41246727	17	43094710	664275	646045	rs1597879808	NC_000017.11:43094709:C:T
NM_007294.4(BRCA1):c.820T>C (p.Cys274Arg)	BRCA1	C274R, C227R, C162R, C204R, C233R, C273R, C106R, C163R, C203R, C271R, C147R, C185R, C207R, C232R, C247R, C146R, C186R, C206R, C226R, C248R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000841619	17	41246728	17	43094711	841619	845459	rs755285181	NC_000017.11:43094710:A:G
NM_007294.4(BRCA1):c.819A>T (p.Pro273=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001127797	17	41246729	17	43094712	1127797	1126298		NC_000017.11:43094711:T:A
NM_007294.4(BRCA1):c.819A>G (p.Pro273=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427325	17	41246729	17	43094712	427325	416517	rs779225364	NC_000017.11:43094711:T:C
NM_007294.4(BRCA1):c.817C>T (p.Pro273Ser)	BRCA1	P226S, P273S, P145S, P146S, P184S, P206S, P225S, P246S, P162S, P202S, P203S, P247S, P105S, P232S, P270S, P272S, P161S, P185S, P205S, P231S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000801088	17	41246731	17	43094714	801088	789631	rs1597879824	NC_000017.11:43094713:G:A
NM_007294.4(BRCA1):c.814G>A (p.Glu272Lys)	BRCA1	E104K, E161K, E183K, E204K, E230K, E231K, E271K, E272K, E160K, E201K, E202K, E225K, E246K, E144K, E145K, E184K, E205K, E245K, E269K, E224K	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV002128795	17	41246734	17	43094717	2128795	2178818		NC_000017.11:43094716:C:T
NM_007294.4(BRCA1):c.814G>T (p.Glu272Ter)	BRCA1	E272*, E225*, E205*, E224*, E269*, E271*, E144*, E160*, E183*, E201*, E204*, E145*, E161*, E202*, E231*, E104*, E184*, E230*, E245*, E246*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	VCV000266581	17	41246734	17	43094717	266581	261977	rs886040321	NC_000017.11:43094716:C:A
NM_007294.4(BRCA1):c.813G>T (p.Val271=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV001762164	17	41246735	17	43094718	1762164	1820300		NC_000017.11:43094717:C:A
NM_007294.4(BRCA1):c.813G>A (p.Val271=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jul 11, 2020)	criteria provided, single submitter	VCV000934452	17	41246735	17	43094718	934452	937975	rs2054043820	NC_000017.11:43094717:C:T
NM_007294.4(BRCA1):c.812T>C (p.Val271Ala)	BRCA1	V271A, V224A, V144A, V203A, V229A, V270A, V182A, V201A, V223A, V230A, V245A, V143A, V183A, V103A, V159A, V160A, V200A, V204A, V244A, V268A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000409371	17	41246736	17	43094719	409371	402120	rs753099787	NC_000017.11:43094718:A:G
NM_007294.4(BRCA1):c.812T>G (p.Val271Gly)	BRCA1	V271G, V224G, V160G, V223G, V103G, V159G, V229G, V245G, V143G, V182G, V183G, V200G, V204G, V230G, V244G, V144G, V201G, V203G, V268G, V270G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000252383	17	41246736	17	43094719	252383	246824	rs753099787	NC_000017.11:43094718:A:C
NM_007294.4(BRCA1):c.811G>T (p.Val271Leu)	BRCA1	V271L, V224L, V103L, V182L, V200L, V201L, V268L, V270L, V183L, V204L, V223L, V229L, V230L, V245L, V144L, V159L, V160L, V244L, V143L, V203L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000187421	17	41246737	17	43094720	187421	185094	rs80357244	NC_000017.11:43094719:C:A
NM_007294.4(BRCA1):c.811G>C (p.Val271Leu)	BRCA1	V271L, V224L, V103L, V160L, V182L, V229L, V268L, V159L, V183L, V203L, V204L, V223L, V230L, V244L, V144L, V270L, V143L, V200L, V201L, V245L	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000055721	17	41246737	17	43094720	55721	70388	rs80357244	NC_000017.11:43094719:C:G
NM_007294.4(BRCA1):c.811G>A (p.Val271Met)	BRCA1	V271M, V224M, V103M, V159M, V183M, V200M, V201M, V230M, V270M, V143M, V160M, V182M, V203M, V244M, V144M, V204M, V223M, V229M, V245M, V268M	Hereditary cancer-predisposing syndrome|Ovarian cancer|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000055720	17	41246737	17	43094720	55720	70387	rs80357244	NC_000017.11:43094719:C:T
NM_007294.4(BRCA1):c.810T>C (p.His270=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427327	17	41246738	17	43094721	427327	416518	rs778359104	NC_000017.11:43094720:A:G
NM_007294.4(BRCA1):c.809A>T (p.His270Leu)	BRCA1	H223L, H270L, H159L, H200L, H203L, H142L, H158L, H182L, H222L, H267L, H229L, H243L, H102L, H143L, H181L, H199L, H202L, H228L, H244L, H269L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001319800	17	41246739	17	43094722	1319800	1310049		NC_000017.11:43094721:T:A
NM_007294.4(BRCA1):c.809A>G (p.His270Arg)	BRCA1	H223R, H270R, H202R, H222R, H142R, H159R, H199R, H228R, H244R, H102R, H158R, H182R, H229R, H243R, H143R, H181R, H200R, H203R, H267R, H269R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000655017	17	41246739	17	43094722	655017	646046	rs1597879864	NC_000017.11:43094721:T:C
NM_007294.4(BRCA1):c.808C>G (p.His270Asp)	BRCA1	H223D, H270D, H142D, H182D, H228D, H244D, H267D, H158D, H200D, H229D, H269D, H181D, H203D, H222D, H243D, H102D, H143D, H159D, H199D, H202D	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001497072	17	41246740	17	43094723	1497072	1382474		NC_000017.11:43094722:G:C
NM_007294.4(BRCA1):c.808C>T (p.His270Tyr)	BRCA1	H223Y, H270Y, H142Y, H159Y, H158Y, H200Y, H228Y, H229Y, H243Y, H269Y, H143Y, H199Y, H202Y, H222Y, H102Y, H181Y, H182Y, H203Y, H244Y, H267Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000843295	17	41246740	17	43094723	843295	845460	rs2054044790	NC_000017.11:43094722:G:A
NM_007294.4(BRCA1):c.807G>A (p.Leu269=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000136540	17	41246741	17	43094724	136540	140243	rs149867679	NC_000017.11:43094723:C:T
NM_007294.4(BRCA1):c.806T>A (p.Leu269Ter)	BRCA1	L227*, L243*, L101*, L199*, L266*, L269*, L141*, L142*, L181*, L198*, L228*, L242*, L268*, L157*, L158*, L180*, L201*, L202*, L221*, L222*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV001761872	17	41246742	17	43094725	1761872	1823814		NC_000017.11:43094724:A:T
NM_007294.4(BRCA1):c.804C>G (p.Asn268Lys)	BRCA1	N268K, N221K, N100K, N140K, N157K, N198K, N265K, N197K, N227K, N156K, N179K, N200K, N201K, N220K, N226K, N141K, N180K, N241K, N242K, N267K	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000441285	17	41246744	17	43094727	441285	435169	rs771076131	NC_000017.11:43094726:G:C
NM_007294.4(BRCA1):c.804C>T (p.Asn268=)	BRCA1		not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	Benign/Likely benign(Last reviewed: Nov 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000415558	17	41246744	17	43094727	415558	402074	rs771076131	NC_000017.11:43094726:G:A
NM_007294.4(BRCA1):c.803A>G (p.Asn268Ser)	BRCA1	N268S, N221S, N200S, N201S, N242S, N157S, N180S, N198S, N226S, N227S, N100S, N140S, N156S, N241S, N141S, N179S, N197S, N220S, N265S, N267S	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000827411	17	41246745	17	43094728	827411	813881	rs1597879900	NC_000017.11:43094727:T:C
NM_007294.4(BRCA1):c.802A>G (p.Asn268Asp)	BRCA1	N268D, N221D, N200D, N201D, N226D, N267D, N180D, N242D, N265D, N100D, N140D, N141D, N157D, N197D, N198D, N241D, N156D, N179D, N220D, N227D	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000482933	17	41246746	17	43094729	482933	478710	rs1555593066	NC_000017.11:43094728:T:C
NM_007294.4(BRCA1):c.800C>A (p.Ser267Ter)	BRCA1	S267*, S220*, S139*, S178*, S179*, S196*, S225*, S264*, S199*, S200*, S219*, S226*, S240*, S266*, S99*, S140*, S156*, S241*, S155*, S197*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	VCV000431201	17	41246748	17	43094731	431201	424861	rs80357392	NC_000017.11:43094730:G:T
NM_007294.4(BRCA1):c.800C>G (p.Ser267Ter)	BRCA1	S267*, S220*, S155*, S178*, S226*, S240*, S264*, S200*, S99*, S139*, S140*, S156*, S196*, S197*, S199*, S219*, S179*, S225*, S241*, S266*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055713	17	41246748	17	43094731	55713	70380	rs80357392	NC_000017.11:43094730:G:C
NM_007294.4(BRCA1):c.799T>C (p.Ser267Pro)	BRCA1	S267P, S220P, S139P, S155P, S179P, S226P, S240P, S241P, S99P, S156P, S200P, S264P, S266P, S140P, S178P, S196P, S199P, S225P, S197P, S219P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000141103	17	41246749	17	43094732	141103	150817	rs587781496	NC_000017.11:43094731:A:G
NM_007294.4(BRCA1):c.796G>A (p.Val266Ile)	BRCA1	V219I, V266I, V139I, V196I, V225I, V265I, V98I, V138I, V154I, V199I, V224I, V177I, V195I, V218I, V239I, V263I, V155I, V178I, V198I, V240I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001473025	17	41246752	17	43094735	1473025	1501270		NC_000017.11:43094734:C:T
NM_007294.4(BRCA1):c.795T>C (p.Ser265=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000055708	17	41246753	17	43094736	55708	70375	rs201441987	NC_000017.11:43094735:A:G
NM_007294.4(BRCA1):c.792T>G (p.Ser264Arg)	BRCA1	S264R, S217R, S175R, S196R, S197R, S222R, S261R, S96R, S153R, S238R, S263R, S137R, S193R, S194R, S216R, S237R, S136R, S152R, S176R, S223R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000055706	17	41246756	17	43094739	55706	70373	rs80357214	NC_000017.11:43094738:A:C
NM_007294.4(BRCA1):c.791G>A (p.Ser264Asn)	BRCA1	S264N, S217N, S153N, S194N, S96N, S137N, S175N, S197N, S237N, S263N, S136N, S152N, S193N, S196N, S222N, S223N, S176N, S216N, S238N, S261N	Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 23, 2023)	criteria provided, single submitter	VCV000055704	17	41246757	17	43094740	55704	70371	rs397509322	NC_000017.11:43094739:C:T
NM_007294.4(BRCA1):c.790A>G (p.Ser264Gly)	BRCA1	S217G, S264G, T264A, S176G, S197G, S223G, S237G, S137G, S153G, S193G, S263G, S96G, S136G, S152G, S196G, S216G, S261G, S175G, S194G, S222G, S238G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV001359110	17	41246758	17	43094741	1359110	1357387		NC_000017.11:43094740:T:C
NM_007294.4(BRCA1):c.790A>T (p.Ser264Cys)	BRCA1	S264C, S217C, S137C, S194C, S196C, S223C, S237C, S222C, S263C, S152C, S153C, S175C, S197C, S216C, S96C, T264S, S136C, S176C, S193C, S238C, S261C	Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 23, 2023)	criteria provided, single submitter	VCV000055703	17	41246758	17	43094741	55703	70370	rs397509321	NC_000017.11:43094740:T:A
NM_007294.4(BRCA1):c.789T>C (p.Gly263=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000055702	17	41246759	17	43094742	55702	70369	rs397509320	NC_000017.11:43094741:A:G
NM_007294.4(BRCA1):c.788G>A (p.Gly263Asp)	BRCA1	G263D, G216D, G135D, G151D, G175D, G136D, G222D, G237D, G262D, G152D, G174D, G193D, G215D, G236D, G192D, G195D, G196D, G221D, G260D, G95D	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000182127	17	41246760	17	43094743	182127	180884	rs397509319	NC_000017.11:43094742:C:T
NM_007294.4(BRCA1):c.788G>T (p.Gly263Val)	BRCA1	G263V, G216V, G136V, G193V, G215V, G152V, G174V, G175V, G192V, G195V, G236V, G260V, G95V, G135V, G151V, G221V, G237V, G196V, G222V, G262V	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2023)	criteria provided, conflicting interpretations	VCV000055701	17	41246760	17	43094743	55701	70368	rs397509319	NC_000017.11:43094742:C:A
NM_007294.4(BRCA1):c.788G>C (p.Gly263Ala)	BRCA1	G263A, G216A, G151A, G174A, G222A, G237A, G175A, G193A, G221A, G236A, G135A, G152A, G195A, G196A, G260A, G136A, G192A, G215A, G262A, G95A	Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 23, 2023)	criteria provided, single submitter	VCV000055700	17	41246760	17	43094743	55700	70367	rs397509319	NC_000017.11:43094742:C:G
NM_007294.4(BRCA1):c.786G>A (p.Gln262=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000055698	17	41246762	17	43094745	55698	70365	rs397509317	NC_000017.11:43094744:C:T
NM_007294.4(BRCA1):c.771T>C (p.His257=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Feb 10, 2022)	criteria provided, single submitter	VCV001124478	17	41246777	17	43094760	1124478	1126299		NC_000017.11:43094759:A:G
NM_007294.4(BRCA1):c.768G>A (p.Arg256=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000183872	17	41246780	17	43094763	183872	185096	rs746067447	NC_000017.11:43094762:C:T
NM_007294.4(BRCA1):c.766A>C (p.Arg256=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427300	17	41246782	17	43094765	427300	416519	rs587781833	NC_000017.11:43094764:T:G
NM_007294.4(BRCA1):c.765G>A (p.Glu255=)	BRCA1		Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	Benign/Likely benign(Last reviewed: Oct 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000136091	17	41246783	17	43094766	136091	139803	rs62625299	NC_000017.11:43094765:C:T
NM_007294.4(BRCA1):c.762T>C (p.Ala254=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000482887	17	41246786	17	43094769	482887	478714	rs1555593173	NC_000017.11:43094768:A:G
NM_007294.4(BRCA1):c.759A>C (p.Ala253=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 8, 2021)	criteria provided, single submitter	VCV001759682	17	41246789	17	43094772	1759682	1813283		NC_000017.11:43094771:T:G
NM_007294.4(BRCA1):c.759A>T (p.Ala253=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427254	17	41246789	17	43094772	427254	416520	rs1131692069	NC_000017.11:43094771:T:A
NM_007294.4(BRCA1):c.756T>C (p.Arg252=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000184217	17	41246792	17	43094775	184217	185097	rs786201338	NC_000017.11:43094774:A:G
NM_007294.4(BRCA1):c.750G>A (p.Glu250=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427360	17	41246798	17	43094781	427360	416521	rs762867923	NC_000017.11:43094780:C:T
NM_007294.4(BRCA1):c.747T>G (p.Thr249=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV001654107	17	41246801	17	43094784	1654107	1526925		NC_000017.11:43094783:A:C
NM_007294.4(BRCA1):c.744C>T (p.Thr248=)	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000506303	17	41246804	17	43094787	506303	506860	rs886037791	NC_000017.11:43094786:G:A
NM_007294.4(BRCA1):c.744C>G (p.Thr248=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000224432	17	41246804	17	43094787	224432	226208	rs886037791	NC_000017.11:43094786:G:C
NM_007294.4(BRCA1):c.741C>T (p.Asn247=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000827036	17	41246807	17	43094790	827036	813884	rs1597880263	NC_000017.11:43094789:G:A
NM_007294.4(BRCA1):c.738G>A (p.Leu246=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000240830	17	41246810	17	43094793	240830	242805	rs768416164	NC_000017.11:43094792:C:T
NM_007294.4(BRCA1):c.736T>C (p.Leu246=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000482941	17	41246812	17	43094795	482941	478792	rs28897675	NC_000017.11:43094794:A:G
NM_007294.4(BRCA1):c.732T>C (p.Asn244=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV001094207	17	41246816	17	43094799	1094207	1083116		NC_000017.11:43094798:A:G
NM_007294.4(BRCA1):c.723C>T (p.Pro241=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Aug 31, 2022)	criteria provided, single submitter	VCV002028072	17	41246825	17	43094808	2028072	2088547		NC_000017.11:43094807:G:A
NM_007294.4(BRCA1):c.711A>G (p.Glu237=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Mar 14, 2022)	criteria provided, single submitter	VCV002109842	17	41246837	17	43094820	2109842	2163717		NC_000017.11:43094819:T:C
NM_007294.4(BRCA1):c.708T>C (p.Thr236=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jan 28, 2022)	criteria provided, single submitter	VCV001530332	17	41246840	17	43094823	1530332	1582117		NC_000017.11:43094822:A:G
NM_007294.4(BRCA1):c.705T>C (p.Asn235=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000481425	17	41246843	17	43094826	481425	478863	rs1165432483	NC_000017.11:43094825:A:G
NM_007294.4(BRCA1):c.702A>G (p.Thr234=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 31, 2022)	criteria provided, single submitter	VCV001756761	17	41246846	17	43094829	1756761	1822572		NC_000017.11:43094828:T:C
NM_007294.4(BRCA1):c.699A>G (p.Val233=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000185425	17	41246849	17	43094832	185425	185099	rs786202162	NC_000017.11:43094831:T:C
NM_007294.4(BRCA1):c.696T>C (p.Asp232=)	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Aug 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000389874	17	41246852	17	43094835	389874	376032	rs1057523563	NC_000017.11:43094834:A:G
NM_007294.4(BRCA1):c.693G>T (p.Thr231=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000055671	17	41246855	17	43094838	55671	70338	rs62625298	NC_000017.11:43094837:C:A
NM_007294.4(BRCA1):c.693G>A (p.Thr231=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000055670	17	41246855	17	43094838	55670	70337	rs62625298	NC_000017.11:43094837:C:T
NM_007294.4(BRCA1):c.692C>G (p.Thr231Arg)	BRCA1	T205R, T230R, T231R, T103R, T104R, T119R, T164R, T183R, T184R, T189R, T204R, T228R, T161R, T163R, T190R, T120R, T142R, T143R, T160R, T186R, T63R	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 10, 2023)	criteria provided, single submitter	VCV002450685	17	41246856	17	43094839	2450685	2423171		NC_000017.11:43094838:G:C
NM_007294.4(BRCA1):c.675T>G (p.Ala225=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000491184	17	41246873	17	43094856	491184	485113	rs1555593332	NC_000017.11:43094855:A:C
NM_007294.4(BRCA1):c.672T>G (p.Ala224=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 14, 2022)	criteria provided, conflicting interpretations	VCV000420455	17	41246876	17	43094859	420455	410024	rs1064794486	NC_000017.11:43094858:A:C
NM_007294.4(BRCA1):c.381T>C (p.Ser127=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 28, 2022)	criteria provided, single submitter	VCV001735259	17	41256199	17	43104182	1735259	1793598		NC_000017.11:43104181:A:G
NM_007294.4(BRCA1):c.378A>G (p.Gln126=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000184064	17	41256202	17	43104185	184064	185115	rs786201256	NC_000017.11:43104184:T:C
NM_007294.4(BRCA1):c.375C>T (p.Ile125=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000629047	17	41256205	17	43104188	629047	618699	rs1311672121	NC_000017.11:43104187:G:A
NM_007294.4(BRCA1):c.372C>T (p.Ile124=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 5, 2021)	criteria provided, single submitter	VCV001692965	17	41256208	17	43104191	1692965	1685405		NC_000017.11:43104190:G:A
NM_007294.4(BRCA1):c.372C>A (p.Ile124=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000054983	17	41256208	17	43104191	54983	69650	rs273900715	NC_000017.11:43104190:G:T
NM_007294.4(BRCA1):c.369T>C (p.Ser123=)	BRCA1		not specified	Uncertain significance(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000929006	17	41256211	17	43104194	929006	917262	rs774583925	NC_000017.11:43104193:A:G
NM_007294.4(BRCA1):c.369T>A (p.Ser123=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427329	17	41256211	17	43104194	427329	416529	rs774583925	NC_000017.11:43104193:A:T
NM_007294.4(BRCA1):c.366T>G (p.Val122=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000185214	17	41256214	17	43104197	185214	185116	rs190900046	NC_000017.11:43104196:A:C
NM_007294.4(BRCA1):c.363A>G (p.Glu121=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Nov 23, 2017)	criteria provided, single submitter	VCV000415545	17	41256217	17	43104200	415545	402558	rs1060504552	NC_000017.11:43104199:T:C
NM_007294.4(BRCA1):c.354A>G (p.Leu118=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000462613	17	41256226	17	43104209	462613	468067	rs1320340280	NC_000017.11:43104208:T:C
NM_007294.4(BRCA1):c.352C>T (p.Leu118=)	BRCA1		Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 20, 2020)	criteria provided, conflicting interpretations	VCV000993048	17	41256228	17	43104211	993048	981176	rs876659315	NC_000017.11:43104210:G:A
NM_007294.4(BRCA1):c.348A>G (p.Glu116=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Feb 1, 2022)	criteria provided, single submitter	VCV002091648	17	41256232	17	43104215	2091648	2156031		NC_000017.11:43104214:T:C
NM_007294.4(BRCA1):c.342T>C (p.Ser114=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Apr 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000797285	17	41256238	17	43104221	797285	785602	rs1597896958	NC_000017.11:43104220:A:G
NM_007294.4(BRCA1):c.339C>T (p.Asn113=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427299	17	41256241	17	43104224	427299	416530	rs587779367	NC_000017.11:43104223:G:A
NM_007294.4(BRCA1):c.333A>G (p.Glu111=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001105887	17	41256247	17	43104230	1105887	1104898		NC_000017.11:43104229:T:C
NM_007294.4(BRCA1):c.330G>A (p.Lys110=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000240791	17	41256250	17	43104233	240791	242813	rs878854947	NC_000017.11:43104232:C:T
NM_007294.4(BRCA1):c.327A>G (p.Lys109=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001547349	17	41256253	17	43104236	1547349	1571892		NC_000017.11:43104235:T:C
NM_007294.4(BRCA1):c.315T>C (p.Tyr105=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000921198	17	41256265	17	43104248	921198	913983	rs2054639807	NC_000017.11:43104247:A:G
NM_007294.4(BRCA1):c.312C>T (p.Ser104=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001727937	17	41256268	17	43104251	1727937	1794805		NC_000017.11:43104250:G:A
NM_007294.4(BRCA1):c.309C>T (p.Asn103=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000232515	17	41256271	17	43104254	232515	236172	rs876659814	NC_000017.11:43104253:G:A
NM_007294.4(BRCA1):c.303T>C (p.Tyr101=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427330	17	41256277	17	43104260	427330	416531	rs80356936	NC_000017.11:43104259:A:G
NM_007294.4(BRCA1):c.300G>A (p.Glu100=)	BRCA1		not specified|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: May 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000511007	17	41256886	17	43104869	511007	506098	rs1555596638	NC_000017.11:43104868:C:T
NM_007294.4(BRCA1):c.295T>C (p.Leu99=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868364	17	41256891	17	43104874	868364	854423	rs2054671155	NC_000017.11:43104873:A:G
NM_007294.4(BRCA1):c.294T>G (p.Gly98=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868363	17	41256892	17	43104875	868363	854424	rs2054671376	NC_000017.11:43104874:A:C
NM_007294.4(BRCA1):c.294T>C (p.Gly98=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868362	17	41256892	17	43104875	868362	854425	rs2054671376	NC_000017.11:43104874:A:G
NM_007294.4(BRCA1):c.294T>A (p.Gly98=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868361	17	41256892	17	43104875	868361	854426	rs2054671376	NC_000017.11:43104874:A:T
NM_007294.4(BRCA1):c.291A>T (p.Thr97=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865638	17	41256895	17	43104878	865638	854432	rs1131692085	NC_000017.11:43104877:T:A
NM_007294.4(BRCA1):c.291A>C (p.Thr97=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000739945	17	41256895	17	43104878	739945	755878	rs1131692085	NC_000017.11:43104877:T:G
NM_007294.4(BRCA1):c.291A>G (p.Thr97=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427275	17	41256895	17	43104878	427275	416532	rs1131692085	NC_000017.11:43104877:T:C
NM_007294.4(BRCA1):c.288C>T (p.Asp96=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000182084	17	41256898	17	43104881	182084	180891	rs146085503	NC_000017.11:43104880:G:A
NM_007294.4(BRCA1):c.285T>G (p.Leu95=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868824	17	41256901	17	43104884	868824	854441	rs2054674739	NC_000017.11:43104883:A:C
NM_007294.4(BRCA1):c.285T>C (p.Leu95=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868353	17	41256901	17	43104884	868353	854442	rs2054674739	NC_000017.11:43104883:A:G
NM_007294.4(BRCA1):c.285T>A (p.Leu95=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV000868352	17	41256901	17	43104884	868352	854443	rs2054674739	NC_000017.11:43104883:A:T
NM_007294.4(BRCA1):c.282G>A (p.Gln94=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865631	17	41256904	17	43104887	865631	854451	rs1597898117	NC_000017.11:43104886:C:T
NM_007294.4(BRCA1):c.279T>C (p.Phe93=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865363	17	41256907	17	43104890	865363	854458	rs2054676882	NC_000017.11:43104889:A:G
NM_007294.4(BRCA1):c.276T>G (p.Ala92=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868821	17	41256910	17	43104893	868821	854466	rs2054677953	NC_000017.11:43104892:A:C
NM_007294.4(BRCA1):c.276T>C (p.Ala92=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868820	17	41256910	17	43104893	868820	854467	rs2054677953	NC_000017.11:43104892:A:G
NM_007294.4(BRCA1):c.276T>A (p.Ala92=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868819	17	41256910	17	43104893	868819	854468	rs2054677953	NC_000017.11:43104892:A:T
NM_007294.4(BRCA1):c.273T>C (p.Cys91=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868340	17	41256913	17	43104896	868340	854473	rs397509006	NC_000017.11:43104895:A:G
NM_007294.4(BRCA1):c.270T>A (p.Ile90=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865617	17	41256916	17	43104899	865617	854479	rs1555596670	NC_000017.11:43104898:A:T
NM_007294.4(BRCA1):c.270T>C (p.Ile90=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: May 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000531521	17	41256916	17	43104899	531521	531340	rs1555596670	NC_000017.11:43104898:A:G
NM_007294.4(BRCA1):c.267C>T (p.Ile89=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV000865350	17	41256919	17	43104902	865350	854484	rs80356963	NC_000017.11:43104901:G:A
NM_007294.4(BRCA1):c.267C>A (p.Ile89=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV000865349	17	41256919	17	43104902	865349	854485	rs80356963	NC_000017.11:43104901:G:T
NM_007294.4(BRCA1):c.264A>G (p.Lys88=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV000868810	17	41256922	17	43104905	868810	854492	rs2054681664	NC_000017.11:43104904:T:C
NM_007294.4(BRCA1):c.261G>A (p.Leu87=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427354	17	41256925	17	43104908	427354	416533	rs757971617	NC_000017.11:43104907:C:T
NM_007294.4(BRCA1):c.259T>C (p.Leu87=)	BRCA1		Hereditary cancer-predisposing syndrome|not specified	Likely benign(Last reviewed: Aug 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000381661	17	41256927	17	43104910	381661	375106	rs80357091	NC_000017.11:43104909:A:G
NM_007294.4(BRCA1):c.258A>C (p.Leu86=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865341	17	41256928	17	43104911	865341	854503	rs777491912	NC_000017.11:43104910:T:G
NM_007294.4(BRCA1):c.258A>T (p.Leu86=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427292	17	41256928	17	43104911	427292	416534	rs777491912	NC_000017.11:43104910:T:A
NM_007294.4(BRCA1):c.258A>G (p.Leu86=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000187586	17	41256928	17	43104911	187586	185120	rs777491912	NC_000017.11:43104910:T:C
NM_007294.4(BRCA1):c.256C>T (p.Leu86=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV000865337	17	41256930	17	43104913	865337	854507	rs2054684036	NC_000017.11:43104912:G:A
NM_007294.4(BRCA1):c.255G>A (p.Glu85=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000186047	17	41256931	17	43104914	186047	185121	rs756499058	NC_000017.11:43104913:C:T
NM_007294.4(BRCA1):c.252A>G (p.Glu84=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868313	17	41256934	17	43104917	868313	854518	rs2054685385	NC_000017.11:43104916:T:C
NM_007294.4(BRCA1):c.249T>G (p.Val83=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, single submitter	VCV000865326	17	41256937	17	43104920	865326	854525	rs780485347	NC_000017.11:43104919:A:C
NM_007294.4(BRCA1):c.249T>A (p.Val83=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865325	17	41256937	17	43104920	865325	854526	rs780485347	NC_000017.11:43104919:A:T
NM_007294.4(BRCA1):c.249T>C (p.Val83=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427335	17	41256937	17	43104920	427335	416535	rs780485347	NC_000017.11:43104919:A:G
NM_007294.4(BRCA1):c.246T>G (p.Leu82=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867374	17	41256940	17	43104923	867374	854530	rs2054687485	NC_000017.11:43104922:A:C
NM_007294.4(BRCA1):c.246T>C (p.Leu82=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV000867373	17	41256940	17	43104923	867373	854531	rs2054687485	NC_000017.11:43104922:A:G
NM_007294.4(BRCA1):c.246T>A (p.Leu82=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV000867372	17	41256940	17	43104923	867372	854532	rs2054687485	NC_000017.11:43104922:A:T
NM_007294.4(BRCA1):c.243A>G (p.Gln81=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000215871	17	41256943	17	43104926	215871	213336	rs863224418	NC_000017.11:43104925:T:C
NM_007294.4(BRCA1):c.240T>C (p.Ser80=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865596	17	41256946	17	43104929	865596	854545	rs2054689945	NC_000017.11:43104928:A:G
NM_007294.4(BRCA1):c.237T>C (p.Phe79=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865310	17	41256949	17	43104932	865310	854554	rs2054691161	NC_000017.11:43104931:A:G
NM_007294.4(BRCA1):c.234A>G (p.Arg78=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867363	17	41256952	17	43104935	867363	854561	rs2054692277	NC_000017.11:43104934:T:C
NM_007294.4(BRCA1):c.232A>C (p.Arg78=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865582	17	41256954	17	43104937	865582	854568	rs2054692881	NC_000017.11:43104936:T:G
NM_007294.4(BRCA1):c.231G>A (p.Thr77=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000142611	17	41256955	17	43104938	142611	152325	rs80356847	NC_000017.11:43104937:C:T
NM_007294.4(BRCA1):c.231G>C (p.Thr77=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000141303	17	41256955	17	43104938	141303	151017	rs80356847	NC_000017.11:43104937:C:G
NM_007294.4(BRCA1):c.231G>T (p.Thr77=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000054533	17	41256955	17	43104938	54533	69200	rs80356847	NC_000017.11:43104937:C:A
NM_007294.4(BRCA1):c.228T>C (p.Ser76=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV000865300	17	41256958	17	43104941	865300	854573	rs1597898400	NC_000017.11:43104940:A:G
NM_007294.4(BRCA1):c.225A>G (p.Glu75=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867982	17	41256961	17	43104944	867982	854582	rs2054695634	NC_000017.11:43104943:T:C
NM_007294.4(BRCA1):c.222A>G (p.Gln74=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000231529	17	41256964	17	43104947	231529	236176	rs730881465	NC_000017.11:43104946:T:C
NM_007294.4(BRCA1):c.219A>T (p.Leu73=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865572	17	41256967	17	43104950	865572	854594	rs876659123	NC_000017.11:43104949:T:A
NM_007294.4(BRCA1):c.219A>C (p.Leu73=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865292	17	41256967	17	43104950	865292	854595	rs876659123	NC_000017.11:43104949:T:G
NM_007294.4(BRCA1):c.219A>G (p.Leu73=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000231377	17	41256967	17	43104950	231377	236177	rs876659123	NC_000017.11:43104949:T:C
NM_007294.4(BRCA1):c.217C>T (p.Leu73=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000183982	17	41256969	17	43104952	183982	185122	rs786201203	NC_000017.11:43104951:G:A
NM_007294.4(BRCA1):c.216C>T (p.Ser72=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV000762118	17	41256970	17	43104953	762118	771555	rs80356967	NC_000017.11:43104952:G:A
NM_007294.4(BRCA1):c.213G>A (p.Arg71=)	BRCA1	M1I, W27*	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867353	17	41256973	17	43104956	867353	854608	rs1441240938	NC_000017.11:43104955:C:T
NM_007294.4(BRCA1):c.187T>C (p.Leu63=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865238	17	41258498	17	43106481	865238	854656	rs2054778672	NC_000017.11:43106480:A:G
NM_007294.4(BRCA1):c.186T>G (p.Pro62=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865236	17	41258499	17	43106482	865236	854658	rs2054778965	NC_000017.11:43106481:A:C
NM_007294.4(BRCA1):c.186T>C (p.Pro62=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865235	17	41258499	17	43106482	865235	854659	rs2054778965	NC_000017.11:43106481:A:G
NM_007294.4(BRCA1):c.186T>A (p.Pro62=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865234	17	41258499	17	43106482	865234	854660	rs2054778965	NC_000017.11:43106481:A:T
NM_007294.4(BRCA1):c.183T>C (p.Cys61=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Aug 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000531482	17	41258502	17	43106485	531482	531388	rs895070717	NC_000017.11:43106484:A:G
NM_007294.4(BRCA1):c.180G>A (p.Gln60=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000867308	17	41258505	17	43106488	867308	854672	rs2054781252	NC_000017.11:43106487:C:T
NM_007294.4(BRCA1):c.177A>T (p.Ser59=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867303	17	41258508	17	43106491	867303	854677	rs2054782640	NC_000017.11:43106490:T:A
NM_007294.4(BRCA1):c.177A>G (p.Ser59=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865228	17	41258508	17	43106491	865228	854678	rs2054782640	NC_000017.11:43106490:T:C
NM_007294.4(BRCA1):c.177A>C (p.Ser59=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865227	17	41258508	17	43106491	865227	854679	rs2054782640	NC_000017.11:43106490:T:G
NM_007294.4(BRCA1):c.174T>G (p.Pro58=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868247	17	41258511	17	43106494	868247	854684	rs2054783548	NC_000017.11:43106493:A:C
NM_007294.4(BRCA1):c.174T>C (p.Pro58=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868246	17	41258511	17	43106494	868246	854685	rs2054783548	NC_000017.11:43106493:A:G
NM_007294.4(BRCA1):c.174T>A (p.Pro58=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868245	17	41258511	17	43106494	868245	854686	rs2054783548	NC_000017.11:43106493:A:T
NM_007294.4(BRCA1):c.171G>T (p.Gly57=)	BRCA1		Hereditary cancer-predisposing syndrome|not specified	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000389985	17	41258514	17	43106497	389985	376044	rs1057523606	NC_000017.11:43106496:C:A
NM_007294.4(BRCA1):c.168A>G (p.Lys56=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Feb 24, 2019)	criteria provided, single submitter	VCV000867911	17	41258517	17	43106500	867911	854691	rs397508898	NC_000017.11:43106499:T:C
NM_007294.4(BRCA1):c.165G>A (p.Lys55=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000819737	17	41258520	17	43106503	819737	813912	rs1597900495	NC_000017.11:43106502:C:T
NM_007294.4(BRCA1):c.162G>A (p.Gln54=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865212	17	41258523	17	43106506	865212	854707	rs772226744	NC_000017.11:43106505:C:T
NM_007294.4(BRCA1):c.159C>T (p.Asn53=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000415601	17	41258526	17	43106509	415601	402109	rs1060504588	NC_000017.11:43106508:G:A
NM_007294.4(BRCA1):c.156C>T (p.Leu52=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867894	17	41258529	17	43106512	867894	854719	rs2054789276	NC_000017.11:43106511:G:A
NM_007294.4(BRCA1):c.156C>G (p.Leu52=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867285	17	41258529	17	43106512	867285	854720	rs2054789276	NC_000017.11:43106511:G:C
NM_007294.4(BRCA1):c.156C>A (p.Leu52=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867284	17	41258529	17	43106512	867284	854721	rs2054789276	NC_000017.11:43106511:G:T
NM_007294.4(BRCA1):c.153T>C (p.Leu51=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865207	17	41258532	17	43106515	865207	854725	rs1131692081	NC_000017.11:43106514:A:G
NM_007294.4(BRCA1):c.153T>A (p.Leu51=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865206	17	41258532	17	43106515	865206	854726	rs1131692081	NC_000017.11:43106514:A:T
NM_007294.4(BRCA1):c.153T>G (p.Leu51=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427270	17	41258532	17	43106515	427270	416537	rs1131692081	NC_000017.11:43106514:A:C
NM_007294.4(BRCA1):c.150A>G (p.Lys50=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000480983	17	41258535	17	43106518	480983	479551	rs1555597289	NC_000017.11:43106517:T:C
NM_007294.4(BRCA1):c.147G>T (p.Leu49=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867888	17	41258538	17	43106521	867888	854739	rs1555597297	NC_000017.11:43106520:C:A
NM_007294.4(BRCA1):c.147G>C (p.Leu49=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV000867887	17	41258538	17	43106521	867887	854740	rs1555597297	NC_000017.11:43106520:C:G
NM_007294.4(BRCA1):c.147G>A (p.Leu49=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV000482886	17	41258538	17	43106521	482886	479553	rs1555597297	NC_000017.11:43106520:C:T
NM_007294.4(BRCA1):c.145C>T (p.Leu49=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867275	17	41258540	17	43106523	867275	854743	rs2054792700	NC_000017.11:43106522:G:A
NM_007294.4(BRCA1):c.141C>G (p.Cys47Trp)	BRCA1	C47W	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865192	17	41258544	17	43106527	865192	854753	rs398122635	NC_000017.11:43106526:G:C
NM_007294.4(BRCA1):c.141C>T (p.Cys47=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000427311	17	41258544	17	43106527	427311	416538	rs398122635	NC_000017.11:43106526:G:A
NM_007294.4(BRCA1):c.141C>A (p.Cys47Ter)	BRCA1	C47*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000091553	17	41258544	17	43106527	91553	97030	rs398122635	NC_000017.11:43106526:G:T
NM_007294.4(BRCA1):c.140G>C (p.Cys47Ser)	BRCA1	C47S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868217	17	41258545	17	43106528	868217	854754	rs80357150	NC_000017.11:43106527:C:G
NM_007294.4(BRCA1):c.140G>T (p.Cys47Phe)	BRCA1	C47F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2022)	criteria provided, multiple submitters, no conflicts	VCV000054247	17	41258545	17	43106528	54247	68914	rs80357150	NC_000017.11:43106527:C:A
NM_007294.4(BRCA1):c.140G>A (p.Cys47Tyr)	BRCA1	C47Y	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054246	17	41258545	17	43106528	54246	68913	rs80357150	NC_000017.11:43106527:C:T
NM_007294.4(BRCA1):c.139T>C (p.Cys47Arg)	BRCA1	C47R	Hereditary breast ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000651975	17	41258546	17	43106529	651975	646060	rs80357370	NC_000017.11:43106528:A:G
NM_007294.4(BRCA1):c.139T>A (p.Cys47Ser)	BRCA1	C47S	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000267508	17	41258546	17	43106529	267508	262990	rs80357370	NC_000017.11:43106528:A:T
NM_007294.4(BRCA1):c.139T>G (p.Cys47Gly)	BRCA1	C47G	Hereditary breast ovarian cancer syndrome	Likely pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000054242	17	41258546	17	43106529	54242	68909	rs80357370	NC_000017.11:43106528:A:C
NM_007294.4(BRCA1):c.138T>G (p.Phe46Leu)	BRCA1	F46L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868216	17	41258547	17	43106530	868216	854755	rs2054795825	NC_000017.11:43106529:A:C
NM_007294.4(BRCA1):c.138T>C (p.Phe46=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868215	17	41258547	17	43106530	868215	854756	rs2054795825	NC_000017.11:43106529:A:G
NM_007294.4(BRCA1):c.138T>A (p.Phe46Leu)	BRCA1	F46L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868214	17	41258547	17	43106530	868214	854757	rs2054795825	NC_000017.11:43106529:A:T
NM_007294.4(BRCA1):c.137T>G (p.Phe46Cys)	BRCA1	F46C	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867881	17	41258548	17	43106531	867881	854758	rs2054796108	NC_000017.11:43106530:A:C
NM_007294.4(BRCA1):c.137T>C (p.Phe46Ser)	BRCA1	F46S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867880	17	41258548	17	43106531	867880	854759	rs2054796108	NC_000017.11:43106530:A:G
NM_007294.4(BRCA1):c.137T>A (p.Phe46Tyr)	BRCA1	F46Y	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867879	17	41258548	17	43106531	867879	854760	rs2054796108	NC_000017.11:43106530:A:T
NM_007294.4(BRCA1):c.136T>G (p.Phe46Val)	BRCA1	F46V	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Oct 3, 2022)	criteria provided, single submitter	VCV000867878	17	41258549	17	43106532	867878	854761	rs2054796556	NC_000017.11:43106531:A:C
NM_007294.4(BRCA1):c.136T>C (p.Phe46Leu)	BRCA1	F46L	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000867877	17	41258549	17	43106532	867877	854762	rs2054796556	NC_000017.11:43106531:A:G
NM_007294.4(BRCA1):c.136T>A (p.Phe46Ile)	BRCA1	F46I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867876	17	41258549	17	43106532	867876	854763	rs2054796556	NC_000017.11:43106531:A:T
NM_007294.4(BRCA1):c.135A>G (p.Lys45=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867875	17	41258550	17	43106533	867875	854764	rs80356883	NC_000017.11:43106532:T:C
NM_007294.4(BRCA1):c.135A>C (p.Lys45Asn)	BRCA1	K45N	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867262	17	41258550	17	43106533	867262	854765	rs80356883	NC_000017.11:43106532:T:G
NM_007294.4(BRCA1):c.135A>T (p.Lys45Asn)	BRCA1	K45N	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Sep 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000054219	17	41258550	17	43106533	54219	68886	rs80356883	NC_000017.11:43106532:T:A
NM_007294.4(BRCA1):c.135-3999C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	VCV000209510	17	41262549	17	43110532	209510	206469	rs75129942	NC_000017.11:43110531:G:A
NM_007294.4(BRCA1):c.132C>T (p.Cys44=)	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2021)	criteria provided, conflicting interpretations	VCV000230061	17	41267745	17	43115728	230061	236178	rs876658362	NC_000017.11:43115727:G:A
NM_007294.4(BRCA1):c.129T>C (p.Phe43=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867832	17	41267748	17	43115731	867832	854773	rs2055245756	NC_000017.11:43115730:A:G
NM_007294.4(BRCA1):c.126A>T (p.Ile42=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867510	17	41267751	17	43115734	867510	854779	rs2055246676	NC_000017.11:43115733:T:A
NM_007294.4(BRCA1):c.126A>C (p.Ile42=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867508	17	41267751	17	43115734	867508	854781	rs2055246676	NC_000017.11:43115733:T:G
NM_007294.4(BRCA1):c.123C>T (p.His41=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000185485	17	41267754	17	43115737	185485	185128	rs786202211	NC_000017.11:43115736:G:A
NM_007294.4(BRCA1):c.120C>T (p.Asp40=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Oct 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000415586	17	41267757	17	43115740	415586	402577	rs1060504580	NC_000017.11:43115739:G:A
NM_007294.4(BRCA1):c.117T>C (p.Cys39=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867816	17	41267760	17	43115743	867816	854797	rs886040898	NC_000017.11:43115742:A:G
NM_007294.4(BRCA1):c.114G>A (p.Lys38=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	VCV000054146	17	41267763	17	43115746	54146	68813	rs1800062	NC_000017.11:43115745:C:T
NM_007294.4(BRCA1):c.111A>T (p.Thr37=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 4, 2021)	criteria provided, single submitter	VCV000865127	17	41267766	17	43115749	865127	854806	rs1293537445	NC_000017.11:43115748:T:A
NM_007294.4(BRCA1):c.111A>C (p.Thr37=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000818374	17	41267766	17	43115749	818374	813913	rs1293537445	NC_000017.11:43115748:T:G
NM_007294.4(BRCA1):c.111A>G (p.Thr37=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Feb 9, 2023)	criteria provided, multiple submitters, no conflicts	VCV000631253	17	41267766	17	43115749	631253	618703	rs1293537445	NC_000017.11:43115748:T:C
NM_007294.4(BRCA1):c.105C>T (p.Val35=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867808	17	41267772	17	43115755	867808	854812	rs2055254108	NC_000017.11:43115754:G:A
NM_007294.4(BRCA1):c.105C>G (p.Val35=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867807	17	41267772	17	43115755	867807	854813	rs2055254108	NC_000017.11:43115754:G:C
NM_007294.4(BRCA1):c.105C>A (p.Val35=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867806	17	41267772	17	43115755	867806	854814	rs2055254108	NC_000017.11:43115754:G:T
NM_007294.4(BRCA1):c.102T>C (p.Pro34=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867488	17	41267775	17	43115758	867488	854820	rs1555599260	NC_000017.11:43115757:A:G
NM_007294.4(BRCA1):c.102T>A (p.Pro34=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867487	17	41267775	17	43115758	867487	854821	rs1555599260	NC_000017.11:43115757:A:T
NM_007294.4(BRCA1):c.102T>G (p.Pro34=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000491025	17	41267775	17	43115758	491025	485408	rs1555599260	NC_000017.11:43115757:A:C
NM_007294.4(BRCA1):c.99A>G (p.Glu33=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865115	17	41267778	17	43115761	865115	854827	rs2055257088	NC_000017.11:43115760:T:C
NM_007294.4(BRCA1):c.96G>A (p.Lys32=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000868134	17	41267781	17	43115764	868134	854833	rs1597912013	NC_000017.11:43115763:C:T
NM_007294.4(BRCA1):c.93C>T (p.Ile31=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Feb 23, 2021)	criteria provided, single submitter	VCV000867791	17	41267784	17	43115767	867791	854840	rs80357000	NC_000017.11:43115766:G:A
NM_007294.4(BRCA1):c.93C>A (p.Ile31=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 21, 2022)	criteria provided, single submitter	VCV000867790	17	41267784	17	43115767	867790	854841	rs80357000	NC_000017.11:43115766:G:T
NM_007294.4(BRCA1):c.90G>A (p.Leu30=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865104	17	41267787	17	43115770	865104	854849	rs2055260326	NC_000017.11:43115769:C:T
NM_007294.4(BRCA1):c.88T>C (p.Leu30=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV000865100	17	41267789	17	43115772	865100	854853	rs2055260993	NC_000017.11:43115771:A:G
NM_007294.4(BRCA1):c.87G>A (p.Glu29=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Oct 17, 2022)	criteria provided, single submitter	VCV000762465	17	41267790	17	43115773	762465	771556	rs1343667553	NC_000017.11:43115772:C:T
NM_007294.4(BRCA1):c.84G>T (p.Leu28=)	BRCA1		Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: May 1, 2020)	criteria provided, single submitter	VCV000867785	17	41267793	17	43115776	867785	854861	rs1555599278	NC_000017.11:43115775:C:A
NM_007294.4(BRCA1):c.84G>C (p.Leu28=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867784	17	41267793	17	43115776	867784	854862	rs1555599278	NC_000017.11:43115775:C:G
NM_007294.4(BRCA1):c.84G>A (p.Leu28=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Oct 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000531292	17	41267793	17	43115776	531292	531130	rs1555599278	NC_000017.11:43115775:C:T
NM_007294.4(BRCA1):c.82C>T (p.Leu28=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000827566	17	41267795	17	43115778	827566	813916	rs1219301058	NC_000017.11:43115777:G:A
NM_007294.4(BRCA1):c.81T>C (p.Cys27=)	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Mar 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000136093	17	41267796	17	43115779	136093	139805	rs587780805	NC_000017.11:43115778:A:G
NM_007294.4(BRCA1):c.81-3426G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	VCV000209554	17	41271222	17	43119205	209554	206513	rs143912779	NC_000017.11:43119204:C:T
NM_007294.4(BRCA1):c.80G>A (p.Cys27Tyr)	BRCA1	C27Y, W27*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely pathogenic(Last reviewed: Oct 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000827453	17	41276034	17	43124017	827453	813918	rs1064793052	NC_000017.11:43124016:C:T
NM_007294.4(BRCA1):c.80G>T (p.Cys27Phe)	BRCA1	C27F, W27L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000481469	17	41276034	17	43124017	481469	478848	rs1064793052	NC_000017.11:43124016:C:A
NM_007294.4(BRCA1):c.80G>C (p.Cys27Ser)	BRCA1	C27S, W27S	Hereditary breast ovarian cancer syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 3, 2022)	criteria provided, conflicting interpretations	VCV000418064	17	41276034	17	43124017	418064	410036	rs1064793052	NC_000017.11:43124016:C:G
NM_007294.4(BRCA1):c.79T>G (p.Cys27Gly)	BRCA1	C27G, W27G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867751	17	41276035	17	43124018	867751	854868	rs2055713838	NC_000017.11:43124017:A:C
NM_007294.4(BRCA1):c.79T>C (p.Cys27Arg)	BRCA1	C27R, W27R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867750	17	41276035	17	43124018	867750	854869	rs2055713838	NC_000017.11:43124017:A:G
NM_007294.4(BRCA1):c.79T>A (p.Cys27Ser)	BRCA1	C27S, W27R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867749	17	41276035	17	43124018	867749	854870	rs2055713838	NC_000017.11:43124017:A:T
NM_007294.4(BRCA1):c.78C>G (p.Ile26Met)	BRCA1	I26M	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867748	17	41276036	17	43124019	867748	854871	rs1555600862	NC_000017.11:43124018:G:C
NM_007294.4(BRCA1):c.78C>A (p.Ile26=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867747	17	41276036	17	43124019	867747	854872	rs1555600862	NC_000017.11:43124018:G:T
NM_007294.4(BRCA1):c.78C>T (p.Ile26=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Sep 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000491187	17	41276036	17	43124019	491187	485412	rs1555600862	NC_000017.11:43124018:G:A
NM_007294.4(BRCA1):c.77T>G (p.Ile26Ser)	BRCA1	I26S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867746	17	41276037	17	43124020	867746	854873	rs879255496	NC_000017.11:43124019:A:C
NM_007294.4(BRCA1):c.77T>C (p.Ile26Thr)	BRCA1	I26T	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV000856169	17	41276037	17	43124020	856169	845477	rs879255496	NC_000017.11:43124019:A:G
NM_007294.4(BRCA1):c.77T>A (p.Ile26Asn)	BRCA1	I26N	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Jul 15, 2010)	no assertion criteria provided	VCV000252890	17	41276037	17	43124020	252890	247291	rs879255496	NC_000017.11:43124019:A:T
NM_007294.4(BRCA1):c.76A>G (p.Ile26Val)	BRCA1	I26V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865067	17	41276038	17	43124021	865067	854874	rs1597923170	NC_000017.11:43124020:T:C
NM_007294.4(BRCA1):c.76A>C (p.Ile26Leu)	BRCA1	I26L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865066	17	41276038	17	43124021	865066	854875	rs1597923170	NC_000017.11:43124020:T:G
NM_007294.4(BRCA1):c.76A>T (p.Ile26Phe)	BRCA1	I26F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000827206	17	41276038	17	43124021	827206	813919	rs1597923170	NC_000017.11:43124020:T:A
NM_007294.4(BRCA1):c.75C>A (p.Pro25=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001674565	17	41276039	17	43124022	1674565	1532571		NC_000017.11:43124021:G:T
NM_007294.4(BRCA1):c.75C>G (p.Pro25=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jul 17, 2020)	criteria provided, single submitter	VCV001125447	17	41276039	17	43124022	1125447	1126308		NC_000017.11:43124021:G:C
NM_007294.4(BRCA1):c.75C>T (p.Pro25=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000055691	17	41276039	17	43124022	55691	70358	rs80356839	NC_000017.11:43124021:G:A
NM_007294.4(BRCA1):c.74C>G (p.Pro25Arg)	BRCA1	P25R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865065	17	41276040	17	43124023	865065	854876	rs876660096	NC_000017.11:43124022:G:C
NM_007294.4(BRCA1):c.74C>T (p.Pro25Leu)	BRCA1	P25L	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2022)	criteria provided, conflicting interpretations	VCV000232955	17	41276040	17	43124023	232955	236182	rs876660096	NC_000017.11:43124022:G:A
NM_007294.4(BRCA1):c.73C>T (p.Pro25Ser)	BRCA1	P25S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865064	17	41276041	17	43124024	865064	854877	rs397509313	NC_000017.11:43124023:G:A
NM_007294.4(BRCA1):c.73C>G (p.Pro25Ala)	BRCA1	P25A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865063	17	41276041	17	43124024	865063	854878	rs397509313	NC_000017.11:43124023:G:C
NM_007294.4(BRCA1):c.73C>A (p.Pro25Thr)	BRCA1	P25T	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000055684	17	41276041	17	43124024	55684	70351	rs397509313	NC_000017.11:43124023:G:T
NM_007294.4(BRCA1):c.72T>C (p.Cys24=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000868783	17	41276042	17	43124025	868783	854879	rs1597923232	NC_000017.11:43124024:A:G
NM_007294.4(BRCA1):c.72T>A (p.Cys24Ter)	BRCA1	C24*	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868782	17	41276042	17	43124025	868782	854880	rs1597923232	NC_000017.11:43124024:A:T
NM_007294.4(BRCA1):c.72T>G (p.Cys24Trp)	BRCA1	C24W	Hereditary breast ovarian cancer syndrome	Pathogenic(Last reviewed: Aug 9, 2022)	criteria provided, single submitter	VCV000652430	17	41276042	17	43124025	652430	646062	rs1597923232	NC_000017.11:43124024:A:C
NM_007294.4(BRCA1):c.71G>T (p.Cys24Phe)	BRCA1	C24F	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868781	17	41276043	17	43124026	868781	854881	rs80357198	NC_000017.11:43124025:C:A
NM_007294.4(BRCA1):c.71G>C (p.Cys24Ser)	BRCA1	C24S	Hereditary breast ovarian cancer syndrome	Likely pathogenic(Last reviewed: Nov 16, 2021)	criteria provided, single submitter	VCV000868780	17	41276043	17	43124026	868780	854882	rs80357198	NC_000017.11:43124025:C:G
NM_007294.4(BRCA1):c.71G>A (p.Cys24Tyr)	BRCA1	C24Y	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2021)	criteria provided, conflicting interpretations	VCV000055678	17	41276043	17	43124026	55678	70345	rs80357198	NC_000017.11:43124025:C:T
NM_007294.4(BRCA1):c.70T>G (p.Cys24Gly)	BRCA1	C24G	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000649351	17	41276044	17	43124027	649351	646063	rs80357410	NC_000017.11:43124026:A:C
NM_007294.4(BRCA1):c.70T>A (p.Cys24Ser)	BRCA1	C24S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 12, 2021)	criteria provided, conflicting interpretations	VCV000638952	17	41276044	17	43124027	638952	646064	rs80357410	NC_000017.11:43124026:A:T
NM_007294.4(BRCA1):c.70T>C (p.Cys24Arg)	BRCA1	C24R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000055674	17	41276044	17	43124027	55674	70341	rs80357410	NC_000017.11:43124026:A:G
NM_007294.4(BRCA1):c.69G>T (p.Glu23Asp)	BRCA1	E23D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868756	17	41276045	17	43124028	868756	854883	rs766004110	NC_000017.11:43124027:C:A
NM_007294.4(BRCA1):c.69G>A (p.Glu23=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000381467	17	41276045	17	43124028	381467	375112	rs766004110	NC_000017.11:43124027:C:T
NM_007294.4(BRCA1):c.69G>C (p.Glu23Asp)	BRCA1	E23D	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000232427	17	41276045	17	43124028	232427	236183	rs766004110	NC_000017.11:43124027:C:G
NM_007294.4(BRCA1):c.68A>T (p.Glu23Val)	BRCA1	E23V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868755	17	41276046	17	43124029	868755	854884	rs1597923307	NC_000017.11:43124028:T:A
NM_007294.4(BRCA1):c.68A>G (p.Glu23Gly)	BRCA1	E23G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868754	17	41276046	17	43124029	868754	854885	rs1597923307	NC_000017.11:43124028:T:C
NM_007294.4(BRCA1):c.68A>C (p.Glu23Ala)	BRCA1	E23A	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000826690	17	41276046	17	43124029	826690	813921	rs1597923307	NC_000017.11:43124028:T:G
NM_007294.4(BRCA1):c.67G>T (p.Glu23Ter)	BRCA1	E23*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 24, 2022)	criteria provided, single submitter	VCV000868753	17	41276047	17	43124030	868753	854886	rs372047427	NC_000017.11:43124029:C:A
NM_007294.4(BRCA1):c.67G>A (p.Glu23Lys)	BRCA1	E23K	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867739	17	41276047	17	43124030	867739	854887	rs372047427	NC_000017.11:43124029:C:T
NM_007294.4(BRCA1):c.67G>C (p.Glu23Gln)	BRCA1	E23Q	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2022)	criteria provided, conflicting interpretations	VCV000441390	17	41276047	17	43124030	441390	435181	rs372047427	NC_000017.11:43124029:C:G
NM_007294.4(BRCA1):c.66A>T (p.Leu22Phe)	BRCA1	L22F	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867738	17	41276048	17	43124031	867738	854888	rs786202533	NC_000017.11:43124030:T:A
NM_007294.4(BRCA1):c.66A>G (p.Leu22=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000481468	17	41276048	17	43124031	481468	478849	rs786202533	NC_000017.11:43124030:T:C
NM_007294.4(BRCA1):c.66A>C (p.Leu22Phe)	BRCA1	L22F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000185882	17	41276048	17	43124031	185882	185130	rs786202533	NC_000017.11:43124030:T:G
NM_007294.4(BRCA1):c.65T>G (p.Leu22Ter)	BRCA1	L22*	Hereditary breast ovarian cancer syndrome	Pathogenic(Last reviewed: May 18, 2022)	criteria provided, single submitter	VCV000867737	17	41276049	17	43124032	867737	854889	rs80357438	NC_000017.11:43124031:A:C
NM_007294.4(BRCA1):c.65T>A (p.Leu22Ter)	BRCA1	L22*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	VCV000252428	17	41276049	17	43124032	252428	246854	rs80357438	NC_000017.11:43124031:A:T
NM_007294.4(BRCA1):c.65T>C (p.Leu22Ser)	BRCA1	L22S	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055656	17	41276049	17	43124032	55656	70323	rs80357438	NC_000017.11:43124031:A:G
NM_007294.4(BRCA1):c.64T>G (p.Leu22Val)	BRCA1	L22V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865056	17	41276050	17	43124033	865056	854890	rs1597923402	NC_000017.11:43124032:A:C
NM_007294.4(BRCA1):c.64T>A (p.Leu22Ile)	BRCA1	L22I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865055	17	41276050	17	43124033	865055	854891	rs1597923402	NC_000017.11:43124032:A:T
NM_007294.4(BRCA1):c.64T>C (p.Leu22=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Aug 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000793201	17	41276050	17	43124033	793201	785603	rs1597923402	NC_000017.11:43124032:A:G
NM_007294.4(BRCA1):c.63C>G (p.Ile21Met)	BRCA1	I21M	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 19, 2021)	criteria provided, single submitter	VCV000865054	17	41276051	17	43124034	865054	854892	rs1555600921	NC_000017.11:43124033:G:C
NM_007294.4(BRCA1):c.63C>A (p.Ile21=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000865053	17	41276051	17	43124034	865053	854893	rs1555600921	NC_000017.11:43124033:G:T
NM_007294.4(BRCA1):c.63C>T (p.Ile21=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000491182	17	41276051	17	43124034	491182	484976	rs1555600921	NC_000017.11:43124033:G:A
NM_007294.4(BRCA1):c.62T>A (p.Ile21Asn)	BRCA1	I21N	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868779	17	41276052	17	43124035	868779	854895	rs1135401834	NC_000017.11:43124034:A:T
NM_007294.4(BRCA1):c.62T>C (p.Ile21Thr)	BRCA1	I21T	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865052	17	41276052	17	43124035	865052	854894	rs1135401834	NC_000017.11:43124034:A:G
NM_007294.4(BRCA1):c.62T>G (p.Ile21Ser)	BRCA1	I21S	not specified	Uncertain significance(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000431195	17	41276052	17	43124035	431195	424867	rs1135401834	NC_000017.11:43124034:A:C
NM_007294.4(BRCA1):c.61A>T (p.Ile21Phe)	BRCA1	I21F	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868778	17	41276053	17	43124036	868778	854896	rs80357406	NC_000017.11:43124035:T:A
NM_007294.4(BRCA1):c.61A>C (p.Ile21Leu)	BRCA1	I21L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868777	17	41276053	17	43124036	868777	854897	rs80357406	NC_000017.11:43124035:T:G
NM_007294.4(BRCA1):c.61A>G (p.Ile21Val)	BRCA1	I21V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 19, 2022)	criteria provided, conflicting interpretations	VCV000055648	17	41276053	17	43124036	55648	70315	rs80357406	NC_000017.11:43124035:T:C
NM_007294.4(BRCA1):c.60A>T (p.Lys20Asn)	BRCA1	K20N	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868776	17	41276054	17	43124037	868776	854898	rs202168814	NC_000017.11:43124036:T:A
NM_007294.4(BRCA1):c.60A>G (p.Lys20=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	Likely benign(Last reviewed: May 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000479236	17	41276054	17	43124037	479236	479565	rs202168814	NC_000017.11:43124036:T:C
NM_007294.4(BRCA1):c.60A>C (p.Lys20Asn)	BRCA1	K20N	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2022)	criteria provided, conflicting interpretations	VCV000182121	17	41276054	17	43124037	182121	180895	rs202168814	NC_000017.11:43124036:T:G
NM_007294.4(BRCA1):c.59A>T (p.Lys20Ile)	BRCA1	K20I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868775	17	41276055	17	43124038	868775	854899	rs2055724752	NC_000017.11:43124037:T:A
NM_007294.4(BRCA1):c.59A>G (p.Lys20Arg)	BRCA1	K20R	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868746	17	41276055	17	43124038	868746	854900	rs2055724752	NC_000017.11:43124037:T:C
NM_007294.4(BRCA1):c.59A>C (p.Lys20Thr)	BRCA1	K20T	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868745	17	41276055	17	43124038	868745	854901	rs2055724752	NC_000017.11:43124037:T:G
NM_007294.4(BRCA1):c.58A>T (p.Lys20Ter)	BRCA1	K20*	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868744	17	41276056	17	43124039	868744	854902	rs2055725050	NC_000017.11:43124038:T:A
NM_007294.4(BRCA1):c.58A>G (p.Lys20Glu)	BRCA1	K20E	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000868743	17	41276056	17	43124039	868743	854903	rs2055725050	NC_000017.11:43124038:T:C
NM_007294.4(BRCA1):c.58A>C (p.Lys20Gln)	BRCA1	K20Q	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868742	17	41276056	17	43124039	868742	854904	rs2055725050	NC_000017.11:43124038:T:G
NM_007294.4(BRCA1):c.57G>T (p.Gln19His)	BRCA1	Q19H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868741	17	41276057	17	43124040	868741	854905	rs2055725365	NC_000017.11:43124039:C:A
NM_007294.4(BRCA1):c.57G>C (p.Gln19His)	BRCA1	Q19H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868740	17	41276057	17	43124040	868740	854906	rs2055725365	NC_000017.11:43124039:C:G
NM_007294.4(BRCA1):c.57G>A (p.Gln19=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868739	17	41276057	17	43124040	868739	854907	rs2055725365	NC_000017.11:43124039:C:T
NM_007294.4(BRCA1):c.56A>T (p.Gln19Leu)	BRCA1	Q19L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867728	17	41276058	17	43124041	867728	854908	rs2055725680	NC_000017.11:43124040:T:A
NM_007294.4(BRCA1):c.56A>C (p.Gln19Pro)	BRCA1	Q19P	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2021)	criteria provided, conflicting interpretations	VCV000867727	17	41276058	17	43124041	867727	854909	rs2055725680	NC_000017.11:43124040:T:G
NM_007294.4(BRCA1):c.56A>G (p.Gln19Arg)	BRCA1	Q19R	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV000864052	17	41276058	17	43124041	864052	845478	rs2055725680	NC_000017.11:43124040:T:C
NM_007294.4(BRCA1):c.55C>G (p.Gln19Glu)	BRCA1	Q19E	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV000867726	17	41276059	17	43124042	867726	854910	rs397509299	NC_000017.11:43124041:G:C
NM_007294.4(BRCA1):c.55C>A (p.Gln19Lys)	BRCA1	Q19K	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867725	17	41276059	17	43124042	867725	854911	rs397509299	NC_000017.11:43124041:G:T
NM_007294.4(BRCA1):c.55C>T (p.Gln19Ter)	BRCA1	Q19*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	VCV000055638	17	41276059	17	43124042	55638	70305	rs397509299	NC_000017.11:43124041:G:A
NM_007294.4(BRCA1):c.54G>T (p.Met18Ile)	BRCA1	M18I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867724	17	41276060	17	43124043	867724	854912	rs1597923450	NC_000017.11:43124042:C:A
NM_007294.4(BRCA1):c.54G>C (p.Met18Ile)	BRCA1	M18I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867723	17	41276060	17	43124043	867723	854913	rs1597923450	NC_000017.11:43124042:C:G
NM_007294.4(BRCA1):c.54G>A (p.Met18Ile)	BRCA1	M18I	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000825781	17	41276060	17	43124043	825781	813922	rs1597923450	NC_000017.11:43124042:C:T
NM_007294.4(BRCA1):c.53T>G (p.Met18Arg)	BRCA1	M18R	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Likely pathogenic(Last reviewed: Aug 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000531241	17	41276061	17	43124044	531241	531135	rs80356929	NC_000017.11:43124043:A:C
NM_007294.4(BRCA1):c.53T>A (p.Met18Lys)	BRCA1	M18K	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome	Likely pathogenic(Last reviewed: Apr 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000055559	17	41276061	17	43124044	55559	70226	rs80356929	NC_000017.11:43124043:A:T
NM_007294.4(BRCA1):c.53T>C (p.Met18Thr)	BRCA1	M18T	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037664	17	41276061	17	43124044	37664	46220	rs80356929	NC_000017.11:43124043:A:G
NM_007294.4(BRCA1):c.52A>T (p.Met18Leu)	BRCA1	M18L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865043	17	41276062	17	43124045	865043	854914	rs2055727017	NC_000017.11:43124044:T:A
NM_007294.4(BRCA1):c.52A>G (p.Met18Val)	BRCA1	M18V	not specified	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000865042	17	41276062	17	43124045	865042	854915	rs2055727017	NC_000017.11:43124044:T:C
NM_007294.4(BRCA1):c.52A>C (p.Met18Leu)	BRCA1	M18L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865041	17	41276062	17	43124045	865041	854916	rs2055727017	NC_000017.11:43124044:T:G
NM_007294.4(BRCA1):c.51T>C (p.Ala17=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869100	17	41276063	17	43124046	869100	854918	rs2055727513	NC_000017.11:43124045:A:G
NM_007294.4(BRCA1):c.51T>A (p.Ala17=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869099	17	41276063	17	43124046	869099	854919	rs2055727513	NC_000017.11:43124045:A:T
NM_007294.4(BRCA1):c.51T>G (p.Ala17=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865040	17	41276063	17	43124046	865040	854917	rs2055727513	NC_000017.11:43124045:A:C
NM_007294.4(BRCA1):c.50C>T (p.Ala17Val)	BRCA1	A17V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869098	17	41276064	17	43124047	869098	854920	rs1412871417	NC_000017.11:43124046:G:A
NM_007294.4(BRCA1):c.50C>G (p.Ala17Gly)	BRCA1	A17G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869097	17	41276064	17	43124047	869097	854921	rs1412871417	NC_000017.11:43124046:G:C
NM_007294.4(BRCA1):c.50C>A (p.Ala17Asp)	BRCA1	A17D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869096	17	41276064	17	43124047	869096	854922	rs1412871417	NC_000017.11:43124046:G:T
NM_007294.4(BRCA1):c.49G>C (p.Ala17Pro)	BRCA1	A17P	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869095	17	41276065	17	43124048	869095	854923	rs1402064476	NC_000017.11:43124047:C:G
NM_007294.4(BRCA1):c.49G>A (p.Ala17Thr)	BRCA1	A17T	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869094	17	41276065	17	43124048	869094	854924	rs1402064476	NC_000017.11:43124047:C:T
NM_007294.4(BRCA1):c.49G>T (p.Ala17Ser)	BRCA1	A17S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: May 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000489728	17	41276065	17	43124048	489728	483006	rs1402064476	NC_000017.11:43124047:C:A
NM_007294.4(BRCA1):c.48T>G (p.Asn16Lys)	BRCA1	N16K	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868730	17	41276066	17	43124049	868730	854925	rs1555600963	NC_000017.11:43124048:A:C
NM_007294.4(BRCA1):c.48T>C (p.Asn16=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000825273	17	41276066	17	43124049	825273	813923	rs1555600963	NC_000017.11:43124048:A:G
NM_007294.4(BRCA1):c.48T>A (p.Asn16Lys)	BRCA1	N16K	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000479225	17	41276066	17	43124049	479225	478851	rs1555600963	NC_000017.11:43124048:A:T
NM_007294.4(BRCA1):c.47A>T (p.Asn16Ile)	BRCA1	N16I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868729	17	41276067	17	43124050	868729	854926	rs2055729319	NC_000017.11:43124049:T:A
NM_007294.4(BRCA1):c.47A>G (p.Asn16Ser)	BRCA1	N16S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868728	17	41276067	17	43124050	868728	854927	rs2055729319	NC_000017.11:43124049:T:C
NM_007294.4(BRCA1):c.47A>C (p.Asn16Thr)	BRCA1	N16T	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868727	17	41276067	17	43124050	868727	854928	rs2055729319	NC_000017.11:43124049:T:G
NM_007294.4(BRCA1):c.46A>T (p.Asn16Tyr)	BRCA1	N16Y	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868726	17	41276068	17	43124051	868726	854929	rs2055729884	NC_000017.11:43124050:T:A
NM_007294.4(BRCA1):c.46A>G (p.Asn16Asp)	BRCA1	N16D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868725	17	41276068	17	43124051	868725	854930	rs2055729884	NC_000017.11:43124050:T:C
NM_007294.4(BRCA1):c.46A>C (p.Asn16His)	BRCA1	N16H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867715	17	41276068	17	43124051	867715	854931	rs2055729884	NC_000017.11:43124050:T:G
NM_007294.4(BRCA1):c.45T>G (p.Ile15Met)	BRCA1	I15M	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867714	17	41276069	17	43124052	867714	854932	rs2055730198	NC_000017.11:43124051:A:C
NM_007294.4(BRCA1):c.45T>C (p.Ile15=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867713	17	41276069	17	43124052	867713	854933	rs2055730198	NC_000017.11:43124051:A:G
NM_007294.4(BRCA1):c.45T>A (p.Ile15=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867712	17	41276069	17	43124052	867712	854934	rs2055730198	NC_000017.11:43124051:A:T
NM_007294.4(BRCA1):c.44T>G (p.Ile15Ser)	BRCA1	I15S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867711	17	41276070	17	43124053	867711	854935	rs80357316	NC_000017.11:43124052:A:C
NM_007294.4(BRCA1):c.44T>A (p.Ile15Asn)	BRCA1	I15N	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867710	17	41276070	17	43124053	867710	854936	rs80357316	NC_000017.11:43124052:A:T
NM_007294.4(BRCA1):c.44T>C (p.Ile15Thr)	BRCA1	I15T	Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Jun 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000055217	17	41276070	17	43124053	55217	69884	rs80357316	NC_000017.11:43124052:A:G
NM_007294.4(BRCA1):c.43A>T (p.Ile15Phe)	BRCA1	I15F	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867709	17	41276071	17	43124054	867709	854937	rs80357031	NC_000017.11:43124053:T:A
NM_007294.4(BRCA1):c.43A>G (p.Ile15Val)	BRCA1	I15V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2021)	criteria provided, conflicting interpretations	VCV000865035	17	41276071	17	43124054	865035	854938	rs80357031	NC_000017.11:43124053:T:C
NM_007294.4(BRCA1):c.43A>C (p.Ile15Leu)	BRCA1	I15L	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2022)	criteria provided, conflicting interpretations	VCV000055192	17	41276071	17	43124054	55192	69859	rs80357031	NC_000017.11:43124053:T:G
NM_007294.4(BRCA1):c.42C>G (p.Val14=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865034	17	41276072	17	43124055	865034	854939	rs80356827	NC_000017.11:43124054:G:C
NM_007294.4(BRCA1):c.42C>T (p.Val14=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000156194	17	41276072	17	43124055	156194	165993	rs80356827	NC_000017.11:43124054:G:A
NM_007294.4(BRCA1):c.42C>A (p.Val14=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000037583	17	41276072	17	43124055	37583	46139	rs80356827	NC_000017.11:43124054:G:T
NM_007294.4(BRCA1):c.41T>G (p.Val14Gly)	BRCA1	V14G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865033	17	41276073	17	43124056	865033	854940	rs2055732014	NC_000017.11:43124055:A:C
NM_007294.4(BRCA1):c.41T>C (p.Val14Ala)	BRCA1	V14A	not provided	Uncertain significance	no assertion criteria provided	VCV000865032	17	41276073	17	43124056	865032	854941	rs2055732014	NC_000017.11:43124055:A:G
NM_007294.4(BRCA1):c.41T>A (p.Val14Asp)	BRCA1	V14D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865031	17	41276073	17	43124056	865031	854942	rs2055732014	NC_000017.11:43124055:A:T
NM_007294.4(BRCA1):c.40G>C (p.Val14Leu)	BRCA1	V14L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869093	17	41276074	17	43124057	869093	854943	rs2055732548	NC_000017.11:43124056:C:G
NM_007294.4(BRCA1):c.40G>A (p.Val14Ile)	BRCA1	V14I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869092	17	41276074	17	43124057	869092	854944	rs2055732548	NC_000017.11:43124056:C:T
NM_007294.4(BRCA1):c.40G>T (p.Val14Phe)	BRCA1	V14F	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV000848933	17	41276074	17	43124057	848933	845480	rs2055732548	NC_000017.11:43124056:C:A
NM_007294.4(BRCA1):c.39T>G (p.Asn13Lys)	BRCA1	N13K	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869091	17	41276075	17	43124058	869091	854945	rs2055733269	NC_000017.11:43124057:A:C
NM_007294.4(BRCA1):c.39T>C (p.Asn13=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869090	17	41276075	17	43124058	869090	854946	rs2055733269	NC_000017.11:43124057:A:G
NM_007294.4(BRCA1):c.39T>A (p.Asn13Lys)	BRCA1	N13K	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869089	17	41276075	17	43124058	869089	854947	rs2055733269	NC_000017.11:43124057:A:T
NM_007294.4(BRCA1):c.38A>T (p.Asn13Ile)	BRCA1	N13I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869088	17	41276076	17	43124059	869088	854948	rs2055733986	NC_000017.11:43124058:T:A
NM_007294.4(BRCA1):c.38A>G (p.Asn13Ser)	BRCA1	N13S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869087	17	41276076	17	43124059	869087	854949	rs2055733986	NC_000017.11:43124058:T:C
NM_007294.4(BRCA1):c.38A>C (p.Asn13Thr)	BRCA1	N13T	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868721	17	41276076	17	43124059	868721	854950	rs2055733986	NC_000017.11:43124058:T:G
NM_007294.4(BRCA1):c.37A>T (p.Asn13Tyr)	BRCA1	N13Y	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868720	17	41276077	17	43124060	868720	854951	rs1597923586	NC_000017.11:43124059:T:A
NM_007294.4(BRCA1):c.37A>C (p.Asn13His)	BRCA1	N13H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868719	17	41276077	17	43124060	868719	854952	rs1597923586	NC_000017.11:43124059:T:G
NM_007294.4(BRCA1):c.37A>G (p.Asn13Asp)	BRCA1	N13D	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000666101	17	41276077	17	43124060	666101	646065	rs1597923586	NC_000017.11:43124059:T:C
NM_007294.4(BRCA1):c.36A>T (p.Gln12His)	BRCA1	Q12H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868718	17	41276078	17	43124061	868718	854953	rs763230080	NC_000017.11:43124060:T:A
NM_007294.4(BRCA1):c.36A>C (p.Gln12His)	BRCA1	Q12H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868717	17	41276078	17	43124061	868717	854954	rs763230080	NC_000017.11:43124060:T:G
NM_007294.4(BRCA1):c.36A>G (p.Gln12=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000230602	17	41276078	17	43124061	230602	236184	rs763230080	NC_000017.11:43124060:T:C
NM_007294.4(BRCA1):c.35A>T (p.Gln12Leu)	BRCA1	Q12L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868716	17	41276079	17	43124062	868716	854955	rs1555601006	NC_000017.11:43124061:T:A
NM_007294.4(BRCA1):c.35A>C (p.Gln12Pro)	BRCA1	Q12P	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000867703	17	41276079	17	43124062	867703	854956	rs1555601006	NC_000017.11:43124061:T:G
NM_007294.4(BRCA1):c.35A>G (p.Gln12Arg)	BRCA1	Q12R	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 14, 2021)	criteria provided, conflicting interpretations	VCV000441517	17	41276079	17	43124062	441517	435182	rs1555601006	NC_000017.11:43124061:T:C
NM_007294.4(BRCA1):c.34C>A (p.Gln12Lys)	BRCA1	Q12K	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867702	17	41276080	17	43124063	867702	854957	rs80357134	NC_000017.11:43124062:G:T
NM_007294.4(BRCA1):c.34C>G (p.Gln12Glu)	BRCA1	Q12E	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV000647021	17	41276080	17	43124063	647021	646066	rs80357134	NC_000017.11:43124062:G:C
NM_007294.4(BRCA1):c.34C>T (p.Gln12Ter)	BRCA1	Q12*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000054902	17	41276080	17	43124063	54902	69569	rs80357134	NC_000017.11:43124062:G:A
NM_007294.4(BRCA1):c.33A>T (p.Val11=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867701	17	41276081	17	43124064	867701	854958	rs1555601010	NC_000017.11:43124063:T:A
NM_007294.4(BRCA1):c.33A>C (p.Val11=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867700	17	41276081	17	43124064	867700	854959	rs1555601010	NC_000017.11:43124063:T:G
NM_007294.4(BRCA1):c.33A>G (p.Val11=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000485374	17	41276081	17	43124064	485374	478729	rs1555601010	NC_000017.11:43124063:T:C
NM_007294.4(BRCA1):c.32T>A (p.Val11Glu)	BRCA1	V11E	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865022	17	41276082	17	43124065	865022	854960	rs80357017	NC_000017.11:43124064:A:T
NM_007294.4(BRCA1):c.32T>G (p.Val11Gly)	BRCA1	V11G	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2023)	criteria provided, conflicting interpretations	VCV000245973	17	41276082	17	43124065	245973	245057	rs80357017	NC_000017.11:43124064:A:C
NM_007294.4(BRCA1):c.32T>C (p.Val11Ala)	BRCA1	V11A	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000054828	17	41276082	17	43124065	54828	69495	rs80357017	NC_000017.11:43124064:A:G
NM_007294.4(BRCA1):c.31G>T (p.Val11Leu)	BRCA1	V11L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865021	17	41276083	17	43124066	865021	854961	rs1555601019	NC_000017.11:43124065:C:A
NM_007294.4(BRCA1):c.31G>A (p.Val11Ile)	BRCA1	V11I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865020	17	41276083	17	43124066	865020	854962	rs1555601019	NC_000017.11:43124065:C:T
NM_007294.4(BRCA1):c.31G>C (p.Val11Leu)	BRCA1	V11L	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jul 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000438922	17	41276083	17	43124066	438922	432927	rs1555601019	NC_000017.11:43124065:C:G
NM_007294.4(BRCA1):c.30A>C (p.Glu10Asp)	BRCA1	E10D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869086	17	41276084	17	43124067	869086	854965	rs2055737161	NC_000017.11:43124066:T:G
NM_007294.4(BRCA1):c.30A>T (p.Glu10Asp)	BRCA1	E10D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865019	17	41276084	17	43124067	865019	854963	rs2055737161	NC_000017.11:43124066:T:A
NM_007294.4(BRCA1):c.30A>G (p.Glu10=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865018	17	41276084	17	43124067	865018	854964	rs2055737161	NC_000017.11:43124066:T:C
NM_007294.4(BRCA1):c.29A>T (p.Glu10Val)	BRCA1	E10V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869085	17	41276085	17	43124068	869085	854966	rs2055737507	NC_000017.11:43124067:T:A
NM_007294.4(BRCA1):c.29A>G (p.Glu10Gly)	BRCA1	E10G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869084	17	41276085	17	43124068	869084	854967	rs2055737507	NC_000017.11:43124067:T:C
NM_007294.4(BRCA1):c.29A>C (p.Glu10Ala)	BRCA1	E10A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869083	17	41276085	17	43124068	869083	854968	rs2055737507	NC_000017.11:43124067:T:G
NM_007294.4(BRCA1):c.28G>T (p.Glu10Ter)	BRCA1	E10*	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869082	17	41276086	17	43124069	869082	854969	rs2055737833	NC_000017.11:43124068:C:A
NM_007294.4(BRCA1):c.28G>C (p.Glu10Gln)	BRCA1	E10Q	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869081	17	41276086	17	43124069	869081	854970	rs2055737833	NC_000017.11:43124068:C:G
NM_007294.4(BRCA1):c.28G>A (p.Glu10Lys)	BRCA1	E10K	not specified|Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Nov 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000869080	17	41276086	17	43124069	869080	854971	rs2055737833	NC_000017.11:43124068:C:T
NM_007294.4(BRCA1):c.27A>T (p.Glu9Asp)	BRCA1	E9D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869079	17	41276087	17	43124070	869079	854972	rs2055738370	NC_000017.11:43124069:T:A
NM_007294.4(BRCA1):c.27A>G (p.Glu9=)	BRCA1		Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV000868710	17	41276087	17	43124070	868710	854973	rs2055738370	NC_000017.11:43124069:T:C
NM_007294.4(BRCA1):c.27A>C (p.Glu9Asp)	BRCA1	E9D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868709	17	41276087	17	43124070	868709	854974	rs2055738370	NC_000017.11:43124069:T:G
NM_007294.4(BRCA1):c.26A>T (p.Glu9Val)	BRCA1	E9V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868708	17	41276088	17	43124071	868708	854975	rs2055738683	NC_000017.11:43124070:T:A
NM_007294.4(BRCA1):c.26A>G (p.Glu9Gly)	BRCA1	E9G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868707	17	41276088	17	43124071	868707	854976	rs2055738683	NC_000017.11:43124070:T:C
NM_007294.4(BRCA1):c.26A>C (p.Glu9Ala)	BRCA1	E9A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868706	17	41276088	17	43124071	868706	854977	rs2055738683	NC_000017.11:43124070:T:G
NM_007294.4(BRCA1):c.25G>T (p.Glu9Ter)	BRCA1	E9*	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868705	17	41276089	17	43124072	868705	854978	rs1567823437	NC_000017.11:43124071:C:A
NM_007294.4(BRCA1):c.25G>A (p.Glu9Lys)	BRCA1	E9K	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868704	17	41276089	17	43124072	868704	854979	rs1567823437	NC_000017.11:43124071:C:T
NM_007294.4(BRCA1):c.25G>C (p.Glu9Gln)	BRCA1	E9Q	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000630444	17	41276089	17	43124072	630444	618705	rs1567823437	NC_000017.11:43124071:C:G
NM_007294.4(BRCA1):c.24T>G (p.Val8=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867697	17	41276090	17	43124073	867697	854980	rs2055739304	NC_000017.11:43124072:A:C
NM_007294.4(BRCA1):c.24T>C (p.Val8=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867696	17	41276090	17	43124073	867696	854981	rs2055739304	NC_000017.11:43124072:A:G
NM_007294.4(BRCA1):c.24T>A (p.Val8=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867695	17	41276090	17	43124073	867695	854982	rs2055739304	NC_000017.11:43124072:A:T
NM_007294.4(BRCA1):c.23T>G (p.Val8Gly)	BRCA1	V8G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867694	17	41276091	17	43124074	867694	854983	rs2055739664	NC_000017.11:43124073:A:C
NM_007294.4(BRCA1):c.23T>C (p.Val8Ala)	BRCA1	V8A	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 9, 2021)	criteria provided, single submitter	VCV000867693	17	41276091	17	43124074	867693	854984	rs2055739664	NC_000017.11:43124073:A:G
NM_007294.4(BRCA1):c.23T>A (p.Val8Asp)	BRCA1	V8D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867692	17	41276091	17	43124074	867692	854985	rs2055739664	NC_000017.11:43124073:A:T
NM_007294.4(BRCA1):c.22G>T (p.Val8Phe)	BRCA1	V8F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2022)	criteria provided, conflicting interpretations	VCV000867691	17	41276092	17	43124075	867691	854986	rs528902306	NC_000017.11:43124074:C:A
NM_007294.4(BRCA1):c.22G>C (p.Val8Leu)	BRCA1	V8L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867690	17	41276092	17	43124075	867690	854987	rs528902306	NC_000017.11:43124074:C:G
NM_007294.4(BRCA1):c.22G>A (p.Val8Ile)	BRCA1	V8I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2022)	criteria provided, conflicting interpretations	VCV000243118	17	41276092	17	43124075	243118	245058	rs528902306	NC_000017.11:43124074:C:T
NM_007294.4(BRCA1):c.21C>G (p.Arg7=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000865008	17	41276093	17	43124076	865008	854988	rs149402012	NC_000017.11:43124075:G:C
NM_007294.4(BRCA1):c.21C>A (p.Arg7=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865007	17	41276093	17	43124076	865007	854989	rs149402012	NC_000017.11:43124075:G:T
NM_007294.4(BRCA1):c.21C>T (p.Arg7=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000136537	17	41276093	17	43124076	136537	140240	rs149402012	NC_000017.11:43124075:G:A
NM_007294.4(BRCA1):c.20G>C (p.Arg7Pro)	BRCA1	R7P	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000865006	17	41276094	17	43124077	865006	854990	rs144792613	NC_000017.11:43124076:C:G
NM_007294.4(BRCA1):c.20G>T (p.Arg7Leu)	BRCA1	R7L	Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 15, 2022)	criteria provided, single submitter	VCV000820717	17	41276094	17	43124077	820717	813924	rs144792613	NC_000017.11:43124076:C:A
NM_007294.4(BRCA1):c.20G>A (p.Arg7His)	BRCA1	R7H	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 16, 2022)	criteria provided, conflicting interpretations	VCV000184875	17	41276094	17	43124077	184875	185131	rs144792613	NC_000017.11:43124076:C:T
NM_007294.4(BRCA1):c.19C>G (p.Arg7Gly)	BRCA1	R7G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869078	17	41276095	17	43124078	869078	854991	rs80356994	NC_000017.11:43124077:G:C
NM_007294.4(BRCA1):c.19C>A (p.Arg7Ser)	BRCA1	R7S	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV000531388	17	41276095	17	43124078	531388	531401	rs80356994	NC_000017.11:43124077:G:T
NM_007294.4(BRCA1):c.19C>T (p.Arg7Cys)	BRCA1	R7C	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2022)	criteria provided, conflicting interpretations	VCV000037440	17	41276095	17	43124078	37440	45996	rs80356994	NC_000017.11:43124077:G:A
NM_007294.4(BRCA1):c.18T>G (p.Leu6=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869077	17	41276096	17	43124079	869077	854992	rs2055741449	NC_000017.11:43124078:A:C
NM_007294.4(BRCA1):c.18T>C (p.Leu6=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869076	17	41276096	17	43124079	869076	854993	rs2055741449	NC_000017.11:43124078:A:G
NM_007294.4(BRCA1):c.18T>A (p.Leu6=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869075	17	41276096	17	43124079	869075	854994	rs2055741449	NC_000017.11:43124078:A:T
NM_007294.4(BRCA1):c.17T>G (p.Leu6Arg)	BRCA1	L6R	not provided	Likely benign(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000869074	17	41276097	17	43124080	869074	854995	rs2055741739	NC_000017.11:43124079:A:C
NM_007294.4(BRCA1):c.17T>C (p.Leu6Pro)	BRCA1	L6P	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869073	17	41276097	17	43124080	869073	854996	rs2055741739	NC_000017.11:43124079:A:G
NM_007294.4(BRCA1):c.17T>A (p.Leu6His)	BRCA1	L6H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869072	17	41276097	17	43124080	869072	854997	rs2055741739	NC_000017.11:43124079:A:T
NM_007294.4(BRCA1):c.16C>G (p.Leu6Val)	BRCA1	L6V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868697	17	41276098	17	43124081	868697	854998	rs1315262605	NC_000017.11:43124080:G:C
NM_007294.4(BRCA1):c.16C>A (p.Leu6Ile)	BRCA1	L6I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868696	17	41276098	17	43124081	868696	854999	rs1315262605	NC_000017.11:43124080:G:T
NM_007294.4(BRCA1):c.16C>T (p.Leu6Phe)	BRCA1	L6F	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2022)	criteria provided, conflicting interpretations	VCV000658584	17	41276098	17	43124081	658584	646067	rs1315262605	NC_000017.11:43124080:G:A
NM_007294.4(BRCA1):c.15T>G (p.Ala5=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868695	17	41276099	17	43124082	868695	855000	rs1339036647	NC_000017.11:43124081:A:C
NM_007294.4(BRCA1):c.15T>A (p.Ala5=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868694	17	41276099	17	43124082	868694	855001	rs1339036647	NC_000017.11:43124081:A:T
NM_007294.4(BRCA1):c.15T>C (p.Ala5=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Oct 13, 2022)	criteria provided, single submitter	VCV000701597	17	41276099	17	43124082	701597	688772	rs1339036647	NC_000017.11:43124081:A:G
NM_007294.4(BRCA1):c.14C>G (p.Ala5Gly)	BRCA1	A5G	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868693	17	41276100	17	43124083	868693	855002	rs1335137805	NC_000017.11:43124082:G:C
NM_007294.4(BRCA1):c.14C>A (p.Ala5Asp)	BRCA1	A5D	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867683	17	41276100	17	43124083	867683	855003	rs1335137805	NC_000017.11:43124082:G:T
NM_007294.4(BRCA1):c.14C>T (p.Ala5Val)	BRCA1	A5V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2021)	criteria provided, conflicting interpretations	VCV000576432	17	41276100	17	43124083	576432	569198	rs1335137805	NC_000017.11:43124082:G:A
NM_007294.4(BRCA1):c.13G>T (p.Ala5Ser)	BRCA1	A5S	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867682	17	41276101	17	43124084	867682	855004	rs1597923713	NC_000017.11:43124083:C:A
NM_007294.4(BRCA1):c.13G>A (p.Ala5Thr)	BRCA1	A5T	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867681	17	41276101	17	43124084	867681	855005	rs1597923713	NC_000017.11:43124083:C:T
NM_007294.4(BRCA1):c.13G>C (p.Ala5Pro)	BRCA1	A5P	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000819110	17	41276101	17	43124084	819110	813925	rs1597923713	NC_000017.11:43124083:C:G
NM_007294.4(BRCA1):c.12T>G (p.Ser4=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867680	17	41276102	17	43124085	867680	855006	rs2055743331	NC_000017.11:43124084:A:C
NM_007294.4(BRCA1):c.12T>C (p.Ser4=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867679	17	41276102	17	43124085	867679	855007	rs2055743331	NC_000017.11:43124084:A:G
NM_007294.4(BRCA1):c.12T>A (p.Ser4=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867678	17	41276102	17	43124085	867678	855008	rs2055743331	NC_000017.11:43124084:A:T
NM_007294.4(BRCA1):c.11C>G (p.Ser4Cys)	BRCA1	S4C	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864992	17	41276103	17	43124086	864992	855009	rs786203152	NC_000017.11:43124085:G:C
NM_007294.4(BRCA1):c.11C>A (p.Ser4Tyr)	BRCA1	S4Y	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864991	17	41276103	17	43124086	864991	855010	rs786203152	NC_000017.11:43124085:G:T
NM_007294.4(BRCA1):c.11C>T (p.Ser4Phe)	BRCA1	S4F	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Sep 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000186697	17	41276103	17	43124086	186697	185132	rs786203152	NC_000017.11:43124085:G:A
NM_007294.4(BRCA1):c.10T>G (p.Ser4Ala)	BRCA1	S4A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864990	17	41276104	17	43124087	864990	855011	rs876658707	NC_000017.11:43124086:A:C
NM_007294.4(BRCA1):c.10T>A (p.Ser4Thr)	BRCA1	S4T	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864989	17	41276104	17	43124087	864989	855012	rs876658707	NC_000017.11:43124086:A:T
NM_007294.4(BRCA1):c.10T>C (p.Ser4Pro)	BRCA1	S4P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2023)	criteria provided, conflicting interpretations	VCV000230684	17	41276104	17	43124087	230684	236185	rs876658707	NC_000017.11:43124086:A:G
NM_007294.4(BRCA1):c.9A>C (p.Leu3Phe)	BRCA1	L3F	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864988	17	41276105	17	43124088	864988	855013	rs780157871	NC_000017.11:43124087:T:G
NM_007294.4(BRCA1):c.9A>G (p.Leu3=)	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000757889	17	41276105	17	43124088	757889	771557	rs780157871	NC_000017.11:43124087:T:C
NM_007294.4(BRCA1):c.9A>T (p.Leu3Phe)	BRCA1	L3F	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2021)	criteria provided, conflicting interpretations	VCV000441496	17	41276105	17	43124088	441496	435183	rs780157871	NC_000017.11:43124087:T:A
NM_007294.4(BRCA1):c.8T>C (p.Leu3Ser)	BRCA1	L3S	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Oct 4, 2021)	criteria provided, single submitter	VCV000869066	17	41276106	17	43124089	869066	855014	rs397509332	NC_000017.11:43124088:A:G
NM_007294.4(BRCA1):c.8T>A (p.Leu3Ter)	BRCA1	L3*	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869065	17	41276106	17	43124089	869065	855015	rs397509332	NC_000017.11:43124088:A:T
NM_007294.4(BRCA1):c.8T>G (p.Leu3Ter)	BRCA1	L3*	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Dec 15, 2017)	reviewed by expert panel	VCV000055746	17	41276106	17	43124089	55746	70413	rs397509332	NC_000017.11:43124088:A:C
NM_007294.4(BRCA1):c.7T>G (p.Leu3Val)	BRCA1	L3V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869064	17	41276107	17	43124090	869064	855016	rs2055745032	NC_000017.11:43124089:A:C
NM_007294.4(BRCA1):c.7T>C (p.Leu3=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869063	17	41276107	17	43124090	869063	855017	rs2055745032	NC_000017.11:43124089:A:G
NM_007294.4(BRCA1):c.7T>A (p.Leu3Ile)	BRCA1	L3I	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869062	17	41276107	17	43124090	869062	855018	rs2055745032	NC_000017.11:43124089:A:T
NM_007294.4(BRCA1):c.6T>G (p.Asp2Glu)	BRCA1	D2E	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869061	17	41276108	17	43124091	869061	855019	rs754763517	NC_000017.11:43124090:A:C
NM_007294.4(BRCA1):c.6T>A (p.Asp2Glu)	BRCA1	D2E	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868686	17	41276108	17	43124091	868686	855020	rs754763517	NC_000017.11:43124090:A:T
NM_007294.4(BRCA1):c.6T>C (p.Asp2=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000415555	17	41276108	17	43124091	415555	402155	rs754763517	NC_000017.11:43124090:A:G
NM_007294.4(BRCA1):c.5A>T (p.Asp2Val)	BRCA1	D2V	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868685	17	41276109	17	43124092	868685	855021	rs2055745664	NC_000017.11:43124091:T:A
NM_007294.4(BRCA1):c.5A>G (p.Asp2Gly)	BRCA1	D2G	Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV000868684	17	41276109	17	43124092	868684	855022	rs2055745664	NC_000017.11:43124091:T:C
NM_007294.4(BRCA1):c.5A>C (p.Asp2Ala)	BRCA1	D2A	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868683	17	41276109	17	43124092	868683	855023	rs2055745664	NC_000017.11:43124091:T:G
NM_007294.4(BRCA1):c.4G>T (p.Asp2Tyr)	BRCA1	D2Y	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868682	17	41276110	17	43124093	868682	855024	rs778775133	NC_000017.11:43124092:C:A
NM_007294.4(BRCA1):c.4G>C (p.Asp2His)	BRCA1	D2H	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868681	17	41276110	17	43124093	868681	855025	rs778775133	NC_000017.11:43124092:C:G
NM_007294.4(BRCA1):c.4G>A (p.Asp2Asn)	BRCA1	D2N	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868680	17	41276110	17	43124093	868680	855026	rs778775133	NC_000017.11:43124092:C:T
NM_007294.3(BRCA1):c.[-1A>G;3G>A]	BRCA1	M1I	Breast-ovarian cancer, familial, susceptibility to, 1	Likely pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000487432	17|17	41276111	17|17	43124094	487432	424868|480485	rs80357475|rs587781565	NC_000017.11:43124093:C:T|NC_000017.11:43124096:T:C
NM_007294.4(BRCA1):c.3G>A (p.Met1Ile)	BRCA1	M1I	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431194	17	41276111	17	43124094	431194	424868	rs80357475	NC_000017.11:43124093:C:T
NM_007294.4(BRCA1):c.3G>C (p.Met1Ile)	BRCA1	M1I	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000267523	17	41276111	17	43124094	267523	262996	rs80357475	NC_000017.11:43124093:C:G
NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	BRCA1	M1I	Breast-ovarian cancer, familial, susceptibility to, 1	Pathogenic(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055072	17	41276111	17	43124094	55072	69739	rs80357475	NC_000017.11:43124093:C:A
NM_007294.4(BRCA1):c.2T>A (p.Met1Lys)	BRCA1	M1K	not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000801069	17	41276112	17	43124095	801069	789636	rs80357111	NC_000017.11:43124094:A:T
NM_007294.4(BRCA1):c.2T>G (p.Met1Arg)	BRCA1	M1R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000054746	17	41276112	17	43124095	54746	69413	rs80357111	NC_000017.11:43124094:A:C
NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	BRCA1	M1T	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV000054745	17	41276112	17	43124095	54745	69412	rs80357111	NC_000017.11:43124094:A:G
NM_007294.4(BRCA1):c.1A>T (p.Met1Leu)	BRCA1	M1L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867672	17	41276113	17	43124096	867672	855027	rs80357287	NC_000017.11:43124095:T:A
NM_007294.4(BRCA1):c.1A>C (p.Met1Leu)	BRCA1	M1L	Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867671	17	41276113	17	43124096	867671	855028	rs80357287	NC_000017.11:43124095:T:G
NM_007294.4(BRCA1):c.1A>G (p.Met1Val)	BRCA1	M1V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Breast neoplasm	Pathogenic(Last reviewed: Oct 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000054432	17	41276113	17	43124096	54432	69099	rs80357287	NC_000017.11:43124095:T:C
NM_007294.4(BRCA1):c.-1A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864977	17	41276114	17	43124097	864977	855029	rs587781565	NC_000017.11:43124096:T:A
NM_007294.4(BRCA1):c.-1A>G	BRCA1		not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2022)	criteria provided, conflicting interpretations	VCV000487486	17	41276114	17	43124097	487486	480485	rs587781565	NC_000017.11:43124096:T:C
NM_007294.4(BRCA1):c.-1A>C	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 28, 2021)	criteria provided, conflicting interpretations	VCV000141194	17	41276114	17	43124097	141194	150908	rs587781565	NC_000017.11:43124096:T:G
NM_007294.4(BRCA1):c.-2A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864976	17	41276115	17	43124098	864976	855030	rs273899693	NC_000017.11:43124097:T:C
NM_007294.4(BRCA1):c.-2A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864975	17	41276115	17	43124098	864975	855031	rs273899693	NC_000017.11:43124097:T:G
NM_007294.4(BRCA1):c.-2A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: May 26, 2005)	no assertion criteria provided	VCV000125485	17	41276115	17	43124098	125485	131023	rs273899693	NC_000017.11:43124097:T:A
NM_007294.4(BRCA1):c.-3G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869051	17	41276116	17	43124099	869051	855032	rs273900720	NC_000017.11:43124098:C:T
NM_007294.4(BRCA1):c.-3G>T	BRCA1		Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000441382	17	41276116	17	43124099	441382	435184	rs273900720	NC_000017.11:43124098:C:A
NM_007294.4(BRCA1):c.-3G>C	BRCA1		not specified	Uncertain significance(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000125484	17	41276116	17	43124099	125484	131022	rs273900720	NC_000017.11:43124098:C:G
NM_007294.4(BRCA1):c.-4A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869050	17	41276117	17	43124100	869050	855033	rs1567823527	NC_000017.11:43124099:T:A
NM_007294.4(BRCA1):c.-4A>G	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000869049	17	41276117	17	43124100	869049	855034	rs1567823527	NC_000017.11:43124099:T:C
NM_007294.4(BRCA1):c.-4A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869048	17	41276117	17	43124100	869048	855035	rs1567823527	NC_000017.11:43124099:T:G
NM_007294.4(BRCA1):c.-5A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869047	17	41276118	17	43124101	869047	855036	rs1567823528	NC_000017.11:43124100:T:A
NM_007294.4(BRCA1):c.-5A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869046	17	41276118	17	43124101	869046	855037	rs1567823528	NC_000017.11:43124100:T:C
NM_007294.4(BRCA1):c.-5A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869045	17	41276118	17	43124101	869045	855038	rs1567823528	NC_000017.11:43124100:T:G
NM_007294.4(BRCA1):c.-6A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869044	17	41276119	17	43124102	869044	855039	rs2055748702	NC_000017.11:43124101:T:A
NM_007294.4(BRCA1):c.-6A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868669	17	41276119	17	43124102	868669	855040	rs2055748702	NC_000017.11:43124101:T:C
NM_007294.4(BRCA1):c.-6A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868668	17	41276119	17	43124102	868668	855041	rs2055748702	NC_000017.11:43124101:T:G
NM_007294.4(BRCA1):c.-7G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868667	17	41276120	17	43124103	868667	855042	rs1567823538	NC_000017.11:43124102:C:A
NM_007294.4(BRCA1):c.-7G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868666	17	41276120	17	43124103	868666	855043	rs1567823538	NC_000017.11:43124102:C:G
NM_007294.4(BRCA1):c.-7G>A	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Dec 14, 2021)	criteria provided, single submitter	VCV000868665	17	41276120	17	43124103	868665	855044	rs1567823538	NC_000017.11:43124102:C:T
NM_007294.4(BRCA1):c.-8A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868664	17	41276121	17	43124104	868664	855045	rs2055749162	NC_000017.11:43124103:T:A
NM_007294.4(BRCA1):c.-8A>G	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Feb 18, 2022)	criteria provided, single submitter	VCV000868663	17	41276121	17	43124104	868663	855046	rs2055749162	NC_000017.11:43124103:T:C
NM_007294.4(BRCA1):c.-8A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868662	17	41276121	17	43124104	868662	855047	rs2055749162	NC_000017.11:43124103:T:G
NM_007294.4(BRCA1):c.-9C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867661	17	41276122	17	43124105	867661	855048	rs1555601059	NC_000017.11:43124104:G:A
NM_007294.4(BRCA1):c.-9C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867660	17	41276122	17	43124105	867660	855049	rs1555601059	NC_000017.11:43124104:G:T
NM_007294.4(BRCA1):c.-9C>G	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV000433682	17	41276122	17	43124105	433682	427576	rs1555601059	NC_000017.11:43124104:G:C
NM_007294.4(BRCA1):c.-10A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867659	17	41276123	17	43124106	867659	855050	rs748057929	NC_000017.11:43124105:T:A
NM_007294.4(BRCA1):c.-10A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867658	17	41276123	17	43124106	867658	855051	rs748057929	NC_000017.11:43124105:T:C
NM_007294.4(BRCA1):c.-10A>C	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2022)	criteria provided, conflicting interpretations	VCV000507346	17	41276123	17	43124106	507346	506102	rs748057929	NC_000017.11:43124105:T:G
NM_007294.4(BRCA1):c.-11A>T	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Oct 3, 2022)	criteria provided, single submitter	VCV000867657	17	41276124	17	43124107	867657	855052	rs273897654	NC_000017.11:43124106:T:A
NM_007294.4(BRCA1):c.-11A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000867656	17	41276124	17	43124107	867656	855053	rs273897654	NC_000017.11:43124106:T:C
NM_007294.4(BRCA1):c.-11A>C	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jun 7, 2022)	criteria provided, single submitter	VCV000125480	17	41276124	17	43124107	125480	131018	rs273897654	NC_000017.11:43124106:T:G
NM_007294.4(BRCA1):c.-12G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864962	17	41276125	17	43124108	864962	855054	rs772037778	NC_000017.11:43124107:C:A
NM_007294.4(BRCA1):c.-12G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864961	17	41276125	17	43124108	864961	855055	rs772037778	NC_000017.11:43124107:C:G
NM_007294.4(BRCA1):c.-12G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864960	17	41276125	17	43124108	864960	855056	rs772037778	NC_000017.11:43124107:C:T
NM_007294.4(BRCA1):c.-13G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864959	17	41276126	17	43124109	864959	855057	rs431825383	NC_000017.11:43124108:C:A
NM_007294.4(BRCA1):c.-13G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864958	17	41276126	17	43124109	864958	855058	rs431825383	NC_000017.11:43124108:C:G
NM_007294.4(BRCA1):c.-13G>A	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jul 8, 2022)	criteria provided, single submitter	VCV000096892	17	41276126	17	43124109	96892	102795	rs431825383	NC_000017.11:43124108:C:T
NM_007294.4(BRCA1):c.-14T>A	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Jul 15, 2022)	criteria provided, single submitter	VCV000869035	17	41276127	17	43124110	869035	855060	rs273897661	NC_000017.11:43124109:A:T
NM_007294.4(BRCA1):c.-14T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000864957	17	41276127	17	43124110	864957	855059	rs273897661	NC_000017.11:43124109:A:C
NM_007294.4(BRCA1):c.-14T>C	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Mar 6, 2022)	criteria provided, single submitter	VCV000125478	17	41276127	17	43124110	125478	131016	rs273897661	NC_000017.11:43124109:A:G
NM_007294.4(BRCA1):c.-15T>C	BRCA1		Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Oct 24, 2022)	criteria provided, single submitter	VCV002099706	17	41276128	17	43124111	2099706	2147264		NC_000017.11:43124110:A:G
NM_007294.4(BRCA1):c.-15T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869034	17	41276128	17	43124111	869034	855061	rs2055750656	NC_000017.11:43124110:A:C
NM_007294.4(BRCA1):c.-15T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869033	17	41276128	17	43124111	869033	855062	rs2055750656	NC_000017.11:43124110:A:T
NM_007294.4(BRCA1):c.-16A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869032	17	41276129	17	43124112	869032	855063	rs777262055	NC_000017.11:43124111:T:A
NM_007294.4(BRCA1):c.-16A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000869031	17	41276129	17	43124112	869031	855064	rs777262055	NC_000017.11:43124111:T:G
NM_007294.4(BRCA1):c.-16A>G	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 20, 2022)	criteria provided, conflicting interpretations	VCV000380340	17	41276129	17	43124112	380340	378301	rs777262055	NC_000017.11:43124111:T:C
NM_007294.4(BRCA1):c.-17C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868648	17	41276130	17	43124113	868648	855065	rs1597923857	NC_000017.11:43124112:G:C
NM_007294.4(BRCA1):c.-17C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868647	17	41276130	17	43124113	868647	855066	rs1597923857	NC_000017.11:43124112:G:T
NM_007294.4(BRCA1):c.-17C>T	BRCA1		Hereditary breast ovarian cancer syndrome	Likely benign(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000766447	17	41276130	17	43124113	766447	771558	rs1597923857	NC_000017.11:43124112:G:A
NM_007294.4(BRCA1):c.-18T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868646	17	41276131	17	43124114	868646	855067	rs1567823580	NC_000017.11:43124113:A:C
NM_007294.4(BRCA1):c.-18T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868645	17	41276131	17	43124114	868645	855068	rs1567823580	NC_000017.11:43124113:A:G
NM_007294.4(BRCA1):c.-18T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868644	17	41276131	17	43124114	868644	855069	rs1567823580	NC_000017.11:43124113:A:T
NM_007294.4(BRCA1):c.-19T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868643	17	41276132	17	43124115	868643	855070	rs2055751504	NC_000017.11:43124114:A:C
NM_007294.4(BRCA1):c.-19T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868642	17	41276132	17	43124115	868642	855071	rs2055751504	NC_000017.11:43124114:A:G
NM_007294.4(BRCA1):c.-19T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	not provided	no assertion provided	VCV000868641	17	41276132	17	43124115	868641	855072	rs2055751504	NC_000017.11:43124114:A:T
NM_007294.4(BRCA1):c.-20G>A	BRCA1|LOC111589215		not provided	Uncertain significance(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	VCV000265509	17	41277288	17	43125271	265509	260175	rs886039588	NC_000017.11:43125270:C:T
NM_007294.4(BRCA1):c.-22A>G	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000323422	17	41277290	17	43125273	323422	346067	rs886052976	NC_000017.11:43125272:T:C
NM_007294.4(BRCA1):c.-25G>A	BRCA1|LOC111589215		not specified	Likely benign(Last reviewed: May 6, 2016)	criteria provided, single submitter	VCV000380721	17	41277293	17	43125276	380721	376051	rs1057520890	NC_000017.11:43125275:C:T
NM_007294.4(BRCA1):c.-26G>T	BRCA1|LOC111589215		not specified	Likely benign(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000387278	17	41277294	17	43125277	387278	375124	rs1057522752	NC_000017.11:43125276:C:A
NM_007294.4(BRCA1):c.-29C>G	BRCA1|LOC111589215		not specified	Likely benign(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000389168	17	41277297	17	43125280	389168	375129	rs774839252	NC_000017.11:43125279:G:C
NM_007294.4(BRCA1):c.-37C>T	BRCA1|LOC111589215		not specified	Likely benign(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000393043	17	41277305	17	43125288	393043	375134	rs1057524754	NC_000017.11:43125287:G:A
NM_007294.4(BRCA1):c.-38C>T	BRCA1|LOC111589215		not specified	Likely benign(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000512052	17	41277306	17	43125289	512052	505955	rs1555601360	NC_000017.11:43125288:G:A
NM_007294.4(BRCA1):c.-40C>T	BRCA1|LOC111589215		not provided	Likely benign	no assertion criteria provided	VCV001275837	17	41277308	17	43125291	1275837	1265717		NC_000017.11:43125290:G:A
NM_007294.4(BRCA1):c.-42T>G	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance	no assertion criteria provided	VCV000433681	17	41277310	17	43125293	433681	427577	rs544342552	NC_000017.11:43125292:A:C
NM_007294.4(BRCA1):c.-44C>T	BRCA1|LOC111589215		Malignant tumor of breast	Uncertain significance	no assertion criteria provided	VCV000433680	17	41277312	17	43125295	433680	427578	rs1262271602	NC_000017.11:43125294:G:A
NM_007294.4(BRCA1):c.-45G>C	BRCA1|LOC111589215		not specified	Likely benign(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000384121	17	41277313	17	43125296	384121	375137	rs1057521869	NC_000017.11:43125295:C:G
NM_007294.4(BRCA1):c.-49G>A	BRCA1|LOC111589215		not specified	Likely benign(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000388359	17	41277317	17	43125300	388359	376053	rs1057523081	NC_000017.11:43125299:C:T
NM_007294.4(BRCA1):c.-53C>T	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803423	17	41277321	17	43125304	803423	791777	rs1597925819	NC_000017.11:43125303:G:A
NM_007294.4(BRCA1):c.-60C>T	BRCA1|LOC111589215		not specified	Uncertain significance(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV001337515	17	41277328	17	43125311	1337515	1328524		NC_000017.11:43125310:G:A
NM_007294.4(BRCA1):c.-61C>T	LOC111589215|BRCA1		not specified	Uncertain significance(Last reviewed: Jul 28, 2016)	criteria provided, single submitter	VCV000434522	17	41277329	17	43125312	434522	429969	rs549332987	NC_000017.11:43125311:G:A
NM_007294.4(BRCA1):c.-62G>A	BRCA1|LOC111589215		not specified	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000434523	17	41277330	17	43125313	434523	429970	rs776540382	NC_000017.11:43125312:C:T
NM_007294.4(BRCA1):c.-75C>G	LOC111589215|BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000888822	17	41277343	17	43125326	888822	877644	rs529629382	NC_000017.11:43125325:G:C
NM_007294.4(BRCA1):c.-79G>T	BRCA1|LOC111589215		Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 20, 2021)	criteria provided, single submitter	VCV001692977	17	41277347	17	43125330	1692977	1685417		NC_000017.11:43125329:C:A
NM_007294.4(BRCA1):c.-86C>T	BRCA1|LOC111589215		not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2023)	criteria provided, conflicting interpretations	VCV000323423	17	41277354	17	43125337	323423	338575	rs143160357	NC_000017.11:43125336:G:A
NM_007294.4(BRCA1):c.-99G>C	BRCA1|LOC111589215		not provided	Likely benign(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV001194833	17	41277367	17	43125350	1194833	1185264		NC_000017.11:43125349:C:G
NM_007294.4(BRCA1):c.-106C>T	BRCA1|LOC111589215		Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 7, 2021)	criteria provided, single submitter	VCV001171499	17	41277374	17	43125357	1171499	1161374		NC_000017.11:43125356:G:A
NM_007294.4(BRCA1):c.-106C>G	BRCA1|LOC111589215		not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2020)	criteria provided, conflicting interpretations	VCV000920681	17	41277374	17	43125357	920681	913987	rs527449526	NC_000017.11:43125356:G:C
NM_007294.4(BRCA1):c.-107A>T	BRCA1|LOC111589215		Familial cancer of breast	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001685584	17	41277375	17	43125358	1685584	1677600		NC_000017.11:43125357:T:A
NM_007294.4(BRCA1):c.-109A>T	BRCA1|LOC111589215		Hereditary breast ovarian cancer syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000323424	17	41277377	17	43125360	323424	328624	rs886052977	NC_000017.11:43125359:T:A
